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Abstract 
In this thesis, the performance of a miniaturised field asymmetric waveform ion mobility 
spectrometry (FAIMS) device hyphenated with time-of-flight mass spectrometry is studied 
and evaluated for analysis of a variety of compounds in different sample matrices. FAIMS is 
a selective spectrometer which is highly orthogonal to mass spectrometry and has the 
potential for enhancing sensitivity and improve selectivity of rapid analyses. 
In Chapter 2, the performance of the miniaturised FAIMS device is tested for stability and 
transmission under a wide range of ion source conditions. An investigation of three different 
systems, including pairs of isobaric, isomeric and near-mass ions shows that miniaturised 
FAIMS has the ability to distinguish between analytes that are challenging to separate by 
mass spectrometry. Chapter 3 explores the effect of changing the composition of the carrier 
gas by observing the effect of adding gas modifiers on the FAIMS spectra of small 
molecules, peptides and proteins. Chapter 4 investigates the advantages of combining a fast 
FAIMS separation with mass spectrometry in the analysis of nitrogen-containing 
pharmaceutical impurities, where FAIMS is found to offer additional selectivity. In Chapter 
5, the development of a UHPLC-FAIMS-MS method for the quantitative determination of a 
drug metabolite in urine is reported. UHPLC-FAIMS-MS shows improvements in signal-to-
noise and linear dynamic range as well as a reduction in chemical noise, demonstrating the 
potential of combining FAIMS with mass spectrometry. 
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Chapter One 
Introduction 
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1. An Introduction to Ion Mobility and Differential Mobility Spectrometry 
High-field asymmetric wave ion mobility spectrometry (FAIMS), also known as differential 
mobility spectrometry (DMS), originated from Russia in the early 1980s and details of the 
technique were first published in English by I. A. Buryakov in 1993.
1
 Since then, FAIMS 
devices are used for a wide variety of applications across different industries worldwide; the 
development of different designs and interfaces with a number of ionisation and detection 
methods have made it a versatile technique for chemical detection.
2
  
Ion mobility defines the velocity of an ion in the presence of an electric field and a buffer gas, 
a phenomenon that can be used for chemical analysis on a time-scale many times faster than 
many other analytical techniques. FAIMS distinguishes ions in the gas phase based on 
differences in ion mobility in the presence of low and high electric fields. The low and high 
electric fields are alternated in an asymmetric waveform, known as dispersion field (DF), 
which separates ions as they travel between two electrodes at atmospheric pressure. FAIMS 
technology differs from conventional drift tube ion mobility spectrometry (IMS) by 
controlling the stream of ions that traverse the device depending on differential mobility, 
rather than separation based on ion drift time, determined by size, shape and charge at low 
electric fields. In FAIMS, interfering ions are neutralised and removed while the analyte ion 
is selectively transmitted based on its differential mobility.  
The separation parameter of FAIMS is compensation field (CF); which can be scanned to 
produce a CF spectrum of all ions entering the device or fixed at a single CF for the selective 
transmission of ions of a particular differential mobility.
3
 The mechanism for FAIMS 
separation is distinct from mass spectrometry (MS) and high performance liquid 
chromatography (HPLC), making it ideal for hyphenation with these techniques,
4
 offering a 
rapid separation step which can potentially remove the need for time consuming sample 
preparation and chromatography steps of analyses.
5,6
 Improvements in signal to noise ratio by 
removing chemical interferences can enhance quantitative performance and increase linear 
dynamic ranges.
7
 FAIMS has been used to separate isobaric ions
8
, isomers
9
 and conformers.
10
  
In this chapter, the theories that describe the behaviour of ions in FAIMS devices and how 
these can be utilised for improving separations will be described. The focus of the 
introduction will be to highlight each technique that is used in this thesis, from sample 
introduction to detection. The advantages offered by combining FAIMS with other analytical 
systems will be discussed. 
10 
 
1.1 Principles of Ion Mobility Spectrometry 
An ion subjected to an electric field in a drift gas will travel along the electric field with a 
velocity (V) defined by: 
V = KE        (Equation 1.1) 
Where E is the electric field strength and ion mobility constant (K) is a constant unique to an 
ion.
11
 The time taken for an ion to traverse an ion mobility drift cell in the presence of an 
electric field and a drift gas is therefore dependent on K. Separation in a drift cell is related to 
mass, charge and collisional cross section of the ion as shown in Equation 1.2.
12
 Ion mobility 
spectrometry (IMS) is able to resolve ions by drift time in the gas phase with a low electric 
field applied. The mobility of an ion is defined:  
K = (
3q
16N
) (
2π
k 𝑇𝑒𝑓𝑓
)
1
2
(
m+M
mM
)
1
2 
(
1
Ω
)     (Equation 1.2) 
And depends on charge (q), number density of the gas (N), effective temperature of the ion 
(Teff), the mass of the buffer gas (m), the mass of the ion (M), and the collisional cross section 
of the ion (Ω, also CCS).13,14 However, the mobility of an ion is independent of electric field 
strength only at low electric field conditions. 
1.2 Field Asymmetric Waveform Ion Mobility Spectrometry 
The first mention of FAIMS in English literature was in 1993 by Buryakov
1
 and given the 
name Field Ion Spectrometry (FIS). The technology was investigated for its applicability to 
explosive detection in North America by Mine Safety Appliances (MSA).
15
 At this stage, the 
design featured two planar electrodes. MSA collaborated with MDS Sciex and the National 
Research Council of Canada to investigate the use of cylindrical electrodes.
2
 Ionalytics 
Corporation was the first company to produce a commercialised FAIMS system which was 
subsequently taken over by Thermo Fisher Scientific. While development of cylindrical 
FAIMS continued, Nazarov with the research group at the Charles Stark Draper Laboratory 
Inc. and researchers of the New Mexico State University collaborated to develop a micro-
machined planar FAIMS device, commonly referred to as Differential Mobility Spectrometry 
(DMS) in literature.
15
 The planar FAIMS device was commercialised by the Sionex 
Corporation and consequently incorporated into the ABSciex SelexIon Spectrometer. More 
recently, a number of electrode designs with cylindrical and planar configurations have been 
11 
 
explored. The most recent being the ultraFAIMS device, or chip-based FAIMS, (Owlstone 
Ltd.) utilising multiple planar channels with small electrode gaps, achieving higher electric 
field strength.
3,16
 
1.2.1 Ion Mobility Behaviour at Low and High Electric Field Strengths 
If E exceeds around 1-10 Td (1 Td = 10
-17 
V cm
2
), ion mobility (K) becomes dependent on 
electric field strength (E) and equation 1.1 no longer holds true.11 The threshold of non-
linearity (E0) can be calculated by dividing the dispersion field (DF) applied to the plate (U0) 
by the distance between the plates (d); that is E0 = U0/d. So where, E > E0 then k(E) ≠ k0. 
FAIMS uses an asymmetric waveform such that:
17
 
Eh th + El tl = 0       (Equation 1.3) 
where t is the time that the electric field (E) is applied and the subscripts h and l relate to high 
and low electric field conditions respectively. The geometry of FAIMS electrodes varies 
between devices (Section 1.2.3), despite this they all utilise a gas flow that carries ions 
through the device and an asymmetric waveform of high and low electric field strengths is 
applied across the gap.
18
 Typically, Eh will be double in magnitude with an opposite polarity 
and applied for half the time compared to El (2:1 ratio), but other asymmetric waveforms 
have been studied.
19,20,21
 After each asymmetric waveform, a difference between low and 
high field components in mobility will cause an ion to have a displaced trajectory through the 
electrodes resulting in a neutralising collision with an electrode before the ion can traverse 
the device; this displacement is corrected by a compensation field (CF) applied to one of the 
electrodes. The CF can be scanned as an extra dimension of separation or to determine the 
optimum transmission conditions for the ion of a particular differential mobility which can 
then be fixed to selectively transmit the ion.
15
 Figure 1.1 demonstrates the three different 
ways ion mobility can behave with increasing electric field strength: increasing (type A ions); 
increasing to a maximum before decreasing (type B ions); or decreasing (type C ions).  
12 
 
 
Figure 1.1 The dependence of ion mobility on electric field strength is shown by A, B and C
22
 
[Reprinted (adapted) with permission from Guevremont, R.; Purves, R. W. J. Am. Soc. Mass 
Spectrom. 1999, 10, 492–501. Copyright 1999 American Society for Mass Spectrometry] 
The change in behaviour of tryptic peptides ions in a drift tube ion mobility spectrometer 
using high electric fields shows the upper limit of low electric field limit plotted against mass 
(Figure 1.2). The upper limit increases with mass and starts to plateau above 1000 amu 
showing that the low-field limit is mass dependent.
23
  
 
Figure 1.2 Low-field limit against mass for tryptic peptide ions showing the working range of 
FAIMS and high-field drift tube IMS
23 
[J. Am.Soc. Mass Spectrom., 15, 2005, 158, The 
influence and utility of varying field strength for the separation of tryptic peptides by ion 
13 
 
mobility-mass spectrometry, B.T. Ruotolo, Figure 6, Copyright 2004 American Society for 
Mass Spectrometry reproduced with kind permission from Springer Science and Business 
Media] 
The dependence of K on electric field strength at higher field strengths is defined by: 
K(E) =  K0 [1 + 𝛼 (
E
N
)]      (Equation 1.4) 
where K0 is the mobility at zero electric field; and α(E/N) is defined by an even power series 
α2(E/N)
2
 + α4(E/N)
4
 + …αn(E/N)
n
 where expressions beyond n = 4 are normally 
negligible.
24,25
 Electric field strength is defined by (E/N) where E is the voltage applied and N 
is the neutral gas density (atoms/cm
3
). The α function is used as a method for determining 
K(E/N) (mobility as a function of electric field strength and gas number density) giving 
information about an ion’s behaviour in FAIMS and enabling comparisons between different 
systems.
2
  
The α functions for a homologous series of ketones plotted against electric field strength are 
shown in Figure 1.3.
26
 Plotting the α function for a group of ions can be used to probe their 
behaviour under high field conditions. The difference in the differential mobility behaviour 
between singly protonated monomers and dimers is distinct. Where the monomers have a 
positive α value which increases with electric field strength, most of the dimers have a 
negative α value that decreases with electric field strength.  The larger monomers and smaller 
dimers are similar, suggesting that when functionality is the same, size can influence α values 
and the peak position. Theoretically and experimentally derived CF values were found to be 
in agreement.
26
 The correlation between α function and ion mass demonstrates the potential 
for predicting the mobility behaviour of ions with similar functionality. Further elucidation of 
the relationship between CF and m/z showed trends but also states that the deviations of CF 
values from a single trend that were observed make FAIMS a more valuable analytical 
technique.
27
 A method for determining the alpha parameter was determined by using a 
spectrometer of ion mobility increments (SIMI)
17
 and a more comprehensive attempt to 
explain the theory of FAIMS without the alpha coefficient was made by Spangler et al.
28
 The 
purpose of the latter work was to estimate where an ion would appear in the compensation 
field spectrum. The resulting equation (not shown) worked best for small ions in a light gas 
and gave an accuracy of 50%. Currently, the best approach for testing the potential for a 
FAIMS separation of a new analyte is still by running a scanning CV experiment at multiple 
14 
 
dispersion fields. Research continues in this area, with the aim to use computer modelling to 
calculate optimum conditions for separations. Another method for modelling the behaviour of 
ions in FAIMS analysers is called the Monte Carlo simulation.
29,30
  
Dispersion field (DF) and compensation field (CF) are measured in Townsend (1 Td = 10
-17
 
V cm
2
) which is calculated from E/N; this is more accurate for measuring electric field 
strengths than the voltage over the gap (V/cm) because changes in pressure/flow and 
temperature are taken into account which aids in instrumental stability and repeatability. The 
use of Townsend is simpler for comparing between different systems and changes in carrier 
gas properties where different gap sizes, temperatures, gas flows and pressures influence the 
electric field strength.
31
 
15 
 
 
Figure 1.3 α(E/N) plot for protonated monomer (top) and proton bound dimer (bottom) 
ketones. Each data series is labelled with a number which indicates the number of carbons in 
the ketones.
26
 [Reprinted with permission from Krylov, E.; Nazarov, E. G.; Miller, R. A.; 
Tadjikov, B.; Eiceman, G. A. J. Phys. Chem. A. 2002, 106, 5437–44. Copyright 2002 
American Chemical Society] 
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1.2.2 Mechanisms of Differential Mobility Separation 
The mechanisms that best describe the behaviour of ions in alternating low and high electric 
field strengths will be discussed in this section. 
Clustering/Declustering 
Under low electric field conditions, an ion is clustered with small neutral molecules, such as 
water, via non-covalent interactions. The increase in velocity resulting from a higher electric 
field increases the number of collisions with the carrier gas resulting in the ion experiencing a 
higher temperature than the carrier gas molecules, a phenomenon called ‘field heating’ which 
causes the clustered ion to decluster (Figure 1.4.a). The removal of neutral molecules results 
in a smaller CCS and increases the ion velocity, hence mobility in high field conditions is 
higher than in low electric field conditions (type A ions).
32
 The magnitude of the difference 
between low and high field mobility is inversely related to the size of ions with the same 
charge because a smaller ion will experience a larger relative change in CCS.
33
 It is possible 
to add different neutral molecules to the carrier gas to change the composition of clustering. 
Clustering with larger molecules, such as 2-butanol, can potentially increase the size of the 
clustered ion and subsequently increase the difference between the size of clustered and 
declustered ions (Figure 1.4.b). The advantage of utilising the clustering/declustering 
mechanism by modifying the carrier gas with different solvent molecules will be discussed in 
section 1.2.5. 
17 
 
 
Figure1.4. Schematic of clustering/declustering mechanism of a positive ion with (a) water 
molecules, and (b) butanol molecules 
The effect of moisture on the differential mobility of organophosphorus compounds has been 
studied in detail, supporting the clustering/declustering mechanism.
34
 Moisture levels 
between 0.1 and 15000 ppm were explored and a threshold of at least 50 ppm was required 
before a trend of increasing α for ions occurred with increasing water concentration was 
observed. The authors suggested that at low hydration levels, the kinetics for an ion to form a 
cluster with water molecules are too slow to occur in the low-field portion of the asymmetric 
waveform. In another study, four different gas modifiers at increasing concentrations 
influenced the differential mobility of 2,6-dinitrotoluene. The gas modifiers compete with 
molecules that would ordinarily cluster with the ion, potentially producing a much larger 
CCS and requiring a higher compensation voltage for it to be successfully transmitted. 
Different modifiers in the carrier gas changed the order of the ions in the FAIMS spectrum 
showing that a degree of selectivity results from the non-covalent interactions between 
analyte ions and gas modifier molecules and that neutral molecules in the carrier gas have an 
active role in the clustering/declustering mechanism.
25
 It has been proposed that polar gas 
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modifier molecules compete with the gas molecules in the buffer gas via intermolecular 
forces (like H-bonding and Van der Waals forces) to increase an ion’s CCS in low field 
conditions. Gas modifiers can be used to exploit this mechanism and potentially improve 
separation.
35
 The effect of gas modifiers on separation will be discussed in greater detail in 
Section 1.2.5. 
Conformation Switching 
Field heating can cause conformational changes to ions in a FAIMS device. For example, 
peptide and protein ions can adopt a less folded conformation during the high-field portion of 
the asymmetric waveform, resulting in the peptide/protein switching between open and 
closed conformations with the cycles of low and high electric fields. Open conformations 
have greater CCSs than closed conformations resulting in a reduction in ion mobility at high 
fields (type C ions). FAIMS was combined with IMS-MS to investigate conformation 
switching of ubiquitin ions and corresponding CCS for each resolved conformer and charge 
state were determined using IMS-MS. FAIMS caused ubiquitin to unfold to the extent that is 
equivalent to 50°C heating above room temperature, although calculations predicted field 
heating would contribute 10°C. Shvartsburg recommended cooling by 75°C to remove these 
effects for more accurate structural characterisation.
10,36
 
Dipole Alignment 
Dipole alignment occurs when a high electric field imposes orientation on ions with a 
permanent electric dipole of at least 400 Debye. An average CCS will typically define ion 
mobility because free rotation permits a number of different orientations, each with their own 
CCS to give an average CCS. An imposed orientation means that the directional CCS will 
define mobility instead of the average CCS. An ion will have an average CCS and directional 
CCS in low and high electric field conditions respectively as it travels between the electrodes, 
creating a difference between low and high field conditions. Type B behaviour (Figure 1.1) 
can result, where cluster/declustering is the primary mechanism resulting in the initial 
increase in mobility in the high field but when the high field becomes sufficiently strong 
enough to impose orientation giving a directional CCS and a decrease in high field 
mobility.
37
 Recently developed FAIMS microchips feature smaller gaps than other devices, 
making higher field strengths achievable (up to 60 kV/cm); it was used to explore the 
influence of higher field conditions on bovine ubiquitin and bovine serum albumin (BSA), 
small and large proteins.
38
 For a protein to exhibit a dipole moment large enough for dipole 
19 
 
alignment to occur the mass needs to be ~ 20-25 kDa, dipole moment increases with protein 
mass. BSA is large enough, ~66 kDa, for dipole alignment to occur. The results shown in 
Figure 1.5 support this theory, where BSA can be distinguished from the smaller protein 
ubiquitin because BSA exhibits type A behaviour opposed to type C as seen with smaller 
proteins and peptides. Dipole alignment makes it possible to resolve peptides and proteins 
from larger proteins (like BSA) potentially allowing larger proteins to be filtered from 
complex biological environments. 
 
Figure 1.5 CF spectra at 60 kV/cm of ubiquitin (left) and BSA (right, black line), showing the 
sum of all the charge states (top), and the individual charge states using a heat map (bottom); 
ubiquitin (red trace) is included on the BSA spectrum for comparison between the two 
proteins
38
 [Reprinted (adapted) with permission from Shvartsburg, A. A.; Smith, R. D. Anal. 
Chem. 2012, 84, 7297–300. Copyright 2012 American Chemical Society] 
1.2.3 Instrumentation for Field Asymmetric Waveform Ion Mobility Spectrometry 
Two fundamental electrode designs exist for FAIMS: planar (Figure 1.6) and cylindrical 
(Figure 1.7). In the literature, cylindrical is commonly (but not always) referred to as FAIMS 
and planar as DMS.
15
 There are a number of devices that fall under the category of 
cylindrical and planar electrode designs but their performance characteristics generally 
correlate to either cylindrical or planar geometries. 
20 
 
 
Figure 1.6 A diagram of a planar geometry FAIMS, showing the dispersion and 
compensation voltages applied to one electrode (although they can also be applied to 
different electrode plates)
18
 
 
Figure 1.7 Cylindrical FAIMS electrode design (cube/dome) with ESI-MS interface
39
 
[Reprinted with permission from Kapron, J. T.; Jemal, M.; Duncan, G.; Kolakowski, B.; 
21 
 
Purves, R. Rapid Commun. Mass Spectrom. 2005, 19, 1979–1983. Copyright 2005, John 
Wiley & Sons, Ltd.] 
The planar devices can simultaneously analyse positive and negative ions due to the uniform 
distance between the electrodes.
18
 The cylindrical electrode FAIMS design can result in an 
ion focussing effect giving an improvement in transmission, however analysing in an 
opposite polarity can cause either ion focussing or ion defocussing effect.
15,40
  Running 
experiments in FAIMS off mode can be challenging with cylindrical devices due to a 93% 
loss in signal compared to 20-30% loss observed with a planar device with the same gap 
diameter. The ability to run in FAIMS off mode with a FAIMS device in place with 
acceptable signal loss saves the need to remove the FAIMS device from a mass spectrometer 
whenever a FAIMS separation is not required, making it simpler to use. When ion focussing 
conditions are met with cylindrical FAIMS devices, transmission is increased which exceeds 
transmission of a planar device.
41
 Ion focussing in cylindrical devices reduces the coulombic 
ion-ion repulsion, enabling longer residences times for improved resolution. In a planar 
device, longer residence times would increase ion loss due to diffusion effects.
18
 Reversing 
polarities dramatically changes the CV spectrum of an ion because the ion focussing effect 
reverses, defocussing ions with increasing electric field strength (Figure 1.8). Ion focussing 
conditions cannot be met for all ions. No focussing occurs with planar devices where the 
velocity increases with dispersion field resulting in more neutralising collisions with the 
electrodes and reducing transmission.
2
 In the past, ion focussing made cylindrical FAIMS 
designs the favourable for interfacing with MS due to a focussed ion beam exiting the 
FAIMS device. 
22 
 
 
Figure 1.8. Simulated ion focussing/defocussing in a cylindrical FAIMS device showing: (a) 
weak, (b)  moderate, (c) strong  focussing conditions; and (d) defocussing  conditions
18
 
[Reprinted (adapted) with permission from Schneider, B. B.; Covey, T. R.; Coy, S. L.; 
Krylov, E. V; Nazarov, E. G. Int. J. Mass Spectrom. 2010, 291, 108–117. Copyright 2010 
Elsevier B.V.] 
  
23 
 
The cylindrical devices described in the literature include cylinder, dome and cube designs; 
cylinder design being the earliest cylindrical device which features two cylinders, an inner 
and outer cylinder electrode with ~2 mm gap for ion separation.
39,43
 Development of the 
dome device, featuring two concentric cylinders and a semi-spherical end, has been hindered 
by only tolerating < 5 µl/min liquid flow rates. The cube electrode design (sometimes 
referred to as dome) was able to cope with higher flow rates when combined with a heated 
electrospray ionisation source which was marketed by Thermo Fisher FAIMS interface 
(Figure 1.7). A drawback of this device was that the source heated the FAIMS electrodes 
resulting in unstable CV values and requiring warm up periods of up to 2 hours.
15,42
 The 
dome design was used for an increase in sensitivity for the analysis of an unnamed amine 
drug in the presence of its metabolites.
39
 Good precision was observed for replicates and the 
FAIMS device found to be compatible with current sample preparation and sampling 
procedures.  
Ion residence time in a planar device is ~1 ms, compared to ~300 ms in a typical cylindrical 
device. Miniaturised FAIMS features 35-100μm gaps and 300-700μm path lengths, enabling 
residence times between 50 and 250μs. The time an ion resides in a FAIMS device will affect 
the resolution, sensitivity and potential CF scanning speed. A longer residence time can 
improve resolution but compromises CF scanning speed and may increase signal loss.
15
 
Cycling between two CF values cannot be carried out faster than 1 cycle of ions per second, 
limiting the speed at which CV can be ramped or hopped. A short residence time is required 
for fast scanning times enabling full CF scan data within the elution time of a 
chromatographic peak and for rapid method optimisation. Longer residence time has the 
potential for improving separation for FAIMS-MS experiments, but the timescale is not 
compatible with chromatography.
2
 Switching between static CF/DF settings (hopping) is 
required to make cylindrical FAIMS compatible with LC-MS instruments.
44
 The ion 
selectivity of cylindrical and planar devices with similar ion residence times were compared, 
the planar devices were found to have 3-5 times better separation.
45
 
A planar FAIMS device interfaced to MS and subjected to conditions of high sample 
contamination was found to be suitable for high throughput and high quantitative accuracy 
environments.
18
 Planar FAIMS devices are easier to manufacture, making them cheaper and 
more reproducible.
15
 Such devices have been used with nanoESI-FAIMS-MS for the 
quantitative analysis of a semi-complex peptide mixture, spiked with 2 µg/ml angiotensin.
35
 
In the past, interfacing planar FAIMS devices with MS was found to be challenging due to 
24 
 
the ion beam being unrestrained from expanding in the gap leading to large losses. 
Introduction of a slit-shaped entrance and exit aided transmission giving an order of 
magnitude increase in signal intensity.
46
  Planar FAIMS devices were found to tolerate higher 
liquid flow rates (< 50 µL/minute) making them better suited to HPLC and MS systems, 
although introduction of the heated electrospray source (HESI) made the Thermo ‘cube’ 
FAIMS more compatible with higher flows.
15
 
Miniaturised, chip-based FAIMS 
The research described in this thesis was carried out using a new miniaturised, chip-based 
planar FAIMS design (Figure 1.9). The FAIMS chip consists of 47 parallel electrodes with 35 
µm gaps, or ~20 electrodes with 100 μm gaps. The small gap generates far higher dispersion 
fields than any other FAIMS devices without causing electric breakdown of the carrier gas, 
up to 60 kV/cm (320 Td). Ion residence time is 50-250 μs, 1% of the shortest residence times 
in other FAIMS devices, enabling faster CF scans and decreasing the time for ion loss from 
diffusion to occur. The waveform frequency is 22 – 27 MHz compared to ~3 MHz in other 
devices, making the number of asymmetric waveforms experienced by ions comparable to 
other FAIMS devices despite the shorter ion residence times. The parallel arrangement of the 
gaps (Figure 1.9) relaxes the coulombic repulsion by spreading the charge between the 
channels for improved transmission, where transmitting the same number of ions through a 
single gap would result in much higher loss of ions. Low residence times cause broader peaks 
when compared with other planar devices but enables fast CF scanning times for full CF 
scans within LC peak timescales.
16
 Other planar and cylindrical FAIMS devices have ion 
residence times of 100 ms (Thermo Fisher) and 20 ms (ABSciex SelexIon),
47
 although 
modified devices may have different residence times. The Owlstone ultraFAIMS stand-alone 
system was first used for homeland security
48
 and has now been interfaced to LTQ ion trap 
MS (Thermo Fisher) and 6230 ToF MS (Agilent Technologies) spectrometers.
3,49
 
Miniaturised FAIMS is discussed in detail in other publications.
16,50
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Figure1.9: Ultra-FAIMS microchip: (a) diagram showing arrangement of microchannels and 
(b) showing asymmetric waveform
16
 [Reprinted (adapted) with permission from Shvartsburg, 
A. A.; Smith, R. D.; Wilks, A.; Koehl, A.; Ruiz-Alonso, D.; Boyle, B. Anal. Chem. 2009, 81, 
6489–95. Copyright 2009 American Chemical Society] 
Each design of FAIMS has its own advantages and disadvantages which need to be 
considered when deciding the most suitable device for a particular application. The research 
discussed in this thesis investigates the performance of the prototype Owlstone ultraFAIMS 
interfaces with TOF MS and explores the enhancements it can offer to liquid chromatography 
and mass spectrometry for small molecule analysis. 
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1.2.4 Effect of Instrumental Parameters on FAIMS Performance 
The development of a FAIMS analysis includes a CF/DF stepping experiment to determine 
optimum DF for separation. Once determined, the CF will be either scanned, fixed or cycled 
between several fixed CF values depending on the sensitivity and selectivity the analysis 
requires. There are also a number of other parameters that can be changed to improve 
analytical performance. These include: carrier gas composition/flow, electrode gap size, ion 
residence time, type of asymmetric waveform and temperature. The importance of each of 
these factors on changing separation, sensitivity and selectivity will be discussed in this 
section. 
Electrode Gap Size, Carrier Gas Flow and Ion Residence Time 
A smaller electrode gap size increases the maximum dispersion field achievable without 
causing electrical breakdown of the carrier gas.
16
 A larger gap size can increase ion residence 
time if the carrier gas flow is not adjusted accordingly, which will improve resolution at the 
cost of transmission. Gas flow and gap size are independent, but when one is changed both 
should be considered.
51
 Changing ion residence time by altering gas flow/gap size affects 
selectivity and sensitivity because decreasing ion residence time increases transmission, but 
compromises peak resolution, and increasing ion residence time will improve resolution at 
the expense of transmission. Ion residence time is more critical for smaller electrode gap 
sizes, where signal loss is greater when compared to a larger gap size (Figure 1.10).  
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Figure 1.10 Ion transmission coefficient for positive reactant ions (H2O)nH
+
 against residence 
time for different gap sizes (DF 45 Td)
51
 [Reprinted (adapter) with permission from Krylov, 
E. Int. J. Ion Mobil. Spectrom. 2012, 15, 85–90. Copyright 2012 Springer-Verlag] 
Optimising sensitivity and selectivity often require a compromise of one against the other. 
Kyrlov’s work in 2012 on optimising analytical characteristics of planar FAIMS discussed 
analytical quality, where a balance between sensitivity and selectivity for a particular 
application can be determined by relating ion transmission and peak width. Ion transmission 
coefficient (G) is defined by: 
𝐺 = exp(−
𝑡𝑟𝑒𝑠𝐷𝜋
2
𝑔2
)        Equation 1.5 
where residence time (tres) and diffusion (D) reduce transmission and effective gap size (g) 
improves transmission; peak width (W) is related by: 
𝑊 =
𝑔
𝐾𝑡𝑟𝑒𝑠
         Equation 1.6 
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where the effective gap width (g) and residence time (tres) are inversely related. G and W 
define analytical quality (A): 
𝐴 =  
𝐺
𝑊
          Equation 1.7 
Analytical quality can be plotted against residence time (Figure 1.11.a) which clearly shows 
that optimum residence time will change depending on the electrode gap size. Figure 1.11.b 
shows the results at the same gap size (0.75 mm) but with different mobilities, showing that 
diffusion (related to mobility) can also influence analytical quality which suggests that even 
if ion residence time is optimised for a set of compounds, it may not necessarily be the 
optimum condition for a different set of compounds.  
A recent publication by Barnett and Ouellette addresses the issue of cost for high flow rates 
of helium in gas mixtures for peptide analysis and an approach for removing the need for gas 
mixtures by decreasing the gap (2.5 mm to 1.25 mm) between the electrodes of a cylindrical 
design. The modified design was found to have a significantly improved performance (in 
pure N2) than commercial FAIMS designs using an equal gas mixture of N2/He with 2.5 mm 
gap.
52
 This example demonstrates the importance of gap size on FAIMS devices. 
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Figure 1.11 Analytical quality has been plotted against residence time with: (a) different gap 
sizes (K = 2 cm
2
/Vs), and (b) different ion mobilities (gap = 0.75 mm)
51
 [Reprinted (adapter) 
with permission from Krylov, E. Int. J. Ion Mobil. Spectrom. 2012, 15, 85–90. Copyright 
2012 Springer-Verlag] 
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Temperature and Pressure effects 
Changes in temperature and pressure can influence where peaks appear in the compensation 
field spectrum.
31
 Figure 1.12 shows FAIMS spectra of methyl salicylate under different 
pressures and temperatures. The dispersion field and a compensation field axis (in Td) are 
adjusted to temperature and pressure. The influence of different pressures results in small 
changes in the position of the positive methyl salicylate ions on the CF axis (Figure 1.12.a), 
although there are large changes in peak height. Temperature has a much larger effect, 
causing a positive shift of peak location in the CF axis (Figure 1.12.b). The influence of 
temperature on the differential mobility of amine ions was the subject of an in-depth study 
published in 1989.
53
 The mobilities of a series of aliphatic and aromatic amines were 
explored in helium, air, CO2 and SF6 over a temperature range 87 to 250 ˚C. Temperature has 
the potential to change differential mobility of ions and may be useful for improving 
selectivity, but caution should be taken when changing temperatures of the ionisation source 
which may result in a different FAIMS spectra and a loss of separation.  
The Asymmetric Waveform 
The asymmetric waveform was not changed in the results described in this thesis, but it is 
important to briefly discuss its effect. Evaluations of the effects of different asymmetric 
waveforms to improve analytical performance have been reported.
19,20,21,54
 Despite the 
advantages of selecting the best asymmetric waveform for better performance, changing the 
waveform can be complex and challenging and is rarely included in routine FAIMS 
optimisation. Optimising waveforms is generally left to manufacturers rather than the 
individual analyst, but certainly should not be neglected entirely in method development. 
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Figure 1:12 Positive FAIMS spectra of methyl salicylate ions with a dispersion field of 100 
Td with (a) different gas pressure, and (b) different temperatures
31
 [Reprinted (adapted) with 
permission from Krylov, E.; Coy, S.; Nazarov, E. Int. J. Mass Spectrom. 2009, 279, 119–125. 
Copyright 2008 Elsevier B.V.] 
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1.2.5 The Importance of Carrier Gas 
Gas Mixtures 
Typically, nitrogen or air are used as the carrier gas for FAIMS analysers. This section will 
discuss the effect that changing the carrier gas composition of the carrier gas has on 
separation, selectivity, sensitivity and transmission. 
Different gases will interact with ions in different ways depending on the size and 
polarisability of gas molecules with the potential to change FAIMS separation and sensitivity. 
Nitrogen has been commonly mixed with helium and/or carbon dioxide, although other gases, 
such as hydrogen, have also been studied.
55
 An increase in the size and polarisability of the 
neutral carrier gas decreases mobility of an ion due to increased collisions which can improve 
separations and, in some cases, peak resolution and transmission. Another way to influence 
differential mobility is to impose a change in the clustering mechanism. Gas modifiers are 
solvent molecules in the vapour phase that change the non-covalent interaction of analyte 
ions with neutral molecules in the carrier gas, changing the collisional cross section of the 
clustered ion and making a bigger difference between mobility in the low field and high 
field.
32
 
Polarisability and reduced mass are important factors affecting ion mobility. Polarisability is 
the interaction potential between a gas molecule and an ion, reduced mass depends on the ion 
mass and gas molecule mass given in Equation 1.2. The mobilities and CCS of aliphatic and 
aromatic amines were determined with six different gases,
56
 with increasing polarisability 
(Ǻ3) as follows: helium (0.205), argon (1.64), air (1.73), nitrogen (1.76), carbon dioxide 
(2.59) and sulfur hexafluoride (4.48). The addition of helium to a nitrogen carrier gas is 
common place for users of cylindrical FAIMS devices and often benefits separation.
57
 
Helium has a lower polarisability than nitrogen which increases the mobility of ions whereas 
carbon dioxide has a higher polarisability than nitrogen which decreases mobility.
56
 Helium 
can result in broader peaks, but improve sensitivity, carbon dioxide may cause a loss in 
signal, but can reduce peaks widths. Anabolic androgenic steroid metabolite detection in 
urine using LC-FAIMS-MS/MS,
58
 the separation of prostanoids,
59
 peptide sequence 
isomers,
60
 glycopeptides with differing sites of glycosylation61 are just a few of many 
examples where gas mixtures have been used to improve FAIMS performance. High helium 
fractions, often up to 50% of the carrier gas, can make analyses considerably more expensive 
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for routine analysis. The addition of CO2 can worsen separation but combined with He and 
N2 can give optimum performance by compromising between separation and sensitivity.
62
  
The balance between different gases may be optimised for specific applications. Shvartsburg 
et al. recently experimented with hydrogen and helium mixed with nitrogen to improve 
resolving power of a planar FAIMS device, using a 50:50 He/N2 mixture revealed four 
partially resolved conformers of Ubiquitin +12H,
63
 and up to 90% H2 was used to separate 
amino acid sequence isomers.
55
 The addition of H2 to the carrier gas is advantageous 
compared to He because higher fractions of H2 (up to 90%) are possible than with He (up to 
50%) due to the higher electrical breakdown threshold of H2, benefiting separation. Greater 
signal losses were observed for the more mobile ions in the presence of H2, and the authors 
suggested that a larger gap with a higher voltage to maintain the same electric field over the 
gap would recover some of the signal. 
The benefits of gas mixtures and modifiers are still being explored; however, work discussed 
previously in this section shows that despite the improvement gained when using gas 
mixtures, the cost of running methods with high helium consumption make it less suitable for 
routine analyses;
52
 alternative methodologies such as the introduction of gas modifiers to the 
carrier gas that are more financially viable are being explored. 
 
Gas Modifiers 
The effect of gas modifiers was first reported in 1993 when Buryakov et al. observed a 
change in the α coefficient of triethylamine with different humidity levels.1 The moisture 
effect was later studied by Eiceman et al.
34
 where the α coefficient of organophosphorus 
compounds changed with different levels of moisture. In 2004, an extension of this work 
focused on improving separation by the addition of other solvent gas modifiers to the carrier 
gas. Water, acetone, propanol and methylene chloride were studied and methylene chloride 
was found to cause 2,6-dinitrotoluene to have the biggest shift in CV, so it was used for 
increasing ‘analytical space’ for analysing a mixture of explosives (Figure 1.13). A 
comparison of the effect on the α function of explosive ions in pure air and in the presence of 
a methylene chloride demonstrates the potential for greater separation by using gas modifiers 
(Figure 1.14).
25
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Gas modifiers need to be introduced in to the carrier gas of a FAIMS analyser and there are 
two published methods for carrying out this process: a gas bubbler
35
 (Figure 1.15) or liquid 
infusion.
64
 The studies discussed in this section have utilised both of these modifier 
introduction techniques. The first commercial instrument with a built-in gas modifier system, 
the ABSciex SelexION
TM
 Technology
65
, has recently been released. The investment in user-
friendly gas modifier technology on a commercial system shows that gas modifiers are 
becoming established as routine for improving FAIMS separations. 
 
 
Figure 1.13 The change in CV against concentration of gas modifier for the detection of 2,6-
dinitrotoluene (50 ppb) at DV (20 kV/cm)
 25 
[Reprinted (adapted) with permission from 
Eiceman, G. A.; Krylov, E. V; Krylova, N. S.; Nazarov, E. G.; Miller, R. A. Anal. Chem. 
2004, 76, 4937–44. Copyright 2004 American Chemical Society] 
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Figure 1:14 α functions of explosive ions in (a) pure air and (b) methylene chloride (1000 
ppm) in air
25
[Reprinted (adapted) with permission from Eiceman, G. A.; Krylov, E. V; 
Krylova, N. S.; Nazarov, E. G.; Miller, R. A. Anal. Chem. 2004, 76, 4937–44. Copyright 
2004 American Chemical Society]
 
 
Figure 1.15 A diagram showing a gas bubbler used to introduce a gas modifier into a FAIMS-
MS system
35 
[Reprinted (adapted) with permission from Levin, D. S.; Miller, R. A; Nazarov, 
E. G.; Vouros, P. Anal. Chem. 2006, 78, 5443–52. Copyright 2006 American Chemical 
Society] 
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Gas modifiers have been shown to compete with water and other small molecules present in 
the nitrogen or air carrier gas, with hydrogen bonding and Van der Waals forces leading to 
cluster formation. This increases the CCS of the clustered ions under low field conditions and 
making a bigger difference between clustered and declustered/partially declustered ions. 
However, the behaviour of differential mobility in the presence of gas modifiers cannot be 
explained by ion-neutral molecule interactions alone: dimer/trimer formation; competitive 
clustering resulting from hydrogen bonding and electrostatic attraction; steric repulsion and 
conformation changes all make significant contributions.
66
  
Nazarov et al. compared the use of nitrogen, nitrogen with 1.5 % 2-propanol and nitrogen 
with 44% helium for large mixture of compounds: 70 in positive ion mode and 24 in negative 
ion mode.
32
 The effect of the different carrier gas conditions were discussed in terms of 
separation (selectivity) and signal intensity (sensitivity). Figure 1.16 shows the results of 
these experiments. When 2-propanol or helium was added to the carrier gas, only ions that 
maintained greater than 5% of the original signal in nitrogen were included. The addition of 
helium reduced the signal for all ions below a threshold of m/z 195 below this threshold, 
likely due to the increase in velocity and a less polarisable carrier gas having a larger 
influence on smaller ions. Modifiers can also cause loss in signal, however this is not related 
to the size of ions but rather the gas phase chemistry. Gas modifiers with a greater gas phase 
proton affinity than that of an analyte ion will be likely to suppress ions in positive ion mode. 
Signal loss with the addition of modifiers has been reported elsewhere.
64
 The authors also 
observed a stabilising effect, where gas modifiers aided the transmission of ions compared to 
ions that were easily lost due to fragmentation or scattering at DF above 104 Td in insert 
gases. It was suggested that excess energy that would usually result in fragmentation is 
absorbed by the ion-neutral cluster bonds. Overall, the addition of 2-propanol benefited 
separation but in some cases a nitrogen/helium mixture separated compounds which were not 
resolved by 2-propanol. There is certainly a complex relationship between modifier and 
analyte that has to be taken in consideration when developing a FAIMS separation. 
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Figure 1.16 FAIMS spectra (DF 132 Td) of a 70-compounds mixture with different carrier 
gas conditions: (a) nitrogen; (b) nitrogen with 1.5% 2-propanol; and (c) nitrogen with 44% 
helium.
32
 [Reprinted (adapted) with permission from Schneider, B. B.; Covey, T. R.; Coy, S. 
L.; Krylov, E. V; Nazarov, E. G. Anal. Chem. 2010, 82, 1867–80. Copyright 2010 American 
Chemical Society.] 
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The separation of a mixture three phthalic acid isomers has been achieved by adding water 
and methanol (separately) as gas modifiers (Figure 1.17) where little or no resolution was 
observed without modifiers.
67
 Interestingly, going from dried nitrogen to nitrogen with water 
or methanol, the para- and ortho-phthalic acids switch in order, which suggests there is a non-
covalent interaction between phthalic acid and modifier that is specific to the position of the 
acid groups. The addition of methanol (8000 ppm) to a FAIMS device has been used to 
separate oligosaccharides, maltopentaose and maltoheptaose. Lacto-N-fucopentaose I (LNFP 
I) and lacto-N-fucopentaose II (LNFP II) remained unresolved, successful separation by gas 
modifiers may be application dependent or perhaps that the correct modifier for a selective 
interaction is yet to be determined.
68
 
 
Figure 1.17 CV scans of a mixture of three phthalic acid isomers acquired with (a) dry 
nitrogen, (b) water vapour added to dry nitrogen(~7000 ppm), and (c) methanol vapour added 
to dry nitrogen (15,000 ppm)
67
 [Reprinted (adapted) with permission from Rorrer III, L. C.; 
Yost, R. A. Int. J. Mass Spectrom. 2010, 300, 173–181. Copyright 2010 Elsevier B.V.] 
An extension of this work focussed on the effect of different gas modifiers on groups of 
structurally similar componds.
69
 2-propanol is commonly used as a modifier of choice,
70
  
Figure 1.18 shows FAIMS spectra of ketamine and sulfadiazine under a number of different 
modifiers. Interestingly, separation is not achieved using 2-propanol (1.5 %) but the best is 
39 
 
observed with ethylacetate. Acetonitrile and acetone also resolve the two compounds well. In 
contract to 2-propanol, methanol resolves the two ions, suggesting that the presence of the 
alcohol group is not the only factor which determines whether a separation is achievable or 
not, steric hindrance around a functional group can influence clustering.  
It has been suggested that by subtracting the CF value observed with one set of conditions 
from a CF value observed with a different set of conditions can be used to determine 
‘orthogonality’ between the two experimental conditions.70 Comparisons were made with 
three different carrier gas conditions and nitrogen; 2-propanol (1.5 %) was found to be 
considerably more orthogonal than hexane (1.5 %) or helium (44 %) when compared with 
nitrogen (data not shown). Selectivity (estimated by orthogonality) is important when 
developing a method because when one modifier does not give the required performance, the 
best chance of achieving separation will be with a modifier that behaves chemically very 
differently rather than one that behaves similarly. Modifiers that are highly orthogonal will 
interact differently and improve the chances of finding the suitable modifier for a separation. 
The differences in selectivity between 2-propanol, ethylacetate, acetonitrile and acetone are 
shown in Figure 1.19. 2-propanol was found to be highly orthogonal to ethylacetate and 
acetonitrile, suggesting that it would be worth investigating each of these modifiers. Figure 
1.19.c shows that there is little orthogonality between acetonitrile and acetone; if one of these 
did not produce a separation, it might be preferable to try an alternative modifier to either of 
these as there will be little difference in gas phase chemistry. 
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Figure 1.18 FAIMS spectra of sulfadiazine (black) and ketamine (grey) at DF 132 Td with a 
number of modifiers, each at 1.5 % in a nitrogen carrier gas
69
 [Reprinted (adapted) with 
permission from Schneider, B. B.; Nazarov, E. G.; Covey, T. R. Int. J. Ion Mobil. Spectrom. 
2012, 15, 141–150. Copyright 2012 Springer-Verlag] 
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Figure 1.19 Orthogonality plotted against m/z for a mixture of 140 compounds at DF 132 Td 
between 1.5 % of the following modifiers: (a) 2-propanol and ethylacetate; (b) 2-propanol 
and acetonitrile; (c) acetonitrile and acetone
70
 [Reprinted (adapted) with permission from 
Schneider, B. B.; Covey, T. R.; Nazarov, E. G. Int. J. Ion Mobil. Spectrom. 2013, 16, 207–
216. Copyright 2013 Springer-Verlag Berlin Heidelberg] 
Nazarov et al. have advanced our understanding  of the use of modifiers in FAIMS systems 
by comparing modifiers with other carrier gas conditions and drawing comparisons between 
different modifiers. However, the complex nature of gas phase chemistry between different 
analytes and different modifiers make it hard to predict which modifier would be best for a 
given set of compounds (if modifiers are even needed at all).  
Gas mixtures and modifiers may not always provide sufficient separation. A recent 
publication achieved further improvement with an ultrahigh-resolution FAIMS device. A 
standard cylindrical Thermo FAIMS device decreased flow rates of gas mixture from 50 – 
75% He (from 2 L/min to 0.5 L/min) to increase the ion residence time (from 0.2 seconds to 
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0.8 seconds). Resolving power was increased up to 300 for multiply charged peptides. 
Phosphorylated peptides with variations in sites of phosphorylation have been resolved, 
previously unresolved by this system at standard flow rates. Further progression for 
improving resolving power of FAIMS is still of great interest.
71
 
Adduct Formation 
Separation of isobaric ions in the gas phase using ion mobility is desirable because of much 
faster analysis times, although separation cannot always be achieved under conventional 
conditions. For example, it has been shown that it is possible to separate disaccharide 
anomers, linkage isomers and positional isomers by observing disaccharide isomers 
adducts.
72
 In positive mode, metal adducts (Na, Li, K, Rb, Cs) and ammonium were 
investigated; in negative mode, CV positions of chloride and acetate adducts with 
disaccharides (acetate, monochloroacetate, monobromoacetate, bromochloroacetate etc.) 
were determined (Figure 1.20). The salts added for cation/anion adduct formation in 
positive/negative modes improved separation when compared with conventional 
protonated/deprotonated ions.
72
 The authors propose that separation results from dipole 
alignment, where disaccharides align with the high field portion of the asymmetric waveform.  
 
 
Figure 1.20 Separation of anomer disaccharides using trichloroacetate (TCA
-
) to form an 
adduct with analytes in negative ion mode
72
 [Reprinted (adapted) with permission from 
Gabryelski, W. J. Am. Soc. Mass Spectrom. 2003, 14, 265–277. Copyright 2003 American 
Society for Mass Spectrometry] 
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1.3 Introduction to Mass Spectrometry 
Mass spectrometry is a tool that has become well established in many areas of chemical 
analysis, including: pharmaceutical, environmental, forensic, biological, food science and 
many more. The ability to measure the mass-to-charge ratio of ions makes mass spectrometry 
a powerful, informative method of detection. Steps in the work flow of a mass spectrometry 
analysis from sample introduction/separation to detection and data analysis are shown in 
Figure 1.21 and discussed. 
  
Figure 1.21 Schematic of workflow of typical mass spectrometry experiments 
The first mass spectrometer (a parabola spectrograph) was reported in the literature by J.J. 
Thomson in 1912. Mass spectra of N2, O2, CO, CO2 and COCl2 were obtained and in 1913 
isomers of Neon (20 and 22) were discovered.
73, 74
 Mass spectrometers have continued to be 
developed, from early magnetic sector instruments with an electron ionisation source to a 
multitude of mass spectrometry systems for a broad range of applications used today. All 
mass spectrometers contain an inlet for sample introduction (e.g. from an HPLC), an 
ionisation source to produce ions, one or more mass analysers, a detector to count ions and a 
data processing system. The focus of this section is to describe each of the techniques used in 
the research presented in this thesis. 
1.3.1 Sample Introduction 
Samples can be introduced into a mass spectrometer using a variety of techniques. One 
method is to directly infuse a liquid sample into the ionisation source. The simultaneous 
ionisation of an entire sample is fast, but may result in suppression of analytes. In order to 
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avoid this, a separation method prior to ionisation is often used. High performance liquid 
chromatography (HPLC) is a common liquid phase separation technique where molecules are 
separated based on their interaction with the stationary phase of a column as they are carried 
through by a liquid mobile phase flow. Thermal desorption is an alternative method for the 
direct introduction of analytes. Using thermal extraction of an analyte by volatilisation from a 
less volatile matrix, interference and suppression from the matrix can be reduced. These 
techniques are discussed in more detail below. 
1.3.2 High Performance Liquid Chromatography 
The development of atmospheric pressure ionization techniques for mass spectrometry 
allowed the robust combination of high performance liquid chromatography with mass 
spectrometry (LC-MS) and is routinely used to separate complex mixtures.
75
 The 
development of electrospray (ESI) dramatically improved the ionisation of high liquid flow 
rates from HPLC into a mass spectrometer.
76
 Other ionisation sources that tolerate HPLC 
flow rates are thermospray, atmospheric pressure chemical ionisation and atmospheric 
pressure photoionisation. 
Liquid chromatography originally utilised a hydrophilic stationary phase which has a strong 
affinity for hydrophilic molecules. Hydrophobic molecules will have a lower affinity for the 
stationary phase and elute from the column first. Elution of the hydrophilic molecules from 
the column is achieved by increasing the polarity of the mobile phase. This is referred to 
normal phase chromatography. 
Reversed phase chromatography is the opposite of normal phase chromatography, in that a 
hydrophobic stationary phase (e.g. alkyl chains bonded to silica particles) is used to retain 
molecules based on hydrophobicity and the polar mobile phase elutes molecules with a 
higher polarity first. The elution of a compound can be controlled by the percentage of water 
and organic solvent (e.g. methanol, acetonitrile), where organic solvent will make 
hydrophobic molecules elute faster. High performance liquid chromatography (HPLC) is 
used to separate components of a liquid mixture. Samples are injected onto a column and 
carried through by a mobile phase with a flow up to 2 mL/min. A wide selection of stationary 
phases is available and can be selected based on their suitability depending on the analysis. 
Sample components are separated and commonly detected by either a UV diode-array 
detector or a mass spectrometer. The technique used in this thesis was reversed phase HPLC. 
HPLC hyphenated with mass spectrometry (LC-MS) is a powerful combination which 
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separates based on retention time and m/z. Reversed phase can be used for a wide range of 
analytes, it is robust and offers a range of controllable variables, including organic solvent 
concentration and type, pH and temperature. 
1.3.3 Electrospray Ionisation and Extractive Electrospray Ionisation 
All the work reported in this thesis is based on FAIMS interfaced with an electrospray 
ionisation (ESI) source of a mass spectrometer and the principles of ESI are discussed in this 
section. Before the introduction of ESI, ionisation methods like electron ionisation were fit 
for some analyses but not suitable for large, non-volatile and thermally labile molecules and 
unable to cope with high liquid flow rates. ESI was pioneered by Malcolm Dole in 1968, 
when his group reported the production of macroions by ESI.
77
 The most significant 
developments of electrospray were made by John Fenn in the 1980s, for which he later 
received the Nobel Prize for Chemistry in 2002.
76, 78, 79
 Since then, electrospray has become a 
well-established technique for mass spectrometers.
80
 
In ESI, a flow of liquid (from LC or direct infusion) enters a capillary and flows into a 
needle. At the charged needle tip, a jet of droplets (electrospray) is produced. The charged 
needle tip removes ions carrying the opposite polarity to allow ions of the same polarity (as 
charged needle tip) to enrich at the tip of the Taylor cone (Figure 1.23).
81
 Charged droplets 
produced from the Taylor cone decrease in size as solvent molecules evaporate from the 
droplet. The charge density on the surface increases until the droplet reaches its Rayleigh 
limit and becomes unstable, producing a cascade of smaller highly charged droplets.
79
 The 
mechanism of ion formation after the small highly charged droplets have been produced is 
explained by two models (Figure 1.22) the charge residue model (CRM) and ion evaporation 
model (IEM).
80
 In CRM an ion is formed after all solvent molecules have evaporated from 
the droplet containing a single ion. IEM involves the loss of an ion from a droplet, due to 
increasing coulombic repulsion at the surface of the droplet.
82
 It is likely that a combination 
of both mechanisms occur for small molecules. 
Desolvation is assisted by gas flows that are typically heated. A sheath gas/nebuliser gas 
creates and assists the initial spray; a counter flow desolvation gas (‘curtain’ or ‘drying’ gas) 
often situated at the orifice of the MS will hinder neutral solvent molecules from entering the 
MS and aid desolvation. Heating of the entrance to the MS either at the orifice or capillary, 
aids in the evaporation of neutral molecules from the ions. The capillary is positioned before 
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the skimmer lens, there is an electrical potential between the capillary and skimmer lens 
which can collisionally induce dissociation of any remaining clusters.
80
 
An ESI source can produce multiply charged species and form ions of non-covalent 
complexes. ESI is concentration dependent making it suitable for quantitative analyses. The 
development of ESI was a big step for mass spectrometry because it has enabled combination 
of MS with the high liquid flow rate separation techniques, like HPLC; and the soft ionisation 
intact molecules. Competitive ionisation can occur where affinities of molecules for charged 
particles vary, meaning that one set of analytes may be preferably ionised over the other. It is 
possible for components within a sample matrix to have a higher proton affinity causing 
suppression of the analyte ions. In this case, extra steps may be required to remove the matrix 
by sample pre-treatment/chromatographic separation, although ion suppression still needs to 
be considered with LC-MS method development.
83
 Regardless of this, the combination of 
HPLC and MS (LC-MS) is a well-established, routinely-used analytical technique with ESI 
as an important part for simple and robust ionisation.
75
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Figure 1.22 A non-specific schematic of an electrospray ionisation source, showing ion evaporation and charge residue models   
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Extractive electrospray ionisation (EESI) is a relatively new ambient ionisation technique 
developed in 2006 by Cooks et al.
84
 Initially, a sample spray was directed into an electrospray 
plume where collisions between sample and charged microdroplets result in liquid-liquid 
extraction and ionization (Figure 1.23). Analytes in a sample matrix were extracted from 
urine, milk, and polluted water and ionised for analysis without sample preparation. The ESI 
spray consists of a standard ESI spraying solution (i.e. acidified water/organic solution).
85, 86
 
EESI is a promising ionisation method for ionising volatile organic compounds with potential 
to perform direct analysis of complex samples.
87
 
 
Figure 1.23 Schematic showing EESI mechanism 
1.3.5 Collision induced Dissociation and In-source Collision Induced Dissociation 
A number of ion fragmentation techniques are in use but only collision induced dissociation 
(CID) will be discussed in this section. CID is well established for ion fragment in tandem 
mass spectrometers. Ions colliding with neutral gas molecules become activated and the 
increase in internal energy, which induces fragmentation.
88
 Precursor ions are selected before 
CID to give characteristic products for identification and structure elucidation. The precursor 
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ion can be mass-selected by monitoring a narrow mass window for selected ion monitoring 
(SIM); or precursor ion can be selected and fragmented to a product ion, this transition can be 
monitored for sensitive detection of a product ion by removal of background noise, selected 
reaction monitoring (SRM). CID is typically performed in a collision cell of a tandem mass 
spectrometer, usually a triple quadrupole, quadrupole time-of-flight (QTOF) or an ion trap 
mass spectrometer (ITMS). CID experiments are typically performed using mass-selection of 
a precursor ion prior to fragmentation for sensitive detection of an analyte. 
Single mass analysers do not have a collision cell, but in-source CID (also known as cone 
voltage CID) can be used instead. In-source CID occurs in the interface of a mass 
spectrometer where reduced pressure causes ions to accelerate and collide with neutral 
molecules which induces fragmentation, allowing the acquisition of fragment data on a single 
mass analyser. This is less favoured than tandem MS because the inability to pre-select a 
precursor ion produces complex mass spectra containing a mixture of both multiple 
precursors and multiple product ions. 
A separation stage prior to ionisation gives a degree of selectivity to in-source CID. For 
example, LC-MS systems have been used to separate oligopeptides before ionisation and in-
source CID, giving a level of selection by fragmenting ions as they are eluted, aiding in 
identifying oligopeptide sequencing.
89
 LC-in-source CID-MS has also been used to probe the 
fragmentation behaviour of peptide aldehydes and acetals
90
 and organic bromine 
compounds.
91
 
In-source CID is not only useful for single mass analysers but can be used to give tandem 
MS/MS an additional fragmentation step.
92
 Analyses of tryptic peptides from bovine and 
human haemoglobin by tandem MS/MS with a Q-TOF were enhanced using in-source CID, 
helping to elucidate sequences.
93
 Use of in-source CID can enhance but also complicate 
tandem MS/MS.
94
 The reproducibility of in-source CID in six different instruments (four 
different manufacturers) was explored to improve identification when using spectral 
libraries.
95
 A method for controlling the ions fragmented by in-source CID would reduce the 
complexity of fragment spectra. The following examples are all the FAIMS-in-source CID-
MS techniques found in the literature. 
The first reported combination of FAIMS and in-source CID showed a change in cluster 
distributions of leucine enkephalin ions in the CV spectrum between gentle and harsh 
conditions of an ESI source, where fragmentation was induced by the harsh ionisation 
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conditions. The authors described the in-source CID MS as comparable to using tandem 
MS/MS, although all further fragmentation in the paper was pursued using tandem MS/MS.
22
 
Eiceman et al described source conditions harsh enough to induce the fragmentation of 
chlorocarbons which complicated identification of ions separated by a Sionex planar FAIMS-
MS system.
24
 The FAIMS-MS analysis of 5 isobaric compounds (m/z 316.07559 – 
316.23889), using a planar FAIMS device, used fragmentation induced by increasing the inlet 
cone voltage in the interface of a quadrupole MS to identify isobaric ions by matching CV 
peaks of fragments with CV peaks of standards.
8
 
FAIMS selection prior to in-source CID MS has not yet been used to isolate ions prior to 
fragmentation for identification of a precursor ion by a product mass spectrum. A FAIMS-
CID-MS system has the potential for gas phase pre-selection of ions prior to fragmentation 
giving single mass analysers the option of selective fragmentation. FAIMS interfaced with a 
tandem MS system (triple quadrupole, IT and QTOF) has the potential of two orthogonal 
methods of separation prior to fragmentation, making a highly selective system. 
1.3.6 Time-of-Flight Mass Spectrometry 
Mass spectrometry separates ions in a vacuum based on their mass to charge (m/z) ratio. 
There are several types of mass analysers, each with their own strengths and weaknesses, but 
for the purpose of describing the techniques used in this research the sole focus will be on 
time-of-flight mass spectrometry (TOF). The idea of TOF mass spectrometry was first 
proposed in 1946 by Stephens and the linear TOF design later published by Wiley and 
McLaren in 1955.
96
 In the 1980s, significant progress was made possible with new 
developments in electronics to allow handling of high data flow and the use of the techniques 
increased because of the compatibility of TOF with laser desorption ionisation due to pulsing 
nature of both techniques. 
In a TOF analyser, ions are accelerated by an electric field into a flight tube at vacuum. The 
ion velocity (v) is defined by: 
𝑣 = (
2𝑧𝑒Vs
𝑚
)1/2        Equation 1.8 
Where an ion of mass (m) and total charge (ze) is accelerated by a potential (Vs). The velocity 
of the ion is constant after the initial acceleration, time (t) can be related to distance (L) and v: 
𝑡 =  
𝐿
𝑣
        Equation 1.9 
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v in equation 1.8 can be substituted by equation 1.9, after rearrangement, t
2
 relates to: 
𝑡2 =  
𝑚
𝑧
 (
𝐿2
2𝑒𝑉𝑠
)        Equation 1.10 
where t
2
 can be used to calculate m/z because the terms in brackets are constant. Ions with the 
same m/z will arrive at the detector at different times if there is an initial kinetic energy 
spread in the accelerated pulse of ions, which will result in peak broadening and a reduction 
in resolution (R): 
R =  
𝑚
∆𝑚
=  
t
2∆t
        Equation 1.11 
where ∆m and ∆t are the mass and flight time for the two adjacent peaks. 
Removal of the variations in initial kinetic energy that result in peak broadening has been 
approached in a number of different ways. The first of these was developed by Wiley and 
McLaren in the 1950s,
96
 a technique called Delayed Pulsed Extraction. Ions that vary in 
kinetic energy will reach the detector at different times; a delayed pulse increases the kinetic 
energy of lower kinetic energy ions correcting for the dispersion of energies of the ion 
population so that they arrive at the detector in a narrower time frame to improve resolution. 
The first TOF mass spectrometer featured a linear flight tube, where the sample was 
introduced at one end and the detector situated at the opposite end (Figure 1.26.a). Samples 
with masses above 300 kDa can be analysed by linear TOF mass spectrometers and in 
principle there is no upper mass limit, although the mass resolution is low. A reflectron is 
another way to improve mass resolution, first proposed in 1973 by Mamyrin.
97
 Ions travelling 
through the flight tube are reflected by a ‘mirror’ lens and reflected in the reverse direction 
towards the source. The reflectron features a series of equally-spaced ring electrodes with a 
resistive network of equal-value resistors. It is positioned at the end of the flight tube and the 
detector is placed at the opposite end, adjacent to the source (Figure 1.24.b). Ions with a high 
kinetic energy will travel further into the reflectron than ions with a lower kinetic energy, 
resulting in the high energy ions spending a longer time in the reflectron which reduces the 
difference between the flight times for ions to reach the detector. The reflectron focusses the 
energy of ions, consequently improving mass resolution. A reflectron TOF will have higher 
resolution than a linear TOF, but the upper mass limit and transmission are reduced due to the 
reflector.
97,98
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Figure 1.24 Schematic of (a) linear, and (b) reflectron time of flight mass spectrometers
99
 
[Reprinted (adapted) with permission from Guilhaus, M.; Selby, D.; Mlynski, V. Mass 
Spectrom. Rev. 2000, 19, 65–107. Copyright 2000 John Wiley & Sons, Inc.] 
1.3.7 Quadrupole Mass Spectrometry 
A quadrupole consists of four electrodes (two pairs) in symmetry around a z-axis in a vacuum 
with an oscillating field.
74
 The opposing rod of each pair has the same polarity, but the two 
pairs of the four parallel rods have the opposite polarity by applying a dc voltage, U. An rf 
voltage, V, is superimposed over U creating a hyperbolic field. In this region, a positive ion 
will travel towards a negatively charged electrode, as the polarities switch between the pairs 
of electrodes the ion will be attracted to another electrode; this process continues as the pairs 
of electrodes switch in polarity and the ion takes a helical path through the quadrupole. The 
trajectory of an ion is related to its mass and charge (m/z), where an ion of a particular m/z 
will have a stable trajectory and ions with a different m/z will have unstable oscillations and 
collide with an electrode and neutralise.
100 
This feature allows ions to be filtered based on 
mass and charge, where a low m/z can be selected using a low U and V and a high m/z using a 
high U and V. Ramping both U and V will produce a mass spectrum as ions with increasing 
m/z have a stable trajectory and can reach the detector. U and V can also be fixed to transmit 
only a selected m/z. Quadrupoles can be arranged in tandem, known as a triple quadrupole, 
where ions are analysed by mass and charge in several stages.  
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1.3.8 Detectors 
A detector is required to record ions separated by m/z, changing ions into response in a mass 
spectrum. Electron multiplier detectors are the most widely used for mass spectrometry. They 
feature a system of dynodes that initially convert ions into electrons which are then amplified 
by the next dynode. The cascade of electrons travels down the set of dynodes; at the end, the 
flow of electrons supply an electrical current for detection. Another type of electron 
multiplier is a microchannel plate (MCP) which consists of a 3D array of detectors each of 
which features a single, continuous dynode. The amplifying region is a series of 
microchannels where the emissive surface initiates the burst of electrons from a ion. The 
cloud of electrons is directed onto an anode for the current to be detected. The short electron 
path length is only a few millimetres resulting in short electron pulse widths, making it the 
detector of choice for TOF MS.
74, 101
 
1.4 Hyphenated Ion Mobility-Mass Spectrometry Techniques 
A variety of analysis methods use mass spectrometers as the detector because of the 
information and selectivity offered by mass spectrometry. However, the complex nature of a 
chemical matrix means that not every compound can be resolved by mass spectrometry, 
hence the development of hyphenated ion mobility-mass spectrometry techniques (IM-MS) to 
add an extra stage of fast separation in the gas phase. 
There are currently two widely used commercial systems based on the drift tube ion mobility 
spectrometers: the Waters Synapt, where a travelling wave is used to transport ions through 
the drift cell; and the Agilent 6560 which uses a static electric field gradient. These are 
important instrument for delivering added separation and the ability to measure the collisional 
cross sections of ions. The ion mobility drift tube is fully integrated into the mass 
spectrometer. However, FAIMS can be added to the inlet of a mass spectrometer with 
relatively minor modifications. This section will discuss the hyphenations of FAIMS with 
mass spectrometry and the benefits associated with differential mobility separation prior to 
MS detection. 
1.4.1 FAIMS-MS Systems and Applications 
Since the publication of Guevremont’s FAIMS-MS system in 1999,102 a number of new 
FAIMS-MS systems have been developed, including variations on both cylindrical and planar 
devices and a microscale chip-based FAIMS device. Publications or FAIMS-MS systems 
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have increased significantly since 1999, showing the growing interest in the combined 
technique.
103
 Commercial FAIMS-MS interfaces include the Ionalytics/Thermo cylindrical 
FAIMS device, the ABSciex SelexIon planar FAIMS, the Owlstone chip-based ‘multi-planar’ 
FAIMS device. 
The first interfacing of a FAIMS device with a mass spectrometer used a cylindrical FAIMS 
device set at a ~45˚ angle to the sampler cone/skimmer of a triple quadrupole mass 
spectrometer.
104, 105
 Combining FAIMS with MS was shown to improve sensitivity when 
compared to mass spectrometry alone by reduction of chemical noise. Transmission of ions 
through FAIMS has a linear relationship with concentration which can help improve the 
linear range of a mass spectrometer at the lower end of a calibration plot by reducing noise 
and improving the signal-to-noise ratio.
102, 106, 107
 The potential to separate isobaric ions gives 
information unattainable by MS alone that is significantly faster than other separation 
techniques used prior to MS analysis.
4
 
The improvement FAIMS offers to mass spectrometry is dependent on the type of mass 
spectrometer it is being interfaced to. A comparison between MS, MS/MS, FAIMS-MS and 
FAIMS-MS/MS systems was made with trace analysis of amino acids introduced by ESI. 
Only when using FAIMS was it possible to separate isobaric amino acids, an advantage that 
enhances mass spectrometer performance where there is no unique selected reaction 
monitoring (MRM) transition that can distinguish fragments of the isobaric compounds. 
FAIMS has the ability to reduce background noise and increases the relative response of an 
analyte was demonstrated in a comparison of MS and MS/MS modes with and without 
FAIMS, made by observing the limits of detection obtained for 20 amino acids (Figure 
1.25).
42
 Sufficient FAIMS resolution and the best detection limits were seen with FAIMS-
MS, making it the preferred method for amino acid analysis in a hydrolysed yeast matrix. An 
advantage of FAIMS-MS over MS/MS is that the former can enable separation and 
quantification of isobaric ions but little advantage was seen when considering limits of 
detection,
42
 suggesting that FAIMS might have a greater benefit on standalone MS systems. 
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Figure 1.25 Protonated proline (m/z 116) in a hydrolysed yeast sample by (a) ESI-MS; and 
(B) ESI-FAIMS-MS (DV = 4000V, CV = -15V and N2 flow at 2.5 l.min
-1
) 
42
 [Reprinted 
(adapted) with permission from McCooeye, M.; Mester, Z. Rapid Commun. Mass Spectrom. 
2006, 20, 1801–8. Copyright 2006 Crown in the right of Canada. Published by John Wiley & 
Sons, Ltd.] 
An ESI-FAIMS-MS (triple quadrupole) method provided sufficient separation and sensitivity 
with far higher throughput to replace current LC methods in the analysis of ephedrine, pseudo 
ephedrine and their metabolites in a health tablet matrix.
5
 Detection limits were in the range 
of 0.1 – 3 ng/ml with a linear range over 2 orders of magnitude. The diastereoisomers were 
resolved for the first time by FAIMS and quantitation required no clean-up step prior to 
analysis.5 Another technique achieved sufficient sensitivity and selectivity by combining 
SPME with ESI-FAIMS-MS to enable the removal of a chromatography step for the 
quantitative determination of amphetamine, methamphetamine and their methylenedioxy 
derivatives in urine. SPME was needed to remove the high salt content to improve the 
electrospray conditions.
6
 The cylindrical FAIMS device gave significant improvements in 
S:N ratio and analysis times of the compounds in urine (Figure 1.26).  
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Figure 1.26 MS of a desorbed SPME sample with methamphetamine (MA) and 3,4-
methylene-dioxymethamphetamine (MDMA) being transmitted (a) with FAIMS and (b) 
without FAIMS
6
 [Reprinted (adapted) with permission from McCooeye, M. A.; Mester, Z.; 
Ells, B.; Barnett, D. A.; Purves, R. W.; Guevremont, R. Anal. Chem. 2002, 74, 3071–5. 
Copyright 2002 American Chemical Society] 
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A cylindrical FAIMS-MS system has made the removal of sample preparation and 
chromatographic separation possible and provided good agreement in terms of accuracy and 
precision with the routine GC-MS method for naphthenic acids analysis.
108
 Also, a 
comparison between using ESI-FAIMS-quadrupole, ESI-FAIMS-QTOF and nanoESI-QTOF 
was carried out. Similar m/z and CV distributions were observed when using ESI-FAIMS-Q 
and ESI-FAIMS-QTOF, but the m/z distribution was significantly different without the 
FAIMS in system. The FAIMS-QTOF dissociated more of the fragile ions than with FAIMS-
Q; however, the FAIMS-QTOF provided high mass resolution, quick detection speed, 
accurate mass and tandem mass spectrometry making it the preferred MS technique. 
Determining the elemental composition of NAs and fragments required less effort than the 
sample preparation steps required when using GC-MS. This was not possible with the single 
quadrupole where neither elemental composition nor structural detail could be obtained.
108
 
Gabryelski and Froese removed the sample preparation step in the analysis of tap water for 
haloacetic acids (HAA) by using ESI-FAIMS-MS (cylindrical); this was compared with 
current GC and GC-MS techniques.
109
 The limits of detection were explored in a number of 
matrices, including tap water, urine and oil, and shown to be sufficient for routine analyses 
without pre-concentration.
110
 
Guevremont et al have reported the separation of peptides into ‘charge state families’ and that 
simplifying interpretation of mass spectra was shown for a peptide mixture analysed using 
ESI sample introduction with cylindrical FAIMS and triple quadrupole MS.
111,112
 The CV for 
a peptide mixture was plotted against m/z (Figure 1.27) showing no correlation between the 
two techniques. Good orthogonal separation shows the importance of FAIMS separation prior 
to mass analysis.
112
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Figure 1.27 Separation of peptide mixture by FAIMS prior to MS
112
 [Reprinted (adapted) 
with permission from Guevremont, R.; Barnett, D. A.; Purves, R. W.; Vandermey, J. Anal. 
Chem. 2000, 72, 4577–84. Copyright 2000 American Chemical Society] 
A cylindrical FAIMS was combined with electron transfer dissociation (ETD) mass 
spectrometry for analysis of isobaric phosphopeptides with identical amino acid sequences 
but different sites of phosphorylation to aid in the identification of the location of the 
phosphorylation site. Partial separation was achieved which provided identification of the 
species in a mixture.
113
 
NanoESI-FAIMS/IMS/MS (Q-TOF) giving a 2-dimensional ion mobility separation prior to 
MS was investigated for the analysis of a mixture of 11 common proteins and 19 typical 
peptides and the degree of orthogonal separation between FAIMS and drift tube IMS 
explored. Peptides with a +1 charge were found to have lower mobility and CV value than 
those with +2 or higher; despite this, the two techniques are different enough to justify 
interfacing them in tandem prior to MS. From a point in the CV spectrum, an IMS scan 
comprised of multiple MS scans gave 3 different gas-phase separation techniques.
114 
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The addition of a nanoESI to FAIMS-MS was compared with a routine technique (LC-
MS/MS) in drug discovery. The authors aimed to show the ability of nanoESI-FAIMS-MS to 
separate metabolite interferences and remove the chromatographic step to dramatically 
reduce run times. A liquid flow rate of 30 nL/min gave the optimum balance for shortening 
sample time and reducing ion suppression. LODs and LOQs were in the ng/mL range with a 
linear dynamic range of 50 – 10 000 ng/mL was observed, an order of magnitude greater than 
the standard LC-MS method. Concentrations determined by the two techniques were in 
agreement showing nanoESI-FAIMS-MS to be a faster alternative, although the exact 
improvements in run time were not detailed.
7
 
An ultraFAIMS-MS system was used to isolate the singly protonated ions from a tryptic 
digest of α-1-acid-glycoprotein (AAG), giving MS similar to a MALDI-MS system (Figure 
1.28). This greatly simplifies the data obtained from ESI which yields ions with single and 
multiple charge states, making protein identification simpler. A doubly charged peptide (m/z 
877) was isolated with the FAIMS prior to fragmentation by the ion-trap MS. This reduced 
the complexity of the fragmentation spectrum and gave a 10-fold improvement in the signal 
to noise ratio. The fragmentation pattern was used to identify the protein from a Mascot 
database search.
3
 
 
Figure 1.28 FAIMS-selected singly protonated tryptic digested peptides from AAG
3
 
[Reprinted (adapted) with permission from Brown, L. J.; Toutoungi, D. E.; Devenport, N. A.; 
Reynolds, J. C.; Kaur-Atwal, G.; Boyle, P.; Creaser, C. S. Anal. Chem. 2010, 82, 9827–34. 
Copyright 2010 American Chemical Society] 
60 
 
1.4.2 LC-FAIMS-MS 
The previous section discusses removal of chromatography and sample preparation steps but 
FAIMS can be used to compliment chromatography-based separation like HPLC. FAIMS has 
been combined with other separation methods but the focus of this section will be on HPLC, 
the technique used in this thesis. A brief summary of FAIMS combined with LC is shown 
below. 
Liquid-liquid extracted urine samples were analysed with LC-FAIMS-MS/MS to detect 
anabolic androgenic steroids in sports drug testing, enhanced by a 4 L/min gas mixture of 
N2/He (50:50). The reduction of S/N ratio and interference reduced ambiguity in the data. 
Metandienone is a long-term metabolite that is only observable (when satisfying the criteria 
for positive finding) by LC-FAIMS-MS/MS where the LC-MS/MS method failed to provide 
a peak above LOD. Helium usage was reduced by only using it upon analyte elution. Positive 
tests can be produced with longer time periods after the drug abuse has occurred when 
enhancing LC-MS/MS with FAIMS.
58
  
The addition of FAIMS separation to LC-MS/MS analysis of prostanoids gave reduced 
background noise and separated the isobaric prostaglandin ions: PGE2 and PGD2. Separation 
of interconverting anomers, thromboxane B2, was also achieved. The prostanoids exist at low 
concentrations in complex tissue matrices which require a reduction in background noise for 
a reliable measurement of inflammation. The method was developed as an alternative to time-
consuming, complex chromatographic runs. Successful quantitation of the prostanoids was 
achieved with the addition of FAIMS.
59
 
An investigation into the benefits offered by adding cylindrical FAIMS to LC-MS/MS for 
addressing the challenge of peptide isomers in proteomics by using a CV stepping method as 
gas-phase fractionation.
115
 A 2-fold increase in the number of peptide assignments was 
observed with FAIMS compared to LC-MS/MS. 
1.5 Overview of Thesis 
The introduction to this thesis has discussed the principles of the differential mobility 
behaviour of ions in the gas phase and the application of technology for chemical detection in 
large number of fields. FAIMS is not only used to separate isobaric ions, but also offers 
chemical noise reduction and simplification of complex data. It is a quantitative technique 
that offers lower detection limits and faster run times when hyphenated with other existing 
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systems. The addition of FAIMS to existing analytical systems has already shown promise in 
improving analytical performance in many applications. 
A miniaturised chip-based FAIMS device has been combined with a TOF mass spectrometer 
using relatively minor modifications to the electrospray source. The thesis presented here 
investigates the performance of the prototype FAIMS-MS system and evaluate the 
application of the technique for small molecule analysis.  
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2.1 Chapter Overview 
An ESI-MS interface was modified to incorporate an miniaturised chip-based FAIMS 
device
1,2 
at the capillary inlet orifice of the TOF MS. A central composite design (CCD) was 
used to explore the robustness and critical parameters of the FAIMS device for signal 
intensity across the full functioning range of the ESI source with liquid flow of up to 1 
mL/min and using different solvent compositions. Critical parameters of the modified source 
were optimised using a test mixture of analytes varying in size, mass, charge and 
functionality. The performance of the miniaturised FAIMS was investigated using three 
different systems of isobaric, isomeric and near-mass ions where analysis by mass 
spectrometry without very high resolution or prior separation cannot be used to distinguish 
them. (i) The behaviour of methylmalonic acid (MMA) and interferant succinic acid (SA) 
ions formed by deprotonation ions and as adducts with group I metal ions has been studied. 
(ii) The quantitative determination of 6β-hydroxytestosterone (6β-HT) requires 
chromatographic separation from 2β-hydroxytestosterone (2β-HT), but this can be time-
consuming when screening many potential drug candidates. The ability to distinguish 
between these hydroxytestosterone isomers by FAIMS and apply the approach as a rapid 
sample introduction method is investigated using different carrier gas temperatures and by 
adding water vapour to the carrier gas flow to achieve appropriate selectivity and sensitivity 
for rapid screening of potential drug candidates. The pharmaceutical excipients, 2-hydroxy-
(4-octyloxy) benzophenone and PEG 400 (n = 7) were successfully isolated and subjected to 
in-source collision-induced dissociation (CID) for identification by characteristic fragment 
ions. Improved mass measurement accuracy and simplified product ion mass spectra were 
observed following FAIMS pre-selection and subsequent in-source CID of ions derived from 
pharmaceutical excipients, sufficiently close in m/z (17.7 ppm mass difference) that they 
could not be resolved by TOFMS alone. 
2.2 Introduction 
Earlier embodiments of FAIMS have been sensitive to change in operating conditions, such 
as peak position in CV spectra, so the first section of this chapter describes the systematic 
investigation of ESI source parameters on the CV transmission voltage and transmission. A 
central composite design (CCD) experiment was used to optimise the miniaturised FAIMS 
device and explore source conditions over the full functioning range to determine the 
functionality of the FAIMS device. The CCD required measurements at the minimum, mid-
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point and maximum of the range of each parameter tested. The CCD program identifies the 
minimum number of experiments required to explore contributing effects of multiple 
parameters which are run in a random order. Parameters like liquid flow rate, liquid 
composition, source voltages and gas flows were investigated because these are likely to be 
changed during routine method development and maybe even within an analysis (like liquid 
composition), it is therefore critical for the peak position of an analyte ion in the FAIMS 
spectrum to be precise despite changes in source conditions. The CCD experiment was 
performed on the first ESI-FAIMS-TOF MS prototype device. Two prototype ESI-FAIMS-
TOF MS prototypes are utilised for the experiments in this chapter. 
FAIMS has been employed as an ion filter to select precursor ions prior to mass spectrometry 
analysis, because differential mobility is largely independent of m/z allowing orthogonal 
separations.
3
 The ability to pre-select using FAIMS has been shown to simplify mass spectra 
by reducing background and isobaric ions.
4-7
 The combination of FAIMS with tandem mass 
spectrometry (FAIMS-MS/MS) has also been reported for the structural and quantitative 
analysis of small molecules and peptides, with CID of mass-selected ions occurring in the 
collision cell located between the mass analysers of a Q-TOF or triple quadrupole 
spectrometer, or after mass isolation in an ion trap.
7-9
  
The in-source fragmentation of ions in FAIMS-MS was reported by Guevremont et al.,
10
 who 
observed a change in cluster distributions of leucine enkephalin of ions under low and high 
energy in an ESI ion source. It was concluded that fragmentation comparable to MS/MS 
analysis was induced under high energy conditions. Subsequent fragmentation studies were 
pursued using MS/MS of mass-selected ions in a triple quadrupole spectrometer rather than 
through in-source CID. Eiceman et al. also described fragmentation of chlorocarbon ions in 
the interface of an atmospheric pressure ionization mass spectrometer, which complicated the 
identification of FAIMS-selected ions.
11
 Measurements were carried out under conditions 
designed to minimise rather than enhance ion decomposition in the mass spectrometer 
interface. The use of FAIMS with in-source CID and selected reaction monitoring MS/MS 
was used by Xia and Jemal to determine the location of source fragmentation in the analysis 
of ifetroban and its acylglucuronide metabolite.
12
 FAIMS was used to transmit either the 
parent drug and its acylglucuronide, from which it was concluded that fragmentation, 
inducing the conversion of the acylglucuronide metabolite to the parent drug form occurred 
almost entirely after the inlet orifice of the mass spectrometer. The objective of this work was 
to minimize the effect of in-source CID on the LC-MS/MS with SRM for the quantitative 
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analysis of prodrugs and metabolites. The targeted use of in-source CID-MS using FAIMS to 
isolate ions from a mixture prior to fragmentation was reported by Coy and co-workers.
13
 The 
separation of a simple mixture containing five isobaric model compounds (m/z 316) was 
achieved by direct infusion into the ESI source and differential mobility spectrometry. Ions 
were transmitted at their optimum CV and fragmentation induced by increasing the inlet cone 
voltage in the interface of a quadrupole MS. 
The second section of this chapter describes an investigation of the ability of FAIMS to 
separate closely related ions using three model systems containing pairs of analytes that are 
isobaric, isomeric or sufficiently close in mass to be difficult to be separated by MS. The first 
of these pairs of analytes are succinic acid (SA) and methylmalonic acid (MMA). The latter is 
commonly used as a biochemical marker of vitamin B12 deficiency, partly due to MMA 
being a thousand times more concentrated in serum than vitamin B12 making it easier to 
measure accurately.
14,15
 SA is an interferant typically removed from MMA using 
chromatography or derivatization prior to analysis by using mass spectrometry.
14,15
 Analysis 
in positive ion mode of adducts formed with group I metals and in negative ion mode of 
deprotonated MMA and SA with corresponding fragments produced by in-source CID using 
ESI-FAIMS-MS is discussed in this chapter. 
6β-hydroxytestosterone (6β-HT) is a major metabolite of testosterone through CYP3A4 
action where testosterone is used as a substrate for measuring inhibition of the enzyme 
CYP3A4 when investigating drug-drug interactions for potential drug candidates. 2β-
hydroxytestosterone (2β-HT) is another metabolite of testosterone whose formation is 
promoted when 6β-HT is inhibited which can prove problematic for the rapid determination 
of 6β-HT levels in the presence of 2β-HT without a time-consuming chromatographic step. 
Isomers 2β-HT and 6β-HT were analysed using ESI-FAIMS-MS and LC-ESI-FAIMS-MS to 
optimise separation by exploring different temperatures and water concentration of the carrier 
gas. Loop injections of the isomers were used to enable evaluation of combining fast sample 
introduction with a rapid FAIMS separation and MRM transition. 
The final section of this chapter describes the development of generic FAIMS-in source CID-
MS procedures (termed FISCID-MS). FISCID-MS exploits the ability to control the 
fragmentation of FAIMS-selected ions in the interface of the mass spectrometer, by 
combining the orthogonal separation characteristics of a miniaturised high field FAIMS 
device and in-source CID with time-of-flight mass spectrometry. The technique is shown to 
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provide major enhancements for the analysis of complex mixtures. FISCID-MS is 
demonstrated for the separation of pharmaceutical excipients: 2-hydroxy-(4-octyloxy) 
benzophenone and PEG 400 (n = 7). 
2.3 Experimental 
2.3.1 Chemicals 
HPLC grade methanol (MeOH), acetonitrile (ACN), water and formic acid (FA) were 
purchased from Fisher Scientific (Loughborough, UK). The test mixture consisting of 
caffeine, MRFA, tetrapentylammonium bromide (TPAB), reserpine, insulin B chain and 
Vancomycin hydrochloride; MMA and SSA; and the two pharmaceutical excipients are 2-
hydroxy-(4-octyloxy) benzophenone and PEG 400, were obtained from Sigma Aldrich 
(Gillingham, UK). 6β-HT and 2β-HT were supplied by Vertex Pharmaceuticals. 
2.3.2 Sample Preparation 
The test mixture was made up at different concentrations (Table 2.1) to give a similar 
response under standard infusion conditions in methanol/water (50:50) with 0.1 % FA. MMA 
and SA (30 μg/ml) were dissolved into methanol/water (50:50) with 0.2 mM ammonium 
acetate for negative ion mode and methanol/water (50:50) with either lithium chloride or 
potassium chloride (1 μg/ml) for positive ion mode. Stock solutions of 2β-HT and 6β-HT 
(100 μM in methanol) were diluted using methanol/water (50:50) with 0.1% formic acid (FA) 
to 5 μM for infusion studies and 0.1 μM for LC-FAIMS-MS experiments. Quantitation was 
pursued with 6β-HT in the range 0.1 μM – 5 μM in methanol/water (50:50) with 0.1 % FA. 2-
hydroxy-(4-octyloxy) benzophenone and PEG 400 were prepared in methanol/water (50:50) 
with 0.1 % FA at respective concentrations of 5.1 and 104 pmol/µl (1:20 molar ratio).  
Table 2.1 Concentrations of test mixture compounds 
Test mixture component Concentration /pmol/μl 
Caffeine 167 
MRFA 16.7 
TPAB 0.167 
Reserpine 8.3 
Insulin B Chain 33.3 
Vancomycin 167 
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2.3.3 Instrumentation 
The FAIMS studies reported in this thesis were carried out under a collaboration with 
Owlstone Limited on the development of miniaturised chip-based FAIMS interfaces for mass 
spectrometry and an evaluation of applications in pharmaceutical and bioanalysis. Two 
prototype FAIMS chips were used in the evaluation and these are described in detail here. 
Both prototypes featured the miniaturised ultra-FAIMS device (Owlstone, Cambridge, UK) 
interfaced to an Agilent 6230 orthogonal acceleration time-of-flight mass spectrometer 
(Agilent Technologies, Santa Clara, CA, USA). The electrospray source of the ToF mass 
spectrometer was modified to accommodate the presence of the ultra-FAIMS chip within the 
spray shield (Figure 2.1).  The first prototype device
16,17
 consisted of 47 electrode pairs with 
an electrode gap of 35 μm, and a channel length of 300 μm. The FAIMS chip was connected 
to a field generator module, containing the electrical circuitry required to generate field 
asymmetric waveforms. The frequency of the applied asymmetric waveform was 25 MHz in 
a roughly 2:1 ratio of low field to high field. Comparative non-FAIMS data were acquired 
with analytes transmitted through the FAIMS chip with the DF and CV set to 0 kV/cm and 0 
V, respectively. 
The first prototype device has the voltages reversed compared to the conventional JetStream 
ESI source, in that the high voltage is applied to the nebuliser (~1.5 kV), and the spray shield, 
nozzle and counter electrode were connected at 400 V (Figure 2.1). The reason for this was 
that the silicon based chip was incompatible with the high voltages of the conventional 
design, the capillary voltage was set at a bias (-100 V to 100 V) to aid transmission. The units 
of the FAIMS parameters were kV/cm for DF and V for CV. The first prototype device was 
used for the analysis of HOBP and PEG, and for the CCD experiment.  
The second prototype device featured a nickel-based chip with a 100 μm electrode gap and 
700 μm channel length which enabled the standard voltage configuration of a JetStream ESI 
source of an Agilent 6230 TOF MS, where the nebuliser is grounded and the capillary 
voltages set to 3000-4000 V (Figure 2.2). The nozzle, spray shield and counter electrode were 
no longer connected. The chip housing was mounted onto the capillary in the same way as 
the earlier version. The units of the FAIMS parameters for this prototype were Td for DF and 
Td for CF. The second prototype was used for the experiments including: MMA, SA, 6β-HT 
and 2β-HT. 
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The ultraFAIMS A1 system is the most recent chip-based FAIMS interface and was fitted to 
a triple quadrupole mass spectrometer (Agilent Technologies 6460C). The quantitative 
experiments of the hydroxytestosterone isomers were performed using this system and with 
HPLC (Agilent Technologies, 1200 series) for loop injections of the isomers which were 
standard LC injections without a column in place. The voltages are the same as in the second 
prototype device but the design of the spray shield and the chip holder is different. 
 
 
Figure 2.1 A schematic of ultra-FAIMS prototype device 1 interface with Agilent Jet Stream 
ESI for incorporating silicon-based chip 
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Figure 2.2 A schematic of ultra-FAIMS chip prototype device 2 interface with Agilent Jet 
Stream ESI for incorporating Nickel-based chip 
Central Composite Design Experiment 
A central composite design (CCD) using DOE PRO software (Microsoft Excel) was used to 
assess the critical source parameters on instrument performance and the stability of CV 
maximum values over a wide range of source conditions (Table 2.2 and 2.3). The CCD 
required measurements at the minimum, mid-point and maximum of range of each parameter 
tested. The CCD program identifies the minimum number of experiments required to explore 
contributing effects of multiple parameters.  
The parameters investigated were: DI flow rates (10 – 50 μl/min) and LC flow rates (100 – 
1000 μl/min), drying gas flow (4 – 12 l/min), nebuliser pressure (10 – 60 psig), sheath gas 
flow (4.6 – 12 l/min), capillary voltage (-100 - +40 V) and % organic solvent (10 – 90%); 
(Figure 1). The only organic solvent used for DI was methanol; methanol and acetonitrile 
were studied using LC flow rates. Other parameters including: fragmentor voltage, drying gas 
Spray shield
FAIMS 
chip
Drying gas 
flow
Agilent Jet Stream 
ESI source
TOF MS
Counter electrode/cage
Transfer capillary
Sheath gas 
flow Nebuliser
Nozzle
Ions
FAIMS chip housing
Liquid sample 
flow
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temperature, sheath gas temperature, nozzle voltage and MS scan rate were kept constant 
throughout the experiment (Table 2.4). The dispersion field applied was 80% (48.8 kV/cm) of 
the maximum with a CV scan range -1 to +4 V. A 5-factor and 4-factor CCD was used for DI 
and LC flow rates respectively. Performance was monitored with a test mixture containing 
caffeine, MRFA, tetrapentylammonium bromide (TPAB), reserpine, insulin B chain and 
Vancomycin. Three replicates were recorded for each CCD row number. 
Table 2.2 Conditions for direct infusion CCD experiment 
Row# 
Liquid flow 
μl/min 
Capillary 
voltage  V 
Drying gas 
l/min 
Sheath gas 
l/min 
Nebulizer 
pressure psig 
1 10 -100 4 5.5 60 
2 10 -100 4 12 10 
3 10 -100 12 5.5 10 
4 10 -100 12 12 60 
5 10 40 4 5.5 10 
6 10 40 4 12 60 
7 10 40 12 5.5 60 
8 10 40 12 12 10 
9 50 -100 4 5.5 10 
10 50 -100 4 12 60 
11 50 -100 12 5.5 60 
12 50 -100 12 12 10 
13 50 40 4 5.5 60 
14 50 40 4 12 10 
15 50 40 12 5.5 10 
16 50 40 12 12 60 
17 30 -30 8 8.75 35 
18 30 -30 8 8.75 35 
19 10 -30 8 8.75 35 
20 50 -30 8 8.75 35 
21 30 -100 8 8.75 35 
22 30 40 8 8.75 35 
23 30 -30 4 8.75 35 
24 30 -30 12 8.75 35 
25 30 -30 8 5.5 35 
26 30 -30 8 12 35 
27 30 -30 8 8.75 10 
28 30 -30 8 8.75 60 
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Table 2.3 Conditions for liquid chromatography CCD experiment 
Row# 
Liquid Flow 
Rate 
Nebuliser 
Pressure 
Drying Gas 
Flow 
% Organic 
Solvent 
1 0.1 10 4 10 
2 0.1 10 4 90 
3 0.1 10 12 10 
4 0.1 10 12 90 
5 0.1 60 4 10 
6 0.1 60 4 90 
7 0.1 60 12 10 
8 0.1 60 12 90 
9 1 10 4 10 
10 1 10 4 90 
11 1 10 12 10 
12 1 10 12 90 
13 1 60 4 10 
14 1 60 4 90 
15 1 60 12 10 
16 1 60 12 90 
17 0.55 35 8 50 
18 0.55 35 8 50 
19 0.1 35 8 50 
20 1 35 8 50 
21 0.55 10 8 50 
22 0.55 60 8 50 
23 0.55 35 4 50 
24 0.55 35 12 50 
25 0.55 35 8 10 
26 0.55 35 8 90 
 
Table 2.4 Constant conditions for CCD experiment 
TOF Settings Value 
Fragmentor voltage 175 V 
Drying gas temperature 150 ˚C 
Sheath gas temperature 250 ˚C 
Nozzle voltage 400 V 
TOF MS Scans 10 scans/s 
  
FAIMS Settings Value 
CV Range -1 to +4 V 
D.F. 0 and 80 % 
Scan rate 0.5 V/s 
CV sweeps 2 
CV scans 4 (10 s each) 
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FAIMS-MS analysis of isobaric, isomeric and near-mass ions 
Methylmalonic acid (MMA) and Succinic acid (SA) were dissolved and diluted into a 
methanol/water (50:50) solution with either 0.1% formic acid, 1 μg/ml of either KCl or LiCl, 
sodium scavenged from glassware was used to produce sodiated ions for analysis in positive 
ion mode or with methanol/water (50:50) with 0.2 mM ammonium acetate for negative ion 
mode. Samples were infused individually into ESI-FAIMS-MS for investigating differential 
mobility behaviour of the different ions formed.  
Separation of 6β-HT and 2β-HT was explored initially using infusion experiments on a TOF 
MS at different drying gas temperatures (50-150˚C) and with a modifier system (Bronkhorst 
controlled evaporator system) to introduce water (0.5 – 1.5 % v/v) with the drying gas 
temperature set to 150˚C. LC-FAIMS-MS used 0.55 ml/min with a 7 minute gradient run of 
water (0.1% formic acid) and acetonitrile (0.1% formic acid) and a 10 μl injection volume 
onto a C18 column (100 x 3.0 mm, Onyx Monolithic C18, CH0-8158, Phenomenex). The 
infusion method was transferred to a triple quadrupole mass spectrometer (Agilent 6460C) 
fitted with ultraFAIMS A1 device and separation conditions retested (DF 280 to 305 Td, 
water 0.75 to 1.5 %). Loop injections (10 μl) of hydroxytestosterone isomers (0.1 μM – 5 
μM) using a mobile phase of acetonitrile (100%, 0.1% formic acid) at 0.2 ml/min without a 
column in place were used for quantitative studies. The triple quadrupole used an MRM 
transition was set to select 305.2 (Q1, unit resolution) and detect the product ion 269.4 (Q3, 
widest resolution) with collision energy set to 13 and dwell time 200 ms. 
HOBP and PEG solutions were infused into the JetStream-ESI ion source at 50 µL/min and 
ionized using a voltage of 1.5 kV. Source conditions for all experiments were: nozzle voltage, 
spray shield and counter electrode, 400 V; skimmer voltage, 65 V; drying gas temperature, 
150 °C; sheath gas temperature, 250 °C; nebulizer gas pressure, 25 psig. HOBP/PEG analysis 
was carried out with the inlet capillary voltage set to -29 V, the drying gas flow to 4.6 L/min 
and the sheath gas flow to 7 L/min. FAIMS separation was carried out at a 47 kV/cm DF, 
over a CV range of -1 V to +4 V at 0.5 V/s CV sweep rate. FAIMS-selected analytes were 
transmitted into the mass spectrometer interface by scanning a 0.1 V window around the 
optimum CV for transmission. The exact CV values and scan windows were experiment 
dependant and as such are indicated in the text where appropriate. FISCID-MS analysis was 
carried out in positive ion electrospray ionization mode with the fragmentor voltage set to 
150 V for transmission of intact analytes without fragmentation and increased to 400 V to 
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induce in-source fragmentation by CID. Data were processed using Mass Hunter version 
B.01.03 (Agilent Technologies, Santa Clara, CA, USA) and Excel 2007 (Microsoft, Seattle, 
USA). 
2.4 Results and Discussion 
The robustness of FAIMS was determined over a wide range of ESI ion source conditions, 
including the use of different solvents and flow rates. The critical source parameters for 
optimising response and the transmission of ions over a range of m/z are discussed in this 
chapter. The separation of isobars, isomers and near-mass ions is demonstrated by 
investigating FAIMS spectra of methylmalonic acid (MMA) and succinic acid (SA), 2β-
hydroxytestosterone (2β-HT) and 6β-hydroxytestosterone (6β-HT), and a PEG 400 (n=6) ion 
and 2-hydroxy-(4-octyloxy) benzophenone (HOBP). 
2.4.1 Central Composite Design for Evaluating FAIMS Performance 
A central composite design can be used to explore the individual and cumulative effect of 
multiple factors, making it an ideal method for evaluating and optimising the modified ESI 
source under the full range of conditions. The test mixture was adjusted to provide variation 
in size, functionality and mass range (m/z 195 to 1448) to investigate the effect of 
instrumental parameters of a wide range of analytes. Signal intensity was monitored for 
optimising sensitivity and the CV maximum recorded to evaluate stability of FAIMS 
performance. 
The impact of the ion source parameters on the response showed that the major contributing 
parameters to the ion response were compound and charge-state dependent (Figure 2.3). 
Capillary voltage, liquid flow and nebuliser pressure have the greatest contribution to 
response while drying gas flow (the flow around the FAIMS chip) had the lowest. Optimum 
response was achieved with the sheath gas flow set to maximum (12 l/min). Critical 
parameters were observed to be similar whether the DF was switched on or off and the 
parameters observed to have a large effect on sensitivity are those known to affect ion 
generation in the ESI source. The CCD model generated optimum settings for each of the 
parameters for each compound and close agreement was found between predicted and 
experimental optimum conditions. Ion response was not investigated for LC-MS due to the 
nature of performing a FAIMS scan within a loop injection, where the position of the FAIMS 
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scan as the compounds eluted from the LC could not be controlled causing a large variation 
in intensity. 
Figure 2.3 CCD parameter coefficients of contribution to response for each parameter 
An important requirement of miniaturised FAIMS is to be able to adjust source parameters to 
optimise performance over a range of liquid flow rates or solvent compositions. The CCD 
explored gas and liquid flow rates at extreme and standard LC-MS conditions. The average 
CV peak maximum for each test mixture ion with direct infusion is shown in Table 2.5 and 
with LC injection in Table 2.6, where the latter has two data sets showing a mobile phase 
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with acetonitrile and water, and with methanol and water. Both Tables 2.5 and 2.6 show 
corresponding standard deviations to demonstrate precision for each test mixture ion. The 
average CV maximum value for each test mixture ion, when using direct infusion, is 
illustrated in Figure 2.4; CV is plotted against CCD experiment number where experiment 
conditions are changing between minimum, medium and maximum conditions for each 
parameter. It was found that the FAIMS chip remains stable even when subjected to extreme 
conditions of flow rates and different solvent compositions, even with a high (90%) aqueous 
mobile phase. The good stability of the FAIMS performance is critical if miniaturised FAIMS 
is to be used to for LC-FAIMS-MS analyses. Without good stability, every time the LC 
conditions are changed the FAIMS conditions would need to be re-optimised again which 
would not be possible in a gradient LC run. The reason for its high stability is likely due to 
the efficiency of desolvation in the ion source, where high temperatures and the drying gas 
reduce the number of neutral solvent molecules entering the FAIMS chip and prevent a 
modifier effect which would otherwise cause peaks to move in the CV spectrum. 
 
Figure 2.4 A plot of CV maximum against CCD experiment number (from Table 2.2) using 
direct infusion of the test mixture in methanol/water at DF 48.8 kV/cm (n=3)  
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Table 2.5 Peak position (CV) and standard deviation for test mixture compounds from the 
direct infusion FAIMS-MS CCD experiments with a methanol/water solvent 
Ion CV /V St. Dev. 
[Caffeine + H]
+
 
0.81 0.07 
[MRFA + 2H]
2+
 
1.61 0.09 
[TPAB - Br]
+
 
1.43 0.07 
[MRFA + H]
+
 
1.25 0.05 
[Reserpine + H]
+
 
0.90 0.04 
[Vancomycin + 2H]
2+
 
1.32 0.08 
[Insulin B Chain + 4H]
4+
 
1.51 0.08 
[Insulin B Chain + 3H]
3+
 
1.37 0.05 
[Vancomycin + H]
+
 
0.53 0.09 
 
Table 2.6 Peak position (CV) and standard deviation for test mixture compounds from the 
LC-FAIMS-MS CCD experiments with methanol/water and acetonitrile/water solvents 
Ion 
Acetonitrile Methanol 
CV /V  Std Dev CV /V  Std Dev 
[Caffeine + H]
+
 0.86 0.09 0.87 0.10 
[MRFA + 2H]
2+
 1.50 0.12 1.53 0.10 
[TPAB - Br]
+
 1.35 0.07 1.36 0.07 
[MRFA + H]
+
 1.19 0.08 1.19 0.05 
[Reserpine + H]
+
 0.84 0.06 0.84 0.05 
[Vancomycin + 2H]
2+
 1.22 0.07 1.23 0.05 
[Insulin B Chain + 3H]
3+
 1.17 0.08 1.22 0.09 
[Vancomycin + H]
+
 0.46 0.07 0.47 0.07 
 
Under optimum conditions, a plot of % transmission of the test mixture ions at a DF of 48.8 
kV/cm relative to a DF of 0 kV/cm against m/z is shown in Figure 2.5. There is a trend of 
increasing % transmission with higher m/z, this levels out at ~ m/z 600 Th but shown to be ~ 
100% at m/z 1450 ([Vancomyncin+H]
+
). Interestingly, the m/z 725 ([Vancomycin+H]
2+
) ion 
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gives a % transmission of 67% at DF 48.8 kV/cm, suggesting that the trend observed here is 
not mass-dependant but also mass-to-charge dependant. Figure 2.5 shows that by applying a 
DF of 48.8 kV/cm, transmission of analyte ions is more critical for smaller ions (<500 Th) 
and should be considered during method development.  
 
Figure 2.5 A plot of % transmission (from DF 0 to 80 % of maximum) against m/z (n=3) 
2.4.2 Separation of isobaric, isomeric and near-mass ions 
The presence of isobaric interferences can be problematic in mass spectrometry, but ion 
mobility has the ability to separate ions of the same mass or close in mass. In this section 
three examples of isobaric and isomeric systems were studied to evaluate the additional 
benefits FAIMS offers to mass spectral analysis. 
2.4.2.1 Methylmalonic acid (MMA) and succinic acid (SA) 
In negative ion mode, the deprotonated ions of MMA and SA (m/z 117.02) are readily formed 
by ESI under fragmention
18
 both undergo the loss of carbon dioxide (m/z 117.02→73.02) due 
to in-source CID (Figure 2.6). The similarity of MMA and SA spectrum means that the 
analytes cannot be distinguished using mass spectrometry alone. 
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Figure 2.6 Negative ESI-MS of (a) MMA and (b) SA 
FAIMS spectra of the [M-H]
-
 and [M-HCO2]
-
 ions were acquired by running MMA and SA 
separately (Figure 2.7). The [MMA-H]
-
 intensity is 2x lower than [SA-H]
-
 (Figure 2.6) and 
Figure 2.7.a shows that with FAIMS spectra using the same signal intensity scale a much 
lower response of [MMA-H]
-
 is observed when compared with the [SA-H]
- 
ion peak. Plotting 
the data on a normalised scale allows the [MMA-H]
-
 peak to be observed. The large loss of 
signal intensity when changing from a DF of 0 Td to 180 Td suggests the high electric fields 
of DF cause [MMA-H]
-
 ion to fragment almost entirely before traversing the FAIMS device. 
Succinic acid Methylmalonic acid
(b)
(a)
85 
 
Interestingly a fragment peak of MMA is observed at CF -1.4Td whereas the fragment peak 
of SA is observed at CF -0.4 Td. The SA fragment overlaps almost exactly with the precursor 
SA ion, suggesting that the fragment is produced after the FAIMS device has transmitted 
[SA-H]
-
 because it is highly unlikely that two separate ions will have exactly the same peak 
position throughout DF range 180 to 240 Td. The MMA fragment is fully resolved from the 
precursor MMA ion peak, suggesting that fragmentation to the product ion m/z 73.02 occurs 
prior to FAIMS separation. There is a small contribution where the [MMA-CO2-H]
-
 fragment 
peak overlaps with [MMA-H]
-
 at CF -0.4 Td (640 counts) which is probably due to the poor 
transmission of the precursor ion (1286 counts). Increasing the DF above 180 Td causes the 
MMA fragment ion to shift in a positive direction bringing it closer to the SA fragment ion. 
In addition, the low mass of the fragment ion (m/z 73.02) means that transmission drops 
rapidly with DF (data not shown), making DF 180 Td the optimum DF for these isomers. 
The unique positioning of FAIMS technology at the inlet of a mass spectrometer allows ions 
formed at different stages in the ESI-MS interface to be distinguished. In this case, MMA 
fragments produced prior to the FAIMS device are separated directly by the FAIMS device 
from the SA fragments that are produced after the FAIMS device has transmitted the SA 
precursor ion. Where the FAIMS device was unable to separate MMA and SA, it is able to 
distinguish between the isobars by separating isobaric fragments that are produced by in-
source CID at different stages of the ESI source.  
MMA and SA form adducts with group I metal ions Li
+
, Na
+
 and K
+
 in a solution containing 
either lithium chloride or potassium chloride, sodium adducts were formed from sodium 
scavenged from glassware. Protonated molecules of MMA and SA were not investigated due 
to low abundances formed under acid conditions. The potential to separate the ions was 
investigated over the DF range 180 to 280 Td to determine the value of adduct formation. 
Discussion of adduct formation to improve FAIMS separation was described in Section 1.2.5. 
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Figure 2.7 SIR (m/z 117.02 and 73.02) showing FAIMS spectra of [MMA-H]
-
 (red), [MMA-
HCO2]
-
 fragment (pink), [SA-H]
-
 (dark green) and [SA-HCO2]
-
 fragment (light green) with 
(a) absolute intensities, and (b) normalised intensities (%); drying gas temperature was set to 
75 ˚C, DF to 180 Td, Fragmentor to 150 V, negative ESI mode 
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FAIMS spectra of Li
+
 and Na
+
 adducts of MMA and SA are shown in Figure 2.8. The 
presence of lithium chloride results in two peaks for both isobars at DF 200 Td. The signal 
intensity of the main peaks of [SA+Li]
+
 (CF -0.4Td) and [MMA+Li]
+
 (CF -0.1 Td) decrease 
rapidly beyond 220 Td. The smaller peaks observed for both ions (CF = 1.2 Td) decrease 
rapidly in signal above DF 200 Td. Figure 2.8.a shows that at DF 200 Td there is no 
separation of the isobars and no improvement in separation was observed at higher DFs. A 
strong overlap of sodiated adducts was observed at 200 Td (CF = 0 Td, Figure 2.8.b). 
Investigation into higher DFs showed that signal decreased with increasing DF and were at 
baseline at DF 220 Td. It is possible that both sodiated and lithiated ions show a large loss in 
signal due the low m/z and a weak binding affinity to sodium and lithium ions. The low 
response and poor separation of these ions demonstrates that sodium and lithium cannot be 
used to distinguish between these isobaric ions. 
Figure 2.8 Selected ion response of lithiated (m/z 125.0421) and sodiated (m./z 141.0158) 
adducts of MMA and SA with (a) lithium chloride, and (b) scavenged sodium from glassware 
scanned at DF 200 Td with drying gas temperature set to 150 ˚C  
Potassium chloride was used to promote adduct formation of MMA and SA with K
+
, FAIMS 
spectra was acquired across a DF range of 180 to 280 Td at 100 ˚C and 150 ˚C to explore the 
behaviour of potassiated ions (shown in Figure 2.9). Regardless of DF and temperature, the 
intensity of the [SA+K]
+
 ion peak does not significantly decrease with increasing DF as was 
observed with sodium and lithium. At DF 200 Td with dry gas temperature set to 100 ˚C, 
both [SA+K]
+ 
and [MMA+K]
+
 overlap at CF 0.1 Td (Figure 2.9.a). Increasing DF to 220 Td 
causes [SA+K]
+
 to shift to CF 0.2 Td and [MMA+K]
+
 to shift to 0.6 Td (Figure 2.9.b). 
[MMA+K]
+
 becomes better resolved at DF 240 Td with the CF maximum at 0.7 Td which is 
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between the main peak (CF 0.3 Td) and a small more shifted peak (CF 1.5 Td) (Figure 2.9.c). 
The source of the second small peak may be from a dimer fragmenting back to the 
potassiated adduct, although there is not a clear dimer peak in the mass spectra for either 
MMA (Figure 2.10.a) or SA (Figure 2.10.c) with potassium to support this theory. With the 
drying gas set to 150 ˚C and DF to 200 Td, [SA+K]+ is at CF 0.1 Td and [MMA+K]+ is at CF 
0.5 Td (Figure 2.9.d) which is different to the overlapped peak observed with the same DF at 
100 ˚C. Both [SA+K]+ and [MMA+K]+ shift with DF until at DF 240 Td the response for 
[MMA+K]
+
 is reduce to baseline (Figure 2.9.e-f). The best separation was achieved at DF 
240 Td with drying set to 100 ˚C with [MMA+K]+ at CF 0.85 Td there is only 1.7 % 
interference from [SA+K]
+
 despite a 2-fold reduction in [MMA+K]
+ 
response. 
A comparison of mass spectra of MMA (Figure 2.10.a and b) and SA (Figure 2.10.c and d) 
using potassium shows that in both cases, FAIMS-selection of either [MMA+K]
+
 or [SA+K]
+
 
results in making the FAIMS-selected ion (m/z 156.98, DF 240 Td, CF 0.3 and 0.85 Td 
respectively) the base peak in the mass spectrum (Figure 2.10.b and c) and mass spectra 
acquired without FAIMS-selection the potassiated adducts were at around 10% of the 
intensity of the base peak. The mass spectra shows that even with KCl in the sample, the 
sodiated ion (m/z 141.02) formed from scavenged sodium has a far higher response 
suggesting that these adducts are either more stable or more readily formed those formed with 
potassium. The change in peak position of analytes formed with group I metal ions shows the 
potential of forming different ions to improve separation and signal intensity compared to the 
more conventional protonated or deprotonated analyte ions. 
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Figure 2.9 Selected ion response (m/z 156.9898) showing FAIMS spectra of [MMA+K]
+
 and 
[SA+K]
+
 at drying gas temperature 100 ˚C with DF set to (a) 200 Td, (b) 220 Td, (c) 240 Td; 
and at drying gas temperature 150 ˚C with DF set to (d) 200 Td, (e) 220 Td, and (f) 240 Td 
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Figure 2.10 Mass spectra of MMA using (a) ESI-MS and (b) ESI-FAIMS-MS (DF 240 Td, 
CF 0.75 Td); and SA using (c) ESI-MS and (d) ESI-FAIMS-MS (DF 240 Td, CF 0.30 Td) 
with the drying gas set to 100 ˚C and with potassium chloride in solution to promote 
formation of potassium adducts 
DF 240 Td
CF 0.85 Td
DF 240 Td
CF 0.30 Td
(a)
(b)
(c)
(d)
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2.4.2.2 2β- and 6β-hydroxytestosterone 
2β-hydroxytestosterone (2β-HT) and 6β-hydroxytestosterone (6β-HT) are isobaric anabolic 
steroids with no unique MRM transition making them challenging to determine by mass 
spectrometry without chromatographic separation. Currently chromatographic methods offer 
the desired selectivity, but the analysis time is increased because of the chromatographic 
separation. There is a need for faster, high-throughput methods for the determination of 6β-
HT, particularly at the early stages of testing potential drug candidates. Rapid online-solid 
phase extraction (SPE) techniques offer a fast way to clean up samples prior to introduction 
into a mass spectrometer but do not separate 2β-HT and 6β-HT. FAIMS has the potential to 
offer a fast separation step that can filter ions before they enter the mass spectrometer and 
was investigated for 2β-HT and 6β-HT. 
 
The effect of temperature on peak location of the 2β-HT and 6β-HT isomers is shown in 
Figure 2.11.a-c. Peak height is highest at 150 ˚C but at 50 ˚C the two isomers are better 
resolved. The DF 240 Td is temperature adjusted in the FAIMS software, a positive shift for 
both isomers at lower temperature is observed and a better separation achievable at lower 
temperatures. The reason for the better resolution at 50 ˚C is that a lower temperature allows 
ions in the low-field stage of the asymmetric waveform to be more clustered making a greater 
difference between clustered and unclustered ions in the respective low and high field 
portions of the cycle. Optimum separation was determined to be at DF 232 Td with CF 1.9 
Td for 2β-HT and CF 1.5 Td for 6β-HT with the drying gas set to 50 ˚C (Figure 2.12.a). 
FAIMS-MS was combined with LC to demonstrate the separation of the mixture. Injection of 
a mixture onto a C18 column and analysis by LC-MS shows two resolved peak for 6β-HT 
(RT = 4.4 mins) and 2β-HT (RT = 4.75 mins) (Figure 2.12.b). FAIMS selection of ions at a 
6β-hydroxytestosterone2β-hydroxytestosterone
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CF of 1.9 Td results in the preferential selection of 6β-HT with only a baseline response for 
2β-HT (Figure 2.12.c-d).  
FAIMS separation may therefore be combined with off-line SPE for the selective 
determination of 6β-HT in the presence of 2β-HT. However, compatibility with online-SPE 
(featuring higher flow rates) requires the drying gas temperature to be at least 150˚C to 
prevent contamination of the ionisation source and aid desolvation to give sufficient signal 
for detection and low levels. 
Initially, separation at a higher temperature (150˚C) was attempted but, at temperatures >100 
˚C the required selectivity (5%) was lost and even setting the DF to 280 Td does not give the 
required selectivity (Figure 2.13.a). An alternative approach of adding solvents to carrier gas 
of FAIMS device is described in detail in the next chapter (Chapter 3). The addition of a 
water vapour (1% v/v) resulted in an improvement in separation at the higher drying gas 
temperature (150 ˚C) with the DF set to 300 Td and the sheath gas set to 250 ˚C. The higher 
drying gas temperature will aid desolvation and help prevent contamination of the source. 
The sheath gas is a heated gas that surrounds the ESI ion beam and can improve sensitivity. 
Increasing the sheath gas from 250˚C to 350˚C increases the signal for 6β-HT by ~3-fold 
without loss of selectivity (Figure 2.13.c). 
The FAIMS method was transferred to a triple quadrupole fitted with a miniaturised FAIMS 
chip, where the MRM transition m/z 305.2>269.4 will improve sensitivity. Optimising the 
FAIMS separation on the triple quadrupole MS, shows sufficient separation at DF 305 Td 
with 1.5 % water (Figure 2.14). At CF 1.65 Td and DF 305 Td (1.5 % water), there is a 
%RSD of 6.9% on the peak height of 6β-HT with 3.6% interference from 2β-HT, which is 
within the acceptable range (<5 %) for the quantitative determination of 6β-HT. 
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Figure 2.11 FAIMS spectra of 2β-HT (red) and 6β-HT (blue) at DF 240 Td with the drying 
gas set to (a) 50˚C, (b) 75˚C, and (c) 100˚C 
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Figure 2.12 Selected ion response of 2β- and 6β-HT at 0.1μM (m/z 305.2111 ±0.02) with the 
drying gas set to 50˚C using (a) direct infusion-FAIMS-MS (DF 232 Td), (b) LC-MS 
(FAIMS off), (c) LC-FAIMS-MS (CF 1.9 Td, DF 232 Td), (c) LC-FAIMS-MS (CF 1.5 Td, 
DF 232 Td) 
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Figure 2.13 Selected ion response (m/z 305.2) showing FAIMS spectra of 2β-HT (red) and 
6β-HT (blue) with the drying gas set to 150˚C with (a) dried nitrogen, DF 280 Td and sheath 
gas set to 250˚C; (b) 1% water (v/v) added to the drying gas, DF 300 Td and sheath gas set to 
250˚C, and (c) 1% water (v/v) added to the drying gas, DF 300 Td and sheath gas set to 
350˚C 
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 Figure 2.14 SRM (305.2>269.4) showing FAIMS spectra of 2β-HT (red) and 6β-HT (blue) 
at DF 305 Td with the drying gas set to 150˚C and sheath gas 350˚C with 1.5% water (v/v) 
added to the drying gas 
Quantitative performance was evaluated by using loop injections to produce data similar to 
an online-SPE method. Standards of 2β-HT and 6β-HT were used to test the potential for the 
separation. Loop injections of 6β-HT alone and a mixture of the 6β-HT and 2β-HT (both at 1 
μM) are shown in Figure 2.15. Without a FAIMS separation the peak is observed for 6β-HT 
when 2β-HT is absent from the sample (Figure 2.15.a). However with 2β-HT present the 
peak area is much higher (Figure 2.15.b) showing that there is a considerable amount of 
interference contributed by the presence of 2β-HT at equimolar concentration to 6β-HT. 
Figure 2.15.c and d show loop injections of 6β-HT in the absence of 2β-HT and 6β-HT with 
2β-HT. The corresponding peak areas for the SRM transition (305.2>269.4) being 4123 and 
4343 when setting the FAIMS to transmit 6β-HT selectively at 1.65 Td. Little difference is 
observed between the samples with and without 2β-HT present due to the significant 
reduction in interference from 2β-HT resulting from the FAIMS separation. 
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Figure 2.15 Loop injections-ESI-MS (no FAIMS) of (a) 6β-HT (1 μM), (b) 2β-HT and 6β-
HT (1 μM); Loop injections-ESI-FAIMS-MS (DF 305 Td, CF 1.65 Td, 1.5% water) of (c) 
6β-HT (1 μM), and (d) 2β-HT and 6β-HT (1 μM)  
Setting FAIMS to transmit 6β-HT also reduces the absolute signal, particularly at high DF, 
but comparison of DF = 0Td and DF = 305 Td (Figure 2.16) shows that despite a 2-fold drop 
in signal, the signal-to-noise ratio is doubled with the DF set to 305 Td, demonstrating the 
advantage of noise reduction by FAIMS helping to improve low levels of quantitation even in 
the SRM transition 305.2>269.4. 
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Figure 2.16 Selected ion response (m/z 305.2) of 6β-HT (1 μM) analysed using Loop 
injections-ESI-MS (no FAIMS) and Loop injections-ESI-FAIMS-MS (DF 305 Td, CF 1.65 
Td, 1.5% water) 
The use of a FAIMS separation for the quantitative determination of 6β-HT was further 
investigated by producing calibration plots using loop injections of 6β-HT and a mixture of 
6β-HT and 2β-HT without FAIMS separation (Figure 2.17.a and b) and with DF set to 305 
Td, CF set to 1.65 Td, with 1.5 % water added to the carrier gas to selectively transmit 6β-HT 
(Figure 2.17 c and d). Figures 2.17.a and 2.17.c show that for 6β-HT without 2β-HT present, 
both calibration plots produced with and without FAIMS are comparable, where good over 
the range 0.1 μM to 5 μM is observed. The lowest concentration used in Figure 2.17.c was 
used to estimate that the LOQ, which is below the required 0.17 μM, with a signal-to-noise at 
0.1 μM of 34:1. The calibration plot of 6β-HT with 2β-HT interference present and without 
FAIMS selection show a loss in linearity and poor R
2
 value of 0.465 (Figure 2.17.b) which 
could not be used for quantitative determination of 6β-HT even at high levels. The addition 
of FAIMS pre-selection of 6β-HT demonstrates that removal of 2β-HT regains the linear 
trend between peak area and concentration of 6β-HT with good precision (R2 = 0.999). The 
potential for using FAIMS combined with a fast method of sample introduction is 
demonstrated and is advantageous where chromatographic separation is not available on the 
timescale required in the fast-paced drug discovery industry.   
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Figure 2.17 Calibration plots showing peak area against [6β-HT] using Loop injection-MS of (a) 6β-HT, (b) 6β-HT with 2β-HT (1μM); and 
using loop injection-FAIMS-MS (DF 305 Td, CF 1.65 Td, 1.5% water) of (a) 6β-HT, (b) 6β-HT with 2β-HT (1μM)  
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2.4.2.3 DI-FAIMS-MS and DI-FAIMS-in-source CID-MS Analysis of Pharmaceutical 
Excipients 
Ions derived from the pharmaceutical excipients 2-hydroxy-4-octyloxybenzophenone 
(HOBP, m/z 327.1955) and PEG 400 were chosen as test analytes because the protonated 
HOBP and PEG n=7 oligomer (m/z 327.2013) are sufficiently close in mass (17.7 ppm mass 
difference) that these ions could not be resolved by the reflectron TOF mass analyser 
(resolving power required ~ 130K). Robust accurate mass measurement of these ions is 
therefore not possible without separation prior to mass analysis.  The two components were 
analysed as a mixture containing a 20 fold molar excess of the PEG (Figure 2.18). CV sweeps 
(-1 to +4 V) with the DF set to 48 kV/cm were used to determine the optimum CV required 
for selected transmission of protonated HOBP and PEG, and subsequent in-source 
fragmentation. The selected ion response for m/z 327.2 (Figure 2.18) shows that the 
protonated PEG n=7 and HOBP ions are resolved by FAIMS. 
 
Figure 2.18 FAIMS-MS CV spectrum (m/z 327.2) of HOBP and PEG 400 at DF 48 kV/cm 
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The mass spectrum of the mixture without FAIMS separation (Figure 2.19.a) shows the 
typical polymer distribution of PEG ions, with the HOPB unresolved from the protonated 
PEG (n=7) ion. The measured mass of the overlapping peaks is m/z 327.1994, a mass 
difference of 11.9 and -5.8 ppm from HOBP and PEG respectively. In-source CID-MS of this 
mixture gives a complex product ion spectrum dominated by PEG fragment ions (Figure 
2.19.b). Quasi-static FAIMS filtering (CV range 0.6– 0.7 V, DF 48 kV/cm) was used to 
transmit the HOPB ion selectively, which appears as the base peak in the resulting mass 
spectrum (Figure 2.19.c), with an observed mass of 327.1966 (3.3 ppm). The FISCID-MS 
product ion spectrum of the FAIMS-selected HOBP ion (Figure 2.19.d) shows the HOBP 
fragment ions free of interference from PEG fragment ion peaks, reducing the complexity of 
the mass spectrum and allowing unambiguous identification of the HOBP fragments.  
These observations demonstrate the mass spectral enhancement possible using FISCID-MS, 
through the FAIMS pre-selection of a precursor ion in a complex mixture, on the basis of 
differential mobility, prior to in-source CID. FISCID-MS allows the unresolved ions to be 
separated and a clean product ion spectrum to be obtained for HOBP using a single mass 
analyser with only minor modification of the ion source to incorporate the miniaturized 
FAIMS device. 
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Figure 2.19 MS, FAIMS-MS and FISCID-MS mass spectra of a mixture of HOBP and PEG 400 (1:20 molar ratio): (a) without FAIMS 
separation or in-source CID, (b) In- source CID-MS without FAIMS separation, (c) FAIMS-selected HOBP ion (CV = 0.6–0.7 V) without in-
source CID; (d) FISCID-MS product ion spectrum of the FAIMS-selected HOBP ion with in-source CID.  
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2.5 Conclusions 
The CCD experiment shows the FAIMS device exhibits a stable CV over a range of 
conditions meaning that once optimum FAIMS conditions are established, the solvent 
composition and flow rate of the HPLC and source conditions can be changed without 
causing significant changes in FAIMS spectra. A plot of %transmission against m/z showed 
that transmission and higher DFs is more critical for smaller ions, ions higher than 500 Th 
experience less than 2-fold loss in transmission. 
Separation of isobaric ions cannot always be achieved by increasing DF alone. The formation 
of deprotonated ions and adducts formed with group I metal ions and changing the 
temperature at the chip can potentially improve the separation of isobaric ions with similar 
functionality. However, whilst a lower temperature may offer an improvement in separation, 
higher temperatures are required for better desolvation. Adding water or other modifiers to 
the carrier gas may be an alternative for improving selectivity at higher gas temperatures. The 
potential to distinguish between isomers was not the only advantage observed when using 
FAIMS, reduction in chemical noise and simplification of mass spectra was also observed. 
Fragmentation mass spectra generated by in-source CID of FAIMS-selected ions provide 
enhanced selectivity for the qualitative and quantitative analysis of analytes in complex 
mixtures. FISCID-MS successfully separated pharmaceutical excipient ions that are too close 
in m/z value to be resolved by TOF-MS alone, providing improved accurate mass 
measurement and product ion spectrum free from interferences. FISCID-MS therefore offers 
significant improvements in selectivity for the mass spectrometric analysis of analytes using a 
single mass analyser, such as a TOF or quadrupole analyser, and has potential as an 
alternative to LC-MS/MS for qualitative and quantitative analysis, or for further enhancing 
selectivity using LC-FISCID-MS/MS routines.  
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Chapter Three 
Investigation of the Effect of Alcohol Gas Modifiers on 
Chip-Based FAIMS Separations of Peptides, Proteins 
and Small Molecules 
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3.1 Chapter Overview 
This chapter describes the development of a method for introducing solvent modifiers into 
the FAIMS carrier gas with the aim of investigating the effect on ion separation and 
conformer distribution. A modifier system was constructed for the introduction of methanol 
and butanol modifiers (0.1-2% v/v) and evaluated using small molecules, peptides and 
proteins. The separation of the small molecules was strongly influenced by the DF, modifier 
type and modifier concentration. The CF spectra of the peptides investigated showed 
narrower peaks in the presence of modifiers than when alcohol modifiers were absent, where 
broad peaks were associated with changes in conformations or solvation of the peptide ions 
conformers. The narrower peaks aided in distinguishing between peptides with variations in 
amino acid sequence. Proteins ions also showed sharper CF peaks in the presence of alcohol 
modifiers and changes in charge distribution.  
3.2 Introduction 
A variety of methods have been utilised to improve FAIMS separations. These methods have 
included: changing the analyser gap width/geometry; temperature; waveform shape and 
frequency; ion residence time; and carrier gas composition which were all discussed in 
Chapter 1. Forming different adducts with group I metal ions was also shown to be effective 
in Chapter 2. The carrier gas typically consists of dried nitrogen or nitrogen/helium 
mixtures
1,2
 and under these conditions sufficient separation cannot always be achieved by 
changing DF and temperature, and high consumption of helium can also prove expensive for 
routine use which has led to exploration of alternative methods. Changing the composition of 
the carrier gas by the addition of modifiers is an alternative approach to improving 
separations, where mixtures of gases and solvent vapour modifiers alter the alpha 
coefficient.
3,4
 Using solvent vapour to modify the carrier gas of FAIMS analysers has been 
reported to significantly increase in selectivity
5
 and lower costs associated with reducing the 
consumption of helium. Gas modifiers are neutral molecules that compete with the ion-dipole 
clustering/declustering mechanism of other molecules found in the nitrogen carrier gas. The 
non-covalent interaction between gas modifier and analyte ion makes it possible, in principle, 
to select a gas modifier based on these interactions to improve selectivity between analytes 
with different chemical properties.
5
 
Methods for introducing liquid modifier vapours into the carrier gas have either used a 
bubbler system
6
 or direct infusion of a liquid into a heated region through to the carrier gas.
4
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Gas modifiers compete with the clustering/declustering mechanism, changing the CCS of 
clustered ions, particularly in the low field portion of the asymmetric waveform and increase 
the difference between the clustered and partially, or fully declustered ion, potentially 
improving separation and analytical space.
7
 
The effects of modifying the carrier gas of a miniaturised FAIMS device using different 
alcohol modifiers was investigated using small isobaric molecules (phthalic acid isomers), 
peptides and proteins. To date, studies with gas modifiers have been focussed on smaller 
molecules (<1000 Da), where clustering with gas modifiers creates a bigger difference 
between the low field and high field CCS and offer a greater chance of improving separation. 
The effect of modifiers on larger molecules (e.g. proteins) has not been described in the 
literature. These studies have the potential to provide new insight into the effect of alcohol 
modifiers on the FAIMS spectra of larger biomolecules. 
3.3 Materials and Methods 
3.3.1 Chemicals 
Phthalic acid, isophthalic acid, terephthalic acid, bradykinin acetate, bombesin, MRFA, 
MFAR, cytochrome C, ammonium acetate, methanol (HPLC grade), water (HPLC grade), 
formic acid and 2-butanol were obtained from Sigma aldrich.  
3.3.2 Sample Preparation 
Phthalic acid solutions were prepared in methanol and diluted using methanol/water (90:10 
with 0.2 mM ammonium acetate) to a concentration of 60 nmol/μl. Peptide and protein 
samples were dissolved in methanol/water (50:50, 0.1% formic acid) and diluted to 10 
pmol/μl. 
3.3.3 Instrumentation 
ESI-FAIMS-MS analyses 
The chip-based FAIMS prototype device 2 (Owlstone, Cambridge, UK), previously described 
in Section 2.3.3, was located in the modified Jet Stream ESI source of an Agilent 6230 TOF 
MS. The asymmetric waveform was supplied by the dispersion field (DF) feeder unit through 
a hole in the desolvation assembly. The FAIMS device used in these studies had a 100 μm 
gap between the electrodes arranged as multiple parallel channels with a 700 μm path length. 
109 
 
Dispersion fields (200-300Td) were applied with a 27 MHz frequency and compensation 
field (CF) scanned between -5 and + 5 Td. Nitrogen (99.5% Purity) was used as the carrier 
gas for the FAIMS device and ESI source. Solvent modifier vapour was introduced into the 
drying gas line (which supplied the carrier gas to the FAIMS chip), using a constructed 
interface described below (Figure 3.1). Samples were directly infused (10-15μL/min) into the ESI 
ion source which was operated in negative ion mode for the phthalic acids and positive ion 
mode for proteins and peptides. ESI-FAIMS-MS conditions were: sheath and drying gas 
flows, 9 and 7 L/min; sheath and drying gas temperatures, 250°C and 150°C; nebuliser 
pressure, 35 psig; spray shield, 2500 V; capillary voltage and nozzle voltage, 3000 V and 
2000 V respectively. Fragmentor voltage was varied between 150 and 300 V, MS acquisition 
rate was set to 10 scan/s. 
Solvent Delivery System 
The solvent delivery system was constructed in-house to enable introduction of aliphatic 
alcohol gas modifiers (up to 3% v/v) into the nitrogen carrier gas flow (Figure 3.1). Liquid 
solvent was introduced using either a syringe pump or a HPLC binary pump (Agilent 1200 
series) at flow rates in the range 10-1000 μl/min using a standard PEEK union and tubing, 
connected to a stainless steel pipe (0.8 mm O.D., 0.6 mm I.D., 37.9 mm length, Swagelok) 
which passed through the tee-union (1/8 inch) and to the end of the nebuliser where it 
protruded (2.2 mm) from a piece of stainless tubing (1/16 inch O.D., 0.045 inch I.D., 123.1 
mm length) fitted to the opposite end of the tee-union. PTFE tubing (1/4 inch) was fitted to 
the outlet of the drying gas line where it was connected to stainless steel tubing (1/8 inch) 
which formed a circle before connecting the tee-union. The gas would pass through the tee-
union and around the stainless steel liquid line to provide gas (nitrogen) at the tip of the 
nebuliser. The interface was heated with heating cord (HTC-060, Omega Ltd), temperature 
controlled using a thermocouple (type K, RS Components Ltd.) in the range 80 ˚C - 120 ˚C, 
below the 150 ˚C of the drying gas to prevent temperature fluctuations in the FAIMS device, 
but high enough so that vapours would not condense before reaching the FAIMS device. The 
solvent delivery system was insulated to keep the temperature constant. Solvent vapour from 
the nebuliser passes through the stainless steel tubing (1/4 inch) to the drying gas inlet of the 
ESI source. 
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Figure 3.1 Schematic of solvent delivery system for introduction of solvent vapour modifiers into the drying gas, featuring a nebuliser and 
heating to the drying gas going in and to the modified drying gas going out for improving evaporation of the liquid solvent 
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3.4 Results and Discussion 
The solvent vapour delivery system was constructed to introduce organic modifiers into the 
nitrogen carrier gas stream. The modifier interface was capable of vaporising a range of 
solvents including water, low molecular weight alcohols and acetonitrile to generate modifier 
concentrations up to 2 % (v/v) in nitrogen. Phthalic acid isomers were used initially as test 
compounds to evaluate effects of methanol and butanol modifiers on small molecules 
analysed by the miniaturised FAIMS. The effect of gas modifiers on larger molecules, such 
as proteins is also discussed in this section. 
3.4.1 Solvent Vapour Clusters in the Mass Spectrum 
The nebuliser solvent delivery system was assembled and tested externally from the mass 
spectrometer to assess if it could produce solvent vapour doped nitrogen. PTFE tubing was 
attached at the outlet of the nebuliser system to help assess whether a droplet free vapour was 
formed by visual inspection. Water was used to test the system because it is a more 
challenging solvent to evaporate than the aliphatic alcohols used for this study, due to its 
higher boiling point. Initially, a LC pump was used to introduce water (0.1-1 ml/min) to the 
nebuliser system. A mist of droplets was observed a short distance from the outlet of the 
nebuliser system as a result of incomplete desolvation of the water droplets. Heating cord (set 
to 100 ˚C) was used to heat the solvent delivery interface and nebuliser and pre-heat the gas 
to aid in the initial evaporation step. Heating the interface resulted in a clear, mist-free flow 
of modified nitrogen gas. Once a reliable system for evaporating liquids was established, the 
effect of introducing solvent vapours to the drying gas flow of the TOF mass spectrometer 
could be investigated. 
Methanol vapour was initially introduced to the drying gas using methanol/water (50:50, 
0.1% FA) ESI solution. Figure 3.2.a shows that when 1% (v/v) methanol vapour was added 
to the carrier gas, both singly protonated and sodiated clusters of methanol were observed in 
the mass spectrum with the n = 4 cluster of protonated methanol being the base peak. The 
peaks associated with methanol clusters were not observed in the absence of a methanol 
vapour. 2-butanol also produced several clusters with [(BuOH)3+H]
+
 being  the base peak 
(Figure 3.2.b). I think that it is most likely that the observation of protonated [(MeOH)n+H]
+
 
and [(BuOH)n+H]
+
 clusters (in the presence of methanol and butanol modifiers) arise as a 
result of proton transfer from protonated water clusters formed in the ESI source because of 
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the higher proton affinities of 2-butanol (815 kJ/mol) and methanol (761 kJ/mol) compared to 
water (697 kJ/mol). 
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Figure 3.2 Mass spectra showing ESI-MS of methanol:water (50:50, 0.1% formic acid) analysed with (a) 1% methanol (v/v), and (b) 1 % 2-
butanol added to the drying gas 
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3.4.2 Application of Gas Modifiers to Improve Separation of Phthalic Acid positional 
isomers 
Separation of deprotonated isomeric o-, m- and p-phthalic acid is challenging using mass 
spectrometry alone and requires chromatographic or other pre-separation for them to be 
distinguished. Some differences are observed when using electron ionisation (EI) although 
this is not sufficient at low levels.
8
 Infusion of each phthalic acid into the ESI-FAIMS-MS 
source was used to explore the potential for separation using FAIMS in dried nitrogen. The 
selected ion responses (SIR) of m/z 165 show that the phthalic acid isomers do not separate at 
DF 230 Td when using dried nitrogen as the carrier gas, although the location of CF maxima 
does vary for each isomer (Figure 3.3). Higher DFs do not improve the separation between 
the isomers. 
 
Figure 3.3 FAIMS spectra of o-phthalic acid (red), m-phthalic acid (blue) and p-phthalic acid 
(green) using a dried nitrogen carrier gas with the FAIMS device set to DF 230 Td 
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The effect of methanol and 2-butanol modifiers was investigated over a range of 
concentrations and DF (200 to 300 Td). Methanol was increased from 0.01 % (v/v) methanol 
to 3 % methanol (v/v) No significant shift was observed up to 0.1 % but at higher modifier 
concentration all of the phthalic acid peaks began to shift towards a negative CF as shown in 
Figure 3.4 for deprotonated p-phthalic acid. At 0.1 % and 0.5 %, there is an initial increase in 
signal. It seems that for smaller ions, a small amount of modifier improves response, which 
could be a result of the methanol clustering with the small ions and giving it a bigger m/z, 
reducing its loss to diffusion because losses are greater for smaller m/z ions. At 1 % and 
above, the signal decreases rapidly, which may result from energetic collisions or due to ion 
scattering at higher modifier concentration. 
 
Figure 3.4 FAIMS spectra (SIR 165.0193) showing the effect of peak position of 
deprotonated p-phthalic acid in the presence of methanol (0-3 % v/v) at DF 230 Td 
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Phthalic acid isomers were selected as a model for testing the constructed modifier system 
and the effect of modifiers with chip-based FAIMS because behaviour of the compounds 
with FAIMS was discussed in the literature. Depending on the modifier type, the isomers 
change the order in which they appear in the FAIMS spectrum.
9
 A comparison of the effect 
of DF on the CF peak location of each phthalic acid with dried nitrogen, 1% methanol and 
1% 2-butanol is shown in Figure 3.5. In dried nitrogen, the phthalic acids shift in a positive 
direction, there is little separation and the isomers do not change in order. The addition of 1% 
methanol reduces the positive shift and instead the CF fluctuates between positive and 
negative shifts with increasing DF (Figure 3.5.a). The phthalic acid peaks are further apart 
with methanol than they are with dried nitrogen. Adding 2-butanol to the carrier gas seems to 
magnify the effect observed with methanol. The positive shift with DF using dried nitrogen is 
now a negative shift for m-phthalic acid and p-phthalic acid. Interestingly o-phthalic acid has 
the most negative CF shift (-1.7 Td) at DF 200 Td but shifts towards the positive CF resulting 
in a different order in the FAIMS spectrum depending on the DF applied (Figure 3.5.b). The 
order of the phthalic acids in dried nitrogen and 1% methanol is the same above DF 240 Td. 
m-Phthalic acid and p-phthalic acid remain close and in the same order at all DFs studied. 
The change in peak positions with DF and change in order in the FAIMS spectrum of the 
isomers suggests that the solvent modifiers added to the chip region are influencing the 
clustering/declustering mechanism and that a true modifier effect is occurring with 
miniaturised FAIMS when using a nebuliser to introduce solvent vapours. It is likely that the 
phthalic acid ions and modifier molecules are interacting through hydrogen bonding. The 
reason for o-phthalic acid behaving differently to m- and p-phthalic acids may be due to the 
adjacent position of the acid groups of o-phthalic acid resulting in intramolecular hydrogen 
bonding. Internal hydrogen bonding will not occur with m-phthalic acid or p-phthalic acid 
because the acid groups are positioned too far apart, resulting in little difference between 
them. There are two possibilities for o-phthalic acid changing from type A to type C, 
discussed previously in Section 1.2.1, effective temperature (Teff) and collisional cross 
section (CCS). In the event of a decreasing mobility (K) with increasing DF (type C), the 
CCS is either smaller in the low field portion or bigger in the high field portion. It is possible 
that without the internal H-bonding occurring in the m- and p-phthalic acids, the 2-butanol 
molecules form a stronger H-bond that is difficult to break in the high-field portion so a 
clustered ion is retained, decreasing the high field mobility. The internal bonding of o-
phthalic acid reduces the number of 2-butanol molecules that can H-bond to its acid groups as 
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for m- and p-phthalic acids, so the ion will become more declustered in the high field than m- 
and p-phthalic acids and have increasing mobility with increasing DF (Type A). A recent 
study on predicting CV of alkyl benzoic acids in the presence of alcohol modifiers showed 
that despite good accuracy between predicted and experimental values, ions that changed 
from type A to type B ions prevented prediction.
10
  
Not only have the peak positions of the isomers changed but peak heights are also affected by 
methanol concentration and DF dependent. Figure 3.6.a shows that o-phthalic has the highest 
intensity at DF 250 Td with 1% methanol, however the intensity decreases when the DF is 
increased to 290 Td, where m-phthalic acid has the highest intensity (Figure 3.6.b). Despite 
the big increase in DF, the peak locations of the isomers are almost unchanged. These 
conditions allow the p-phthalic acid to be selectively transmitted by FAIMS; however the 
other o- and m-phthalic acid isomers cannot be clearly distinguished. Increasing the 
concentration of methanol vapour causes a bigger shift but a large loss in intensity was also 
observed (Figure 3.4). An alternative to increasing concentration is to explore different 
modifiers, Figure 3.5.b shows that 2-butanol offers greater peak shifts and alters the peak 
order throughout the DF range 200 to 300 Td giving the potential for gaining selectivity 
between the isomers where methanol could not.  
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Figure 3.5 Peak location (n=3) of o-phthalic acid (red), m-phthalic acid (blue) and p-phthalic 
acid (green) with (a) dried nitrogen, (b) 1% methanol, and (c) 1% 2-butanol 
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Figure 3.6 FAIMS spectra of o-phthalic acid (red), m-phthalic acid (blue) and p-phthalic acid 
(green) with 1% methanol set to (a) 250 Td, (b) 290 Td 
A comparison of FAIMS spectra of the phthalic acid isomers at two different 2-butanol 
concentrations and DFs is shown in Figure 3.7. At 1% v/v 2-butanol, DF 290 Td gave the 
best separation (Figure 3.7.a). Increasing the 2-butanol concentration to 2% v/v 2-butanol 
resulted in a reduction to noise level at DF 290 Td due to either a combination of suppression 
of analytes at higher modifier concentration or loss in transmission typically seen at high DF. 
However, 2% 2-butanol and a DF of 210 Td, where little separation was observed with 1% 2-
butanol, resulted in a big improvement in separation of the isomers (Figure 3.7.b). 
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Interestingly, if the DF had been set to 290 Td (based on the separation achieved with 1% 2-
butanol) during the investigation of the effect of changing 2-butanol concentration, the 
separation at 210 Td with 2% 2-butanol would have been missed. These data demonstrate 
that when exploring the use of modifiers to optimise selectivity and sensitivity the combined 
influence of modifier type, modifier concentration and DF on FAIMS behaviour of ions 
needs to be explored. The effect of temperature also needs to be considered as it may 
influence the differential mobility of ions in the presence of a modifier. 
Resolution was calculated for the phthalic acids in dried nitrogen, 1% 2-butanol at DF 290 Td 
and 2% 2-butanol at DF 210 Td using equation 3.1 to determine which conditions offer the 
best separation. The CF peak maximum and width at half maximum height for the phthalic 
acid are shown in Table 3.1. The presence of 2-butanol results in a slightly greater peak width 
with 1% 2-butanol and a narrower width at 2% for o-phthalic acid compared to dried 
nitrogen. Peak width decreased with 1% and 2% 2-butanol for the m- and p-phthalic acids. 
Peak location and width at half maximum was used to calculated resolution between each 
pair of isomers, shown in Table 3.2. Dried nitrogen gives the worst resolution in all cases. 
The resolution of m-phthalic acid and p-phthalic acid is best at 1% 2-butanol. Resolution 
between o-phthalic acid and p-phthalic acid is also best at 1% 2-butanol, but resolution 
between o-phthalic acid and m-phthalic acid is best at 2% 2-butanol. Figure 3.7 shows that 
there are additional peak features at around 10% relative intensity in the response of 2% 2-
butanol (Figure 3.7.b). The identity of these ions is not known. FAIMS can be used as a filter 
and ‘hop’ between static CF/DF values to transmit FAIMS-selected analyte ions. At 1% 2-
butanol, there is considerably less isomer interference when selecting the CF maximum for 
each isomer than if isomers were being selected with 2% 2-butanol, where interference is 
close to 10%. Based on this observation, 1% 2-butanol with DF set to 290 Td would be the 
optimum conditions to use to analyse each of the phthalic acid isomers. 
2(CF2−CF1)
𝑤0.5 (2) +𝑤0.5 (1)
        Equation 3.1 
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Figure 3.7 FAIMS spectra of o-phthalic acid (red), m-phthalic acid (blue) and p-phthalic acid 
(green) with (a) 1% 2-butanol set to 290 Td, and (b) 2% 2-butanol set to 210 Td 
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Table 3.1 Peak maximum (CF) and peak width and half maximum height (w0.5) of o-, m- and 
p-phthalic acid with dried nitrogen and 1% 2-butanol 
Carrier Gas 
 
 
o-phthalic m-phthalic p-phthalic 
CF /Td w0.5 /Td CF /Td w0.5 /Td CF /Td w0.5 /Td 
Dry N2 (DF 
290 Td) 
 1.7 0.53 1.5 0.53 1 0.6 
1% 2-BuOH 
(DF 290 Td) 
 
 
-0.5 0.65 -1.9 0.47 -2.7 0.34 
2% 2-BuOH 
(210 Td) 
 -2.7 0.4 -1.2 0.3 -1.8 0.4 
 
 
Table 3.2 Peak resolution between each phthalic acid pair, calculated from width at half 
maximum height 
Carrier Gas 
Resolution 
o- and m-phthalic 
acid 
m- and p-phthalic 
acid 
o- and p-phthalic 
acid 
Dry N2 (DF 
290 Td) 
0.22 0.52 0.73 
1% 2-BuOH 
(DF 290 Td) 
1.47 1.16 2.61 
2% 2-BuOH 
(210 Td) 
2.5 1.0 1.3 
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3.4.3 Exploring the Effect of Gas Modifiers on Peptides and Proteins 
The nebuliser-based solvent modifier system was used in the previous section to demonstrate 
that small ions can be shifted in FAIMS spectra when adding solvent vapours to the gas flow 
that primarily contributes to the carrier gas flow of the FAIMS analyser. However, there is 
little reported evidence of the effect of solvent vapours (or gas modifiers) on larger ions, like 
peptides and proteins. In this section, the effect of solvent vapours on the FAIMS spectra and 
mass spectra of peptides and proteins is discussed. 
Bombesin and Bradykinin in dried nitrogen and 2-butanol 
The effect of 2-butanol on doubly charged bradykinin (Bk) and bombesin (Bo) was initially 
explored. The peak shape of the [Bk+2H]
2+
 ion suggests that multiple partially resolved 
conformers may be present when analysed with dried nitrogen carrier gas (Figure 3.8.a). This 
is consistent with reported drift-tube and FAIMS spectrum of this ion.
11,12
 The addition of 2-
butanol (0.25%) results in the broad peak becoming narrower (Figure 3.8.b), but must involve 
the collapse of several distinct conformers to a single conformer, or a narrow range of 
conformers in the presence of 2-butanol vapour. The intensity for [Bk+2H]
2+
 at CF 1.2 Td is 
reduced, enabling the selective transmission of [Bo+2H]
2+
 with less interference from 
[Bk+2H]
2+
 (Figure 3.8.i and ii). [Bk+2H]
2+
 has a negative CF shift  at higher levels of 2-
butanol, becoming more overlapped with [Bo+2H]
2+
 (data not shown). 
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 Figure 3.8 CF spectra of [Bo+2H]
2+
 (SIR m/z 810) and [Bk+2H]
2+
 (SIR m/z 530) at DF 210 
Td with: (a) dried nitrogen and (b) 0.25% 2-butanol; and (c) mass spectra from CF spectra 
(indicated by grey line) using: (i) dried nitrogen, and (ii) 0.25% 2-butanol 
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MRFA and MFAR 
Earlier in this section, the separation of phthalic acids demonstrated that small ions with little 
structural differences could be distinguished using FAIMS-MS by the addition of 2-butanol 
to the carrier gas. Consequently, the possibility of applying this method to peptide ions that 
differ only in amino acid sequence was investigated. The potential for separating sequence 
isomers MRFA and MFAR using FAIMS was explored using dried nitrogen, methanol and 2-
butanol at the 1% v/v level as the carrier gas. Figure 3.9.a demonstrates that the protonated 
ions could not be resolved using only dried nitrogen at DFs up to 300 Td, but the location of 
the peak maximum for the peptides does differ with protonated MFAR at CF 2.6 Td and 
protonated MRFA at CF 3.1 Td. The presence of either methanol or 2-butanol results in a 
negative CF shift compared to the peak location in dried nitrogen (Figure 3.9.b-c). Protonated 
MFAR shifts from CF 2.6 Td to 2.3 Td by the addition of methanol and to CF 1.4 Td when in 
the presence of 2-butanol (both at 1% v/v). Protonated MRFA also shifted negatively, from 
CF 3.1 Td to 2.7 Td by adding methanol to the carrier gas, and to CF 1.9 with 2-butnaol. 
Despite the negative shift, the protonated peptides retain positive CF values unlike the 
negative CF values observed with the phthalic acids, which suggests that the magnitude of 
the modifier effect is dependent on size or mass. The difference between the peak maxima is 
affected by the addition of alcohols to the carrier gas, in fact 2-butanol addition resulted in 
the peak maximum of MRFA and MFAR being closer (0.4 Td) than when in the absence of 
alcohol (0.5 Td difference). However, even though the peaks get closer, the protonated 
MRFA peak is narrower with the addition of 2-butanol, due to the asymmetry on the left hand 
side of the MRFA peak being removed. This results in a partial separation of MRFA and 
MFAR in the presence of 1% v/v 2-butanol modifier which means that MFAR could be 
transmitted by selecting a point CF of ~1.2 Td which would remove most of the MRFA 
interference. 
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Figure 3.9 CF spectra of SIR m/z 524.1 at DF 300 Td with: (a) dried nitrogen; (b) 1% methanol; (c) 1% 2-butanol 
127 
 
Proteins: Cytochrome C 
The effect of gas modifiers on proteins has not previously been explored so cytochrome c 
was selected as it is a commonly used model protein.
13
 Denatured cytochrome C was 
introduced into the ESI source with different drying gas compositions. Dried nitrogen results 
in multiple peaks which could be associated with different conformers or different levels of 
hydration of the protein. The number of peaks present is dependent on charge stage, with +12 
giving 2 peaks and +19 3 defined peaks (Figure 3.10). The addition of methanol vapour 
reduces the number of peaks observed at higher charge states (Figure 3.10.b-c) whereas lower 
charge states (e.g. +12) there is no change in the number of peaks seen in the FAIMS 
spectrum (Figure 3.10.a) and no shift in peak location that would usually be observed with 
smaller ions.  
The +20, +21 and +22 charge states of cytochrome C were observed in the mass spectrum 
only under dried nitrogen conditions, but were reduced to baseline by addition of 1% 
methanol modifier (Figure 3.11). The higher charge states produce more peaks in the FAIMS 
spectrum which appear on the negative side of the peaks that exist at lower charge states, 
suggesting that it is the unfolded conformers that are being removed or modified by the 
addition of methanol. The higher charge states that are suppressed are likely to be more 
unfolded conformations than the lower charge states that are much less affected by methanol 
vapour. For cytochrome C to produce fewer peaks in the FAIMS spectrum, it could be 
hypothesised that methanol is either causing a charge state reduction/stripping effect or a 
change in conformation. In these preliminary studies, the existing higher charge states lose 
peaks associated with unfolded conformers at lower concentrations before there is a reduction 
in the more folded conformers (Figure 3.10.b) which may suggest that either the unfolded 
conformers are more exposed for charge stripping or that the protein is favouring a more 
folded conformation. A study of alcohol modifiers suggested loss of ions may be due to 
charge exchange to a modifier with a higher proton affinity.
10
 More experiments are needed 
to further understand the cause of the effect that is seen with cytochrome C in the presence of 
modifiers. 
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Figure 3.10 CF spectra of Cytochrome c charge states: (a) +12 (m/z 1030.9), (b) +18 (m/z 
687.6), (c) +19 (m/z 651.5); at DF 300 Td with dried nitrogen (dashed line), 0.5% methanol 
(grey line) and 1% methanol (black line) 
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Figure 3.11 Mass spectra of Cytochrome C with (a) dried nitrogen, and (b) 1% methanol; without FAIMS separation 
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3.5 Conclusion 
Significant shifts in CF peak maxima were observed for small molecules with % level 
modifiers. Positional isomers of phthalic acids could be selectively transmitted through the 
FAIMS device depending on the DF, choice of modifier and modifier concentration. The CF 
spectra of peptides and proteins produced fewer peaks in the CF spectrum when alcohol 
modifiers were introduced into the carrier gas, showing a preference for some conformers. 
CF peak shifts with the addition of a modifier are greater for small molecules, where the 
difference between clustered and declustered ions is larger. Separation, selectivity and signal 
intensity of analytes are influenced by the choice of modifier, the modifier concentration and 
the applied dispersion field. 
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Chapter 4 
Direct Analysis of Pharmaceutical Impurities by Direct 
Infusion and Thermal Desorption combined with Field 
Asymmetric Waveform Ion Mobility Spectrometry-
Mass Spectrometry 
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4.1 Chapter Overview 
The first part demonstrates the rapid, direct determination of N-methyl pyrrolidine (NMP), an 
impurity in the cephalosporin antibiotic cefepime, by direct infusion ESI combined with field 
asymmetric waveform ion mobility spectrometry-mass spectrometry (ESI-FAIMS-MS). The 
addition of a chip-based FAIMS separation prior to detection by time-of-flight mass 
spectrometry enables selective transmission of NMP in the presence of cefepime without 
interference from NMP formed by in-source CID. The limits of detection and quantification 
of NMP in cefepime were well below the 0.3% (w/w) threshold concentration for NMP in 
cefepime.  
The second part of this chapter shows thermal desorption in combination with FAIMS-MS 
for the rapid, direct analysis of isobaric potentially genotoxic impurities (PGIs) in a surrogate 
active pharmaceutical ingredient. PGI vapours released by thermal desorption were ionized 
by extractive electrospray ionization. FAIMS-selected PGIs were detected below the 1 ppm 
threshold of toxicological concern.  
4.2 Part A: Cefepime and its impurity N-methyl pyrrolidine 
4.2.1 Introduction 
Cefepime (I) is a fourth-generation cephalosporin antibiotic that was developed as a broad 
range activity antibiotic in the 1990s.
1,2
 Cefepime was found to be particularly effective 
against pseudomonas aeruginosa strains which exhibited resistance against other 
cephalosporin antibiotics, such as ceftazidime and cefotaxime.
3
 Cefepime has greater activity 
against Gram-negative bacteria compared to other cephalosporins,
4
 and is used to treat a wide 
degree of infectious diseases.
5
 However, cefepime is unstable and slowly degrades over time. 
The degradation rate is greatly increased at higher temperatures (25-37 ˚C) and in an aqueous 
solution, the loss affects the antibiotic activity significantly enough that it is recommended 
cefepime not be used for clinical use in aqueous conditions at >25 ˚C for more than a few 
hours.
6
 
134 
 
 
    I          II 
The impurity N-methyl pyrrolidine (NMP, II) may be present in cefepime samples as a result 
of degradation of the drug. NMP has been reported as having unknown toxicity by the US 
Environmental Protection Agency,
7
 and the potential for toxicity to patients receiving the 
drug is yet to be determined. An experimental study performed on monkeys, in which NMP 
(50 mg/kg) was administered over 28-30 consecutive days resulted in them developing 
esotropia and ataxia.
8
 The dosage of NMP used in the study was much greater than the 
amount expected to be received in a daily dose of cefepime (~6g) administered to patients, 
but the presence of the potentially harmful impurity is still undesirable. It has been reported 
that an increase in the NMP level is proportional to the decline in the antibiotic potency of 
cefepime.
9,10
 Monitoring the level of NMP in cefepime is, therefore,  important for ensuring 
drug quality for clinical use and a threshold concentration of NMP in cefepime has been set at 
0.3 % (w/w). 
The determination of NMP in cefepime presents an analytical challenge because of the rapid 
degradation of cefepime to NMP in aqueous solution above 4 ˚C and outside the pH range 4-
6, resulting in the presence of higher levels of NMP in solution than are present in the solid 
cefepime sample. At present, there are four main techniques that have been employed for 
NMP determination: high performance liquid chromatography (HPLC), ion chromatography 
(IC), capillary electrophoresis (CE) and gas chromatography (GC).
5,6,9-11
 There are limitations 
associated with all these techniques. The HPLC method requires a mobile phase of pH 2 and 
the IC method uses a column temperature of 40 ˚C; both of these conditions could lead to 
degradation of cefepime and reduce measurement accuracy. Poor detection and quantification 
limits for CE and the use of a solvent with high toxicity, pyridine, to extract NMP for the GC 
NMPCefepime
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technique makes these methods less desirable for routine analysis of NMP.  The preparation 
of a cefepime sample for analysis therefore requires either the extraction of the NMP from 
the cefepime matrix to minimise the contribution from NMP produced by degradation in 
solution prior to analysis, or rapid analysis of the sample solution before significant 
degradation occurs.
12
 
A further challenge in the determination of NMP in cefepime is that the singly and doubly 
protonated cefepime generated by electrospray mass spectrometry (ESI-MS) are readily 
fragmented in the mass spectrometer interface by ‘in-source’ collision-induced dissociation 
(in-source CID) to form protonated NMP. The NMP generated by in-source CID interferes 
with response from the protonated NMP formed from NMP present in the cefepime sample, 
since NMP resulting from the sample and via in-source CID cannot be distinguished by mass 
spectrometry alone. 
In this chapter, the potential for combining a miniaturised FAIMS device with direct 
infusion-ESI-MS to remove interference from NMP fragment ions generated by in-source 
CID, enabling the determination of NMP in cefepime is demonstrated and the quantitative 
performance evaluated. 
4.2.2 Materials and Methods 
4.2.2.1 Chemicals 
Cefepime was obtained from Orchid Chemicals and Pharmaceuticals Limited (Chennai, 
India). N-methyl pyrrolidine was supplied by Sigma-Aldrich Limited (Gillingham, UK). 
4.2.2.2 Sample Preparation 
NMP standards 
A stock solution of NMP (1 mg/ml) was prepared in methanol/water (50:50). The stock was 
subsequently diluted to 1 μg/ml with methanol/water (50:50) + 0.1% formic acid. A series of 
dilutions in the range 0.01 – 1 μg/ml (2-fold at each step) were used for standard addition 
experiments. 
Cefepime samples 
Fresh solutions of cefepime (5 mg/ml) were prepared in methanol 10 minutes prior to 
analysis. A single 100-fold dilution of the cefepime solution (to 50 μg/ml, 10μl) in 
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methanol/water (50:50) + 0.1% formic acid (990 μl), or NMP solution (500 μl + 490 μl 
diluent) for the standard additions calibration, was performed immediately before analysis. 
NMP solution and methanol/water (50:50) + 0.1% formic acid portions were combined 
before preparation of cefepime samples so that weighing cefepime, dissolving cefepime, and 
transferring  a 10 μl aliquot of cefepime solution to the diluted NMP solution were the only 
steps performed between each acquisition. 
4.2.2.3 Instrumentation 
Sample solutions and standards were infused (15 μl/min) using a syringe pump into the 
JetStream ESI source of an Agilent 6230 TOF MS (Agilent Technologies, UK) operated in 
positive ion mode. The ESI source was operated with a grounded nebuliser pressure of 35 
psig, a nozzle voltage of 2000 V, a sheath gas temperature of 250 ˚C at a flow of, 8 L/min, a 
drying gas temperature of 150 ˚C at a flow of 7 L/min and a spray shield voltage of 2500 V.  
The second prototype chip-based FAIMS device (Owlstone Ltd., Cambridge, UK) was fitted 
at the inlet to the mass spectrometer for the analysis of cefepime samples. The MS inlet 
transfer capillary was operated at 3000 V with a nebulizer voltage of 2000 V. The chip-based 
FAIMS consists of multiple parallel electrode gaps (100 μm) with a short path length (700 
μm), as described previously in Section 2.3.3. The fragmentor voltage applied at the TOF 
inlet and was varied between 75 and 375 V (25 V steps), but set to 200 V for quantitative 
measurements. The MS acquisition rate was set to 10 scans/s for FAIMS scanning 
experiments and 1 scan/s for quantification using static FAIMS. 
Scanning FAIMS experiments were carried out in the range CF -2 to 5 Td (scan speed 0.5 
Td/s) at each DF, which was incremented in the range  180-230 Td in 5 Td steps to determine 
optimum conditions to separate NMP from cefepime. Static FAIMS experiments used a fixed 
CF (0 Td) and DF (180 Td) to pre-select NMP generated in the ESI ion source. Cefepime 
solutions were infused into the source and data acquired for 2 min/sample. Data were 
acquired using Agilent MassHunter Acquisition B.05.00 and processed using Agilent 
MassHunter Qualitative Analysis B.05.00. Microsoft Excel 2010 was used to produce CF 
plots. 
4.2.3 Results and Discussion 
Cefepime degrades rapidly in solution, so the time between preparing a cefepime solution for 
analysis and acquiring data for the determination of NMP can potentially influence the 
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accuracy of the quantification of NMP in the original cefepime sample. Sample preparation 
and analysis time therefore needs to be minimised, making the direct infusion of the sample 
into the ESI source of a mass spectrometer a potentially rapid alternative to conventional 
approaches for NMP determination. However, the conditions used for ESI-MS may lead to 
fragmentation of cefepime ions to protonated NMP in the mass spectrometer interface, which 
will increase the NMP response. The potential of FAIMS to separate the response for NMP in 
the original cefepime sample from NMP generated by in-source CID was therefore 
investigated. 
4.2.3.1 ESI-MS of cefepime: in-source CID 
ESI-MS analysis of a cefepime solution spiked with NMP (0.1% w/w), shows the presence of 
intense doubly (m/z 241) and singly (m/z 481) protonated cefepime peaks in the spectrum, 
with a relatively weak response for protonated NMP (m/z 86; Figure 4.1). The voltage 
applied to a lens in the mass spectrometer interface affects transmission of ions into the mass 
spectrometer and can also cause in-source collision-induced dissociation (in-source CID).
2,3
 
The response for NMP in Figure 4.1 may therefore be attributed to contributions from NMP 
in the cefepime sample and from in-source CID of protonated cefepime. Optimising the lens 
voltage (termed the fragmentor voltage for the mass spectrometer used in this study) is 
important for the analysis because it has a significant impact on the analyte response. The 
effect of fragmentor voltage on the intensity of the NMP (m/z 86) and cefepime (m/z 481) 
ions was investigated to determine the extent of cefepime fragmentation by in-source CID. 
NMP and cefepime were infused separately into the ESI source and the fragmentor voltage 
varied in the range 75-375 V (Figure 4.2). The maximum response for transmission of the 
NMP ion was at a fragmentor voltage of 200 V (Figure 4.2.a). However, infusion of a 
cefepime standard also resulted in a response for NMP, which increased at fragmentor 
voltages above 200 V as a result of in-source CID at all fragmentor voltages studied (Figure 
4.2.b). The NMP response in the cefepime sample directly infused into the ESI source 
therefore arises from a combination of the NMP in the cefepime sample and in-source CID of 
the cefepime ion generated by ESI, preventing the direct determination of NMP by ESI-MS.  
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Figure 4.1 Electrospray mass spectrum of cefepime sample with NMP spiked at 0.1% (w/w). 
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Figure 4.2 Selected ion responses for [NMP+H]
+
 (m/z 86) and [Cefepime+H]
+
 (m/z 481) at 25 
V increments of the fragmentor voltage (75-375 V), (a) NMP standard; and (b) Cefepime 
standard  
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4.2.3.2 Direct infusion ESI-FAIMS-MS studies 
The FAIMS dispersion field (DF) and compensation field (CF) characteristics of protonated 
cefepime and NMP were investigated to determine whether these ions could be separated on 
the basis of differences in their high field and low field mobility. Figure 4.3 shows the mass-
selected ion responses for cefepime (m/z 241 and 481, solid grey and dashed line) and NMP 
(m/z 86, solid black line) in the FAIMS compensation field (CF) spectrum (-1.5 – 2 Td) of a 
solution of cefepime containing 0.1 % (w/w) NMP. A DF stepping experiment was used to 
determine the optimum DF (180 Td) for the separation of NMP and cefepime. The protonated 
NMP selected ion response shows two peaks at CF 0 Td and at CF 0.7 Td. The first peak (CF 
0 Td, Figure 4.3 insert) matches the CF spectrum of an NMP standard without cefepime in 
the sample (data not shown) indicating that this peak arises from the NMP ions produced in 
the ESI source. The second peak (CF 0.7 Td) is associated with NMP formed by in-source 
CID of the protonated cefepime in the mass spectrometer interface after transmission of the 
intact cefepime ion through the FAIMS, which therefore appears in the FAIMS spectrum at 
the same CF as cefepime. Separation of NMP (0 Td) and cefepime (0.7 Td) with NMP at 
0.1% (w/w) demonstrates the effectiveness of FAIMS to transmit NMP in the presence of a 
1000 fold excess of cefepime.  
The mass spectrum extracted from the FAIMS CF scan at a CF of 0 Td shows the protonated 
NMP to be the base peak in the mass spectrum (Figure 4.4). There is a weak response from 
the protonated cefepime at this CF, because of the 1000 fold excess of the drug, but this is 
small compared to the relative responses for NMP and cefepime in the absence of a FAIMS 
separation (Figure 4.4). The FAIMS device is therefore able to transmit the NMP generated 
in the ESI source from the original cefepime solution selectively, with no contribution from 
the NMP formed by in-source CID, making it possible to determine NMP in cefepime by 
direct ESI-FAIMS-MS without prior chromatographic separation.  
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Figure 4.3 CF spectra showing selected ion response (SIR) of [NMP+H]
+
 (m/z 86) and 
[Cefepime+H]
+
 (m/z 481) at a 1:1000 ratio (w/w) at DF 180 Td 
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Figure 4.4 Mass spectrum of an infused sample of Cefepime spiked with NMP at 0.1% (w/w) obtained by ESI-FAIMS-MS (DF 180 Td; CF 0 
Td) 
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The FAIMS was operated in static mode (CF 0.1 Td, DF 180 Td) to selectively transmit NMP 
generated in the ESI ion source through the device for the determination of NMP in cefepime. 
Cefepime solutions were infused into the source and data acquired for 2 min/sample. The 
limit of detection for NMP was estimated to be 0.011% (w/w), giving a limit of quantitation 
0.036% (w/w), which is well below the 0.3% threshold concentration for NMP in cefepime. 
The %RSD for replicate samples was 3.85% (n=6, 0.37 μg/ml) for NMP, with good linearity 
(R
2
 0.9979) for standard additions of NMP in the range 0.005 – 0.5 μg/ml (Figure 4.5). The 
level of NMP in this cefepime was calculated from the calibration plot and found to be 0.32 
μg/ml (0.64 %), which is higher than the 0.3 % limit as a result of degradation over time 
during storage. These preliminary quantitative data demonstrate the potential of direct ESI-
FAIMS-MS for the determination of NMP in cefepime at, and below, the threshold 
concentration, subject to full validation of the method. 
 
Figure 4.5 Standard addition calibration plot of NMP (0.005 – 0.5 μg/ml) in cefepime (50 
μg/ml) 
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4.3 Part B: Potentially genotoxic impurities 
4.3.1 Introduction 
Potentially genotoxic impurities (PGIs) have characteristic structures that may exhibit 
carcinogenicity.
13,14
 PGIs need to be monitored during the production of active 
pharmaceutical ingredients (APIs) to ensure that their concentrations remain below the 
threshold value of toxicological concern (TTC) required by the European Medicines 
Agency;
15,16
 which is typically ~1.5 μg/day, equivalent to 1.5 ppm assuming a 1 g/day dose. 
Gas chromatography-mass spectrometry (GC-MS) and high performance liquid 
chromatography-mass spectrometry (LC-MS) are widely used techniques for monitoring the 
levels of PGI compounds in APIs. However, these conventional pharmaceutical analysis 
methods require lengthy sample preparation and/or chromatographic separation. 
Consequently, there is a need for new analytical strategies to meet the fast-paced 
pharmaceutical research and discovery environment.
17,18
 
Thermal desorption is an extraction technique, where an analyte is transferred into the gas 
phase from a solid or liquid. The technique requires minimal sample preparation and is often 
interfaced with gas chromatography-mass spectrometry.
19
 Desorbed PGIs have been ionised 
via extractive electrospray in an electrospray ionisation source (ESI) and detected by mass 
spectrometry.
5,20
 Thermal desorption has also been interfaced with drift tube ion mobility-
mass spectrometry (IM-MS) for the analysis of breath samples collected on solid adsorbents, 
with the ion mobility separation adding selectivity to the analyses.
21
 
This section describes a rapid method for the determination of the isobaric PGIs, 2,4,6-
trimethylaniline (III) and N,N-dimethyl-m-toluidine (IV) by thermal desorption from a 
surrogate API with a FAIMS separation prior to detection using mass spectrometry. Good 
precision was observed at the 1 ppm level for the FAIMS pre-selected PGIs, with a limit of 
quantification established well below the required TTC. 
 
(III) (IV)
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4.3.2 Materials and Methods 
4.3.2.1 Chemicals 
2,4,6-trimethylaniline (2,4,6-TMA), N,N-dimethyl-m-toluidine (N,N-DMT),  starch, and 
HPLC grade acetonitrile, methanol, water and formic acid were obtained from Sigma Aldrich 
(Gillingham, UK).  
4.3.2.2 Sample Preparation 
Standard solutions of 2,4,6-TMA (50 ng/ml) and N,N-DMT (50 ng/ml) were prepared in 
methanol/water (50:50) with 0.1% formic acid for infusion studies and in acetonitrile for 
thermal desorption studies. The PGI mixture (4 μL, 2.5 μg/mL) was added to a surrogate API, 
starch (10 mg) which was immediately inserted into a thermal desorption tube between two 
pieces of Siltek Deactivated Wool (Borosilicate, Markes Int.), as shown in Figure 4.2. The 
concentration of each of the PGIs in the starch was 1 ppm (w/w).  
4.3.2.3 Instrumentation 
TD-ESI-FAIMS-MS analyses were carried out using a Markes UNITY1 thermal desorption 
unit (Markes International, Swansea, UK) combined with an Agilent 6230 TOFMS (Agilent 
technologies, U.K.) fitted with the prototype chip-based FAIMS device. The experimental 
arrangement is shown schematically in Figure 4.6. 2,4,6-TMA and N,N-DMT were desorbed 
from the surrogate API (starch) at 230 °C for 2 min onto a cold trap (Tenax, -10 °C) and then 
rapidly desorbed from the trap (250 °C, >40 °C/s, 2 mins). The thermal desorption cycle time 
was ~10 minutes. The heated transfer line from the thermal desorber, containing a fused silica 
capillary (0.25 mm i.d.) was maintained at 200°C and introduced into the JetStream ESI of 
the TOFMS by removing the glass from a viewing window in the source housing. The tip of 
the fused silica capillary was positioned in the source at an angle of approximately 55˚ to the 
nebuliser, but set back ~10 mm to give the maximum response. Extractive electrospray and 
direct infusion electrospray were carried out in positive ion mode using a 10 μL/min infusion 
of methanol/water (50:50) with 0.1% formic acid. The ESI spray nebuliser pressure was set to 
30 psig with an 8 L/min sheath gas flow at 250 °C. The nozzle voltage was set to 2000 V; the 
transfer capillary, spray shield and counter electrode were set to 3000 V and the drying gas 
flow to 6 L/min at 150 °C.   
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The miniaturised chip-based FAIMS prototype device 2 (Owlstone Ltd, Cambridge), 
consisting of multiple parallel electrode gaps (100 μm) with a short path length (700 μm),22-24 
was used for the analysis. Scanning FAIMS-MS experiments were carried out by direct 
infusion of 2,4,6-TMA and N,N-DMT individually to evaluate the potential for separation of 
these isobaric compounds. The DF was stepped (10 Td) from 200 to 300 Td and the CF was 
scanned from -2 to +5 Td to determine optimum separation conditions. The mass 
spectrometer fragmentor voltage was set to 175 V for FAIMS-selected transmission 
experiments. The MS scan rates were 10 scans/s and 1 scan/s in the mass range m/z 70-1000 
for direct infusion and thermal desorption experiments respectively. 
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Figure 4.6 A schematic diagram of the thermal desorber interfaced to the ESI-FAIMS-MS ion source  
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4.3.3 Results and Discussion 
The thermal desorption of volatile compounds from a less volatile solid sample, such as an 
API, has the potential to speed up analysis by removing time consuming sample preparation 
and chromatographic separation steps. Furthermore, there is an even greater potential 
advantage in that such approaches are matrix independent and can be applied to the analysis 
of a wide range of PGI/API combinations. Increasing sample throughput is important for 
efficient quality control, but selectivity may be compromised to reduce analysis times, 
particularly for isobaric analytes that cannot be distinguished by mass spectrometry.
25,26 
Miniaturised, chip-based FAIMS into the ion source of a time-of-flight mass spectrometer 
(FAIMS-MS), was therefore investigated for the separation of the isobaric PGIs 2,4,6-
trimethylaniline (2,4,6-TMA) and N,N-dimethyl-m-toluidine (N,N-DMT). 
4.3.3.1 Direct infusion FAIMS-MS studies 
The two substituted anilines, 2,4,6-TMA and N,N-DMT, were introduced by direct infusion 
into the ESI-FAIMS-MS to explore the potential for a rapid separation step which would be 
compatible with the thermal desorption of these analytes. A DF stepping experiment, with the 
CF scanned at each DF, was used to determine the optimum DF for maximum separation 
without compromising sensitivity.
27
 The CF spectrum obtained at the optimum DF, which 
was determined to be 230 Td, is shown in Figure 4.7. The spectrum contains two peaks 
corresponding to 2,4,6-TMA and N,N-DMT centered at a CF at 1.0 and 1.5 Td respectively. 
There is also a small peak at CF 2 Td in Figure 4.7, which is assigned to the protonated dimer 
of 2,4,6-TMA. The N,N-DMT peak lies between the 2,4,6-TMA monomer and dimer peaks 
where there is no significant interference from either. 2,4,6-TMA and N,N-DMT were 
sufficiently resolved at a DF of 230 Td to enable the selective transmission of each without 
significant interference from the other. 
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Figure 4.7 FAIMS CF scan of 2,4,6-TMA (dashed) and N,N-DMT (solid) with DF set to 230 
Td 
4.3.3.2 TD-FAIMS-MS analysis of 2,4,6-TMA and N,N-DMT 
2,4,6-TMA and N,N-DMT are sufficiently volatile to be thermally desorbed from a surrogate 
API (starch) and transferred to the ESI source via a heated transfer line. The desorbed 
molecules were ionised using extractive electrospray (EESI) and detected using FAIMS-time-
of-flight mass spectrometry (TOF MS). The FAIMS CF was set to transmit either 2,4,6-TMA 
(CF 1.0 Td) or N,N-DMT (CF 1.5 Td) selectively at a DF of 230 Td following ionization. 
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Figure 4.8 shows typical thermal desorption profiles (m/z 136) for the FAIMS pre-selected 
2,4,6-TMA and N,N-DMT, spiked as a mixture into a surrogate API (starch) at 1 ppm (w/w). 
A good peak shape for the thermal desorption profile of each PGI was achieved by using a 
single sorbent (Tenax) in the desorber cold trap. The time axis corresponds to the mass 
spectrometry acquisition time, which was started 1 minute before the heating of the cold trap. 
Figure 4.8.a and 4.8.b inserts show mass spectra corresponding to the maximum point of the 
thermal desorption profiles of FAIMS-selected 2,4,6-TMA and N,N-DMT respectively, 
showing the protonated ions at m/z 136. The use of a FAIMS separation at the appropriate DF 
and CF determined from the direct infusion studies, adds selectivity to the analysis by 
discriminating between N,N-DMT and 2,4,6-TMA. 
 
Figure 4.8 TD-ESI-FAIMS-MS selected ion profiles (m/z 136.1) of (a) 2,4,6-trimethylaniline 
(CF = 1 Td, DF 230 Td); and (b) N,N-dimethyl-m-toluidine (CF = 1.5 Td, DF 230 Td), 
desorbed directly from starch at 1 ppm (w/w). Inset are the corresponding mass spectra at the 
desorption peak maxima.  
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The quantification limits and precision were evaluated to test performance of the prototype 
TD-FAIMS-MS analysis (Table 4.1). The limit of quantification (LOQ) was determined to be 
0.19 ppm and 0.13 ppm for the FAIMS pre-selected 2,4,6-TMA and N,N-DMT respectively 
(10:1 signal: noise), spiked as a mixture into 10 mg of the surrogate API. These LOQs are 
approximately an order of magnitude below 1.5 ppm, the TTC limit assuming a 1 g/day dose 
(European Medicines Agency). However, detection of PGIs at ‘as low as reasonably possible’ 
(the so-called ALARP concept) levels
13,14
 is encouraged, but not essential, for unusually toxic 
impurities where detection below the TTC may be required. This requirement is easily met 
using TD-FAIMS-MS, as well as reducing sample preparation and analysis times. 
Table 4.1 Quantitative determination of 2,4,6-TMA and N,N-DMT by TD-FAIMS-MS 
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4.4 Conclusion 
Chip-based FAIMS combined with TOF MS has been used for the rapid determination of the 
isobaric PGIs 2,4,6-TMA and N,N-DMT, without the need for a chromatographic separation. 
The ability to filter ions based on differential mobility, an orthogonal technique to mass 
spectrometry, provides an added dimension of separation to the TD-MS analysis. Direct 
thermal desorption of 2,4,6-TMA and N,N-DMT from a solid matrix was demonstrated at 1 
ppm, below the TTC, with good precision (< 8.4%). The combination of good reproducibility 
and limits of quantification almost an order of magnitude below the TTC, shows that TD-
FAIMS-MS has the potential as a rapid, quantitative screening method for monitoring 
volatile PGIs in active pharmaceutical ingredients. Other API matrices would need to be 
investigated to demonstrate the ubiquity of this technique. The approach may also be used for 
the analysis of volatile organic compounds in other solid matrices 
The solution degradation and in-source CID of cefepime to NMP presents an analytical 
challenge for the determination of NMP in cefepime. The use of a FAIMS separation of NMP 
and cefepime ions prior to mass spectrometric analysis allows NMP in a cefepime sample to 
be distinguished from NMP ions generated by in-source CID in the mass spectrometer 
interface. Direct infusion of a cefepime solution using ESI-FAIMS-MS is shown to be a 
rapid, selective method for the quantitative determination of NMP in cefepime with an LOQ 
well below the required 0.3 % threshold and good precision. The method reported here for 
NMP in cefepime has potential for generic application to the direct determination of 
impurities present in other active pharmaceutical ingredients which fragment to yield the 
impurity ion by in-source CID.  
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Chapter 5 
Enhanced Performance in the Determination of 
Ibuprofen 1-β-O acyl glucuronide in Urine by 
Combining High Field Asymmetric Waveform Ion 
Mobility Spectrometry with Liquid Chromatography-
Time-of-Flight Mass Spectrometry 
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5.1 Chapter Overview 
The incorporation of a chip-based high field asymmetric waveform ion mobility spectrometry 
(FAIMS) separation in the ultra (high)-performance liquid chromatography-high resolution 
mass spectrometry (UHPLC-HRMS) determination of the (R/S) ibuprofen 1-β-O acyl 
glucuronide metabolite in urine has been investigated. UHPLC-FAIMS-HRMS reduced 
matrix chemical noise, improved the limit of quantitation approximately two-fold and 
increased the linear dynamic range compared to the determination of the metabolite without 
FAIMS separation. A quantitative evaluation of the prototype UHPLC-FAIMS-HRMS 
system showed better reproducibility for the drug metabolite (%RSD 2.7%) at biologically 
relevant concentrations in urine. In-source collision induced dissociation of the FAIMS-
selected deprotonated metabolite was used to fragment the ion prior to mass analysis, 
enhancing selectivity by removing co-eluting species and aiding the qualitative identification 
of the metabolite by increasing the signal-to-noise ratio of the fragment ions. 
5.2 Introduction 
The performance of a liquid chromatographic separation is determined both by the on-column 
separation and by the selectivity of the detector. UHPLC can significantly reduce 
chromatographic run times, but the use of selective detection, such as mass spectrometry, is 
required if the highest sensitivity, selectivity and throughput is to be achieved. Tandem mass 
spectrometry using a triple quadrupole mass spectrometer capable of mass-selecting 
precursor ions for selected reaction monitoring is widely used in the quantitative 
chromatographic determination of drugs and metabolites. However, recent years have seen 
the emergence of high resolution mass spectrometry (HRMS), using TOF or Orbitrap mass 
analysers, as an alternative to triple quadrupole instruments.
1,2
 The advantage of coupling 
UHPLC with HRMS is that HRMS provides both robust quantification and qualitative 
analysis using a single mass spectrometer platform. However, HRMS may lack the selectivity 
and sensitivity of selected reaction monitoring on a tandem mass spectrometer. 
One approach to enhancing the selectivity of LC-MS analyses is the incorporation of a rapid 
gas-phase separation by ion mobility (IM) spectrometry between the LC and the mass 
spectrometer. Two ion mobility approaches are currently utilised: drift tube-ion mobility 
spectrometry, which separates ions based on time taken to traverse a drift tube,
3
 and field 
asymmetric waveform ion mobility spectrometry (FAIMS), or differential mobility 
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spectrometry.
4
 The details of these techniques were discussed in detail in Section 1.1. Drift-
tube IM has been interfaced with ultra (high)-performance liquid chromatography-mass 
spectrometry (UHPLC-IM-MS) to enhance the quantitative determination of drugs and 
metabolites in urine by removing co-eluting interferences.
5,6
 However, incorporation of a 
drift-tube ion mobility separation can significantly reduce the linear dynamic range (LDR) 
compared to LC-MS alone.
7-10
 
FAIMS separation is orthogonal to MS and acts as an on-line filter for ions entering the MS 
because ions are pre-selected by FAIMS based upon their differential ion mobility. The 
compensation field (CF) for transmission of an ion in FAIMS is a characteristic of ion 
structure and is scanned at a fixed DF to determine the optimum CF at which the ion is 
preferentially transmitted, whilst other interfering ions are neutralised and filtered out.
4,11
 
FAIMS devices interfaced with MS can improve analytical selectivity by providing a 
differential mobility separation prior to MS detection of small molecules, metabolites and 
peptides.
12-14
 
Fragmentation of ions using a single mass analyser can be achieved by increasing voltages in 
the interface region between the ESI source and the vacuum of the mass spectrometer, called 
in-source CID (Section 1.5), which will fragment all co-eluting ions generated in the ESI 
source.
15
 However, the production of fragments from multiple precursors, without ion pre-
selection, complicates fragmentation spectra making identification difficult. The effect of in-
source CID on the analysis of glucuronide metabolites in biological matrices has been 
explored.
16
 A comparison between in-source CID and collision cell CID using a triple 
quadrupole mass spectrometer for characterising microcystins in water samples showed that 
even though in-source CID proved to be more sensitive, CID of a mass-selected precursor ion 
in a collision cell was found to be more selective for analyte identification. Fragmentation 
patterns were found to be similar for the two techniques.
17
 Combining FAIMS-selection with 
in-source CID, referred to FISCID-MS (Section 2.2), has been used for the identification of 
an active pharmaceutical ingredient in a common pharmaceutical excipient and the 
qualitative and quantitative analysis of peptides in plasma by LC-FISCID-MS and was 
described in Section 2.4.2.3.  
This chapter reports an investigation into the potential of FAIMS for enhancing performance 
of a UHPLC-MS analysis of the drug metabolite (R/S) ibuprofen 1-β-O acyl glucuronide, 
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IAG (Figure 5.1, I), in urine. The analysis was carried out without prior sample clean-up, by 
the incorporation of a FAIMS separation using the prototype chip-based FAIMS device. 
FAIMS pre-selection of the metabolite is shown to improve the limit of quantification, linear 
dynamic range and reproducibility, and allow a shorter chromatographic run time compared 
to UHPLC-MS by reducing chemical/matrix interference. The FAIMS device was also used 
to pre-select IAG for UHPLC-FISCID-MS, enhancing the qualitative identification of the 
metabolite. 
Figure 5.1 Fragments produced from [IAG – H]- (I) by CID: decarboxylated di-dehydrated 
glucuronate (II); dehydrated glucuronate (III); glucuronate (IV); and aglycone (V).
20
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5.3 Experimental 
5.3.1 Chemicals 
HPLC grade methanol (MeOH), acetonitrile (ACN), water, formic acid (FA) and ammonium 
acetate were purchased from Fisher Scientific (Loughborough, UK). (R/S) Ibuprofen 1-β-O-
acyl glucuronide was supplied by AstraZeneca (Alderley Park, UK). Ibuprofen was extracted 
into methanol from an ibuprofen tablet (200 mg). 
5.3.2 Sample Preparation 
Aliquots of urine (5 ml) from healthy adult males (x2) and females (x2) (AstraZeneca, UK) 
was pooled (20 ml) and filtered (0.45 µm), diluted (2x) with a solution of the IAG metabolite 
(0.055 to 44 μg/ml in 50:50 acetonitrile:aqueous ammonium acetate (10 mM) at pH 3) and 
with diluent to include a urine blank (to check for any existing IAG in the urine), 
corresponding to IAG  urine concentrations in the range 0.028 to 22 μg/ml. 
5.3.3 Instrumentation 
UHPLC-FAIMS-MS and UHPLC-FISCID-MS analyses of IAG were carried out using an 
Agilent 1200 series HPLC interfaced with an Agilent 6230 time-of-flight mass spectrometer 
fitted with a JetStream ESI source operated in negative ion mode (Agilent Technologies, 
Santa Clara, CA, USA).  The chip-based FAIMS prototype device 2 (Owlstone, Cambridge, 
UK) has been previously described in Section 2.3.3 and was located in front of the transfer 
inlet capillary, behind a modified spray shield within a Jet Stream ESI source. FAIMS 
devices with a 100 µm electrode gap and a depth of 700 µm were used for the analysis. The 
FAIMS electrodes were arranged as multiple parallel channels, linked by a serpentine 
channel with trench lengths of 51.7, 78.1 and 97.0 mm. Dispersion fields in the range 200 to 
300 Td were applied at a 27 MHz frequency with an approximate low to high field ratio of 
2:1. Nitrogen (99.5 % purity) was used as the carrier gas for the FAIMS system and for the 
ESI source and mass spectrometer interface. 
Samples were introduced into the ESI source either by direct infusion at a flow rate of 15 
μl/min or from the liquid chromatograph. UHPLC separation was carried out, with a 5 µl 
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sample injection volume on a Zorbax C18 column (2.1 x 50 mm, 1.8 µm, Agilent 
Technologies) with an isocratic 0.2 ml/min flow of 50:50 acetonitrile:aqueous ammonium 
acetate (10 mM) at pH 3. The scan rate of the TOF MS was 10 scans/sec for scanning 
FAIMS-MS experiments and 1 scan/sec for UHPLC-FAIMS-MS and UHPLC-FISCID-MS 
experiments. Data were acquired with the instrument mode set to extended dynamic range (2 
GHz) at a resolution of 5700. Source conditions for LC experiments were: nozzle voltage, 
2000 V; sheath gas temperature and flow, 350 °C and 11 L/min; drying gas temperature and 
flow, 150°C and 10 L/min; nebuliser pressure, 25 psig; transfer capillary, 4000 V; skimmer 
voltage, 65 V; fragmentor voltage, -150 V and -250 V for transmission and in-source CID 
respectively. Data were processed using Mass Hunter Qualitative Software B.04.00 (Agilent 
Technologies, Santa Clara, CA, USA) and Microsoft Excel 2010 (Microsoft, Seattle, USA).  
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5.4 Results and Discussion 
5.4.1 Direct Infusion FAIMS analysis of IAG and ibuprofen 
Direct infusion of ibuprofen and the IAG metabolite (0.65 µg/ml) was used to optimise the 
microscale FAIMS conditions for separation and sensitivity. FAIMS compensation field (CF) 
spectra of the [M-H]
- 
ions of the
 
analytes obtained at a dispersion field (DF) of 200, 230 and 
260 Td are shown in Figure 5.2. The IAG response is separated from that of the parent drug 
ibuprofen as a result of structural differences between the two ions with IAG showing a 
greater CF shift at all DFs. The separation of IAG and the parent drug improved with 
increased DF. A decrease in the absolute intensity of IAG was observed when the DF was 
increased from 200 to 260 Td, but with a significant increase in the response relative to 
ibuprofen, which falls sharply with increasing DF. A decrease in ion intensity with DF is 
commonly observed for low mass ions as a result of losses by diffusion, where diffusion 
increases with DF.
4
   The optimum CF for transmission of IAG was at 2.2 Td with a DF of 
260 Td, based on the best separation without significant loss of signal intensity for IAG, and 
these conditions were used in the high resolution UHPLC-FAIMS-MS analyses. 
Figure 5.2 FAIMS CF spectra of ibuprofen, m/z 205, (dashed line) and IAG, m/z 381 (solid 
line) at DF: (a) 200 Td, (b) 230 Td and (c) 260 Td. 
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The FAIMS devices with different serpentine channel lengths of 51.7, 78.1 and 97.0 mm 
were investigated to determine the most suitable for the analysis. The CF spectra in Figure 
5.3.a-c shows that the peak width for IAG decreases with increasing trench length. The exact 
peak widths are shown in Table 5.1; the corresponding full width at half maximum (FWHM) 
demonstrate improvement in FWHM with increasing trench length. The most likely 
hypothesis for peak widths becoming smaller for larger trench length is that the ion residence 
time is higher in the FAIMS chip with a large trench length. This is because the flow through 
the chip is slower when the trench length is longer, and that a smaller trench length results in 
a higher flow with a lower ion residence time. The vacuum pump of the MS pulls the carrier 
gas flow through the FAIMS chip which determines the carrier gas flow rate; a longer trench 
length effectively creates a larger cross section tube resulting in a lower flow rate just as a 
shorter trench length creates a smaller cross section giving a higher flow rate. The flow/ion 
residence time of an ion in the FAIMS device changes the width of the peak but also results 
in a change in ion intensity, where longer ion residence times increase signal loss due to 
diffusion. Figure 5.4 shows that trench length has a far greater impact on peak area of 
deprotonated ibuprofen than on IAG. The peak area of ibuprofen is reduced by ~5 times 
compared to ~3 times for IAG when changing from 51.7 mm to 78.1 mm trench length. The 
chip with a trench length of 78.1 mm was selected for quantitative studies because it offers a 
good compromise between small peak widths and acceptable transmission. The option of 
FAIMS chips with different trench lengths means that FAIMS devices can be selected to be 
better suited for an analysis that either requires greater transmission or narrower peak widths. 
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Figure 5.3 FAIMS CF spectra of ibuprofen, m/z 205, (dashed line) and IAG, m/z 381 (solid line) at DF 220 Td using FAIMS chips with different 
trench lengths:  (a) 51.7 mm, (b) 78.1 mm and (c) 97.0 mm
0
10
20
30
40
50
60
70
80
90
100
-1 0 1 2 3
R
el
a
ti
v
e 
In
te
n
si
ty
 /
%
Compensation Field /Td
0
10
20
30
40
50
60
70
80
90
100
-1 0 1 2 3
R
el
a
ti
v
e 
In
te
n
si
ty
 /
%
Compensation Field /Td
0
10
20
30
40
50
60
70
80
90
100
-1 0 1 2 3
R
el
a
ti
v
e 
In
te
n
si
ty
 /
%
Compensation Field /Td
[Ibuprofen - H]-
[IAG - H]-
(a) (b) (c)
164 
 
 
Figure 5.4 Bar chart showing peak area of ibuprofen (blue) and IAG (red) against trench 
length 
Table 5.1 The effect of different FAIMS chip trench lengths on peak width at half height and 
resolution of IAG peak 
Trench Length /mm Peak width at half height Resolution 
51.7 0.66 1.7 
78.1 0.32 3.4 
97.0 0.28 3.9 
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5.4.2 Determination of IAG by UHPLC-FAIMS-TOF-MS 
The UHPLC-MS (FAIMS off) and UHPLC-FAIMS-MS (FAIMS on) selected ion 
chromatograms ([M-H]
-
; m/z 381) obtained for the analysis of IAG spiked into urine with a 
high resolution mass window of m/z 381±0.02 (±50 ppm) is shown in Figure 5.5.a. The 
UHPLC gradient was adjusted to minimise the run time for the IAG, but this resulted in a 
significant overlap between the IAG peak and urine matrix components. The observed co-
elution of IAG with matrix components could be reduced by changing the UHPLC conditions 
to separate the metabolite from the urine matrix, but at the cost of a significantly increased 
chromatographic run time. A narrower mass window, m/z 381±0.008 (±20 ppm) was 
therefore investigated to determine whether this would improve selectivity without extending 
the chromatographic run time. The absolute intensity of the IAG peak, with the FAIMS 
switched off, is reduced by a factor of two if the mass window is narrowed from ±50 ppm  to 
±20 ppm (Figure 5.5.b), but there is no additional discrimination against the chemical noise 
from the urine matrix at the mass resolution used in the analysis (5700 FWHM).  
The advantage of the incorporation of the FAIMS separation is demonstrated by a significant 
reduction in the co-eluting chemical noise from the urine matrix (Figure 5.5.c and d), whilst 
maintaining a rapid elution time. Ionization suppression in the ESI source was not 
determined, but was the same in both FAIMS on and FAIMS off modes, allowing an 
evaluation of the improvement in the chromatographic performance offered by FAIMS. The 
removal of chemical noise resulted in a better signal-to-noise ratio and peak integration with 
FAIMS on, even though the absolute intensity of the IAG peak was reduced because of ion 
losses in the device. FAIMS pre-selection of IAG removes matrix ions to baseline for both 
the m/z 381 ±0.02 and ±0.008 mass windows, but at a cost of lower sensitivity and signal-to-
noise ratio for the narrower window. The ±0.02 mass window was therefore used in 
subsequent studies.  
Setting the mass window to 381 ±0.5 instead of the narrower mass windows associated with 
TOF mass spectra can be used to mimic the selected ion chromatograms that would be 
produced if using a low resolution (e.g. single quadruple) mass analyser (Figure 5.6). The 
intensity of the IAG peak is higher with the wider mass window than when using a mass 
window of ±0.02 or ±0.008, although the benefit of the higher intensity is negated by the 
presence of greater chemical interference in the chromatogram (Figure 5.6.a). The high mass 
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resolution possible when using the narrow mass range of the TOF mass analyser reduced 
some of the interference observed in the ±0.5 mass window, although the overall matrix 
profile is similar for all three mass windows. However, effective removal of chemical 
interference was again achieved by using FAIMS-selective transmission of the IAG ion 
(Figure 5.6.b). These observations emphasise the orthogonality of the FAIMS and MS 
separations and demonstrate the potential of FAIMS to enhance quantitative performance of 
both low and high resolution mass analysers. 
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Figure 5.5 Selected ion chromatograms (m/z 381) for IAG (highlighted) spiked into urine 
(0.55 µg/ml) analysed by UHPLC-MS (FAIMS off) using a mass window of (a) m/z 
381±0.02 and (b) m/z 381±0.008; and by UHPLC-FAIMS-MS (FAIMS on) with selective 
transmission of IAG (DF 260 Td, CF 2.2 Td) using a mass window of (c) m/z 381±0.02 and 
(d) m/z 381±0.008 
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Figure 5.6 Selected ion chromatograms (m/z 381) for IAG (highlighted) spiked into urine 
(0.55 µg/ml) analysed by UHPLC-MS (FAIMS off) using a mass window of (a) m/z 381±0.5; 
and by UHPLC-FAIMS-MS (FAIMS on) with selective transmission of IAG (DF 260 Td, CF 
2.2 Td) using a mass window of (c) m/z 381±0.5 
The mass spectrum taken from the IAG UHPLC peak with FAIMS off (Figure 5.7.a) showed 
IAG (m/z 381.1570; -3.9 ppm) to be a minor peak in a complex mass spectrum. The effect of 
the FAIMS selection of IAG across a wide mass range is apparent from the mass spectrum 
for IAG with FAIMS on (Figure 5.7.b) which is simplified compared to FAIMS off, with 
IAG as the base peak in the mass spectrum (m/z 381.1553; 0.52 ppm), as a result of 
discrimination against interferences from urine matrix. 
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Figure 5.7 Mass spectra at retention time (RT) 0.98-1.02 mins with (a) FAIMS off, and (b) FAIMS on (DF 260 Td, CF 2.2 Td)
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Figure 5.8 and Table 5.2 compare the quantitative performance of the UHPLC-MS and 
UHPLC-FAIMS-MS methods for the determination of IAG in urine. The limit of quantitation 
(LOQ; signal-to-noise 10:1) for IAG was reduced from 18 ng/ml (FAIMS off) to 10 ng/ml 
(FAIMS on), based on the selected ion peak areas of IAG (m/z 381 ±0.02) using UHPLC-
FAIMS-MS.  Calibration graphs for the IAG spiked into urine and analysed by UHPLC-MS 
with FAIMS off (Figure 5.8.a) and FAIMS on (Figure 5.8.b) are shown in Figure 5.8. The 
upper limit of the linear dynamic range (LDR) was the same in both FAIMS off and on 
modes, giving an increased LDR of >3 orders of magnitude for the miniaturised FAIMS-MS 
as a result of the lower LOQ, in contrast to a LDR of ~2 orders of magnitude with cylindrical 
FAIMS-MS 
18,19
 and <2.5 orders of magnitude for drift tube IM-MS.
5,6
 The intra-day 
reproducibility of the prototype UHPLC-FAIMS-MS system was compared with UHPLC-
MS by analysing IAG spiked into urine (15.5 µg/ml) and running FAIMS in on and off 
modes respectively (Table 5.2). %RSDs, sufficient for good quantification, were obtained for 
both UHPLC-MS (5.0%) and UHPLC-FAIMS-MS (2.7%), with the UHPLC-FAIMS-MS 
showing better reproducibility. These data demonstrate that the FAIMS device enhances 
quantitative performance compared to high resolution UHPLC and MS analysis. 
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Figure 5.8 Calibration plots of IAG spiked into urine analysed by (a) UHPLC-MS (FAIMS 
off, unshaded triangle); and by (b) UHPLC-FAIMS-MS (FAIMS on, black square) with 
selective transmission of IAG (DF 260 Td, CF 2.2 Td) 
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Table 5.2 A comparison of LOQ; LDR (R
2
) and intra-day reproducibility for the 
determination of IAG spiked into urine (15.5 µg/ml, n=5) 
  
5.4.3 Qualitative identification of IAG by UHPLC-FISCID-MS 
The in-source CID fragmentation of IAG ion was used to assess the improvement offered by 
the UHPLC-FISCID-MS technique for the qualitative identification of IAG. The FAIMS-
selected [M-H]
-
 ion of IAG was subjected to in-source CID to produce the characteristic 
fragments of the ion (Figure 5.1). A comparison of the selected ion chromatograms of the 
aglycone fragment (m/z 205.1234) for a urine sample spiked with IAG (3.9 µg/ml), with and 
without FAIMS pre-selection prior to in-source CID, was used to define the level of isobaric 
chemical interference present in the sample spiked with IAG (Figure 5.9.a and b). Peak 
integration of the UHPLC-FISCID-MS data was more reliable than UHPLC-MS data because 
chemical interference was reduced almost to baseline. 
Mass spectra extracted from the aglycone peaks (Figure 5.10) shows the effect of applying 
the FAIMS separation to the UHPLC-CID-MS analysis of IAG.  Four diagnostic fragment 
ions for IAG are observed in the production mass spectrum (Figure 5.1):
20
 decarboxylated di-
dehydrated glucuronate (II, m/z 113); dehydrated glucuronate (III, m/z 175); glucuronate (IV, 
m/z 193); and the aglycone (V, m/z 205). In Figure 5.10, these fragments are difficult to 
locate due to the complexity of the mass spectrum and poor signal to noise as a result of other 
ions in the matrix. Pre-selecting IAG using FAIMS before in-source CID reduced the 
intensity of interfering ions, increasing the relative intensity of the IAG (Figure 5.10.b). The 
signal-to-noise ratios for the fragment ions increased by approximately 2-fold with FAIMS 
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on (Table 5.3), enhancing the response of the IAG fragments relative to other interfering 
peaks to aid identification. 
Figure 5.9 Selected ion chromatograms (m/z 205 ±0.02) of the [Aglycone – H]- for the urine 
blank (grey) and IAG (black) spiked into urine (3.9 µg/ml) by (a) UHPLC-CID-MS and (b) 
UHPLC-FISCID-MS 
Table 5.3 A comparison of signal-to-noise ratios for in-source CID generated IAG fragment 
ions from the analysis of a spiked urine sample with FAIMS off and FAIMS on
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Figure 5.10 Mass spectra at RT 0.97-1.02 mins with (a) UHPLC-CID-MS, and (b) UHPLC-
FISCID-MS  
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5.5 CONCLUSIONS 
The incorporation of the chip-based FAIMS in the ESI source of the UHPLC-TOF 
spectrometer is shown to be a novel approach for improving the qualitative and quantitative 
performance of the chromatographic analysis of IAG by reducing co-eluting chemical 
interference from the urine matrix. UHPLC-FAIMS-HRMS showed a lower LOQ, increased 
LDR and better reproducibility, compared to UHPLC-HRMS without a FAIMS separation. 
The FAIMS device was able to distinguish IAG from ibuprofen, preventing interference from 
the drug when observing the aglycone fragment. The UHPLC-FISCID-MS technique 
removed interference from urine in the chromatogram for IAG and enhanced the qualitative 
identification of fragments of IAG by reducing the relative response of interfering peaks from 
the urine. An important conclusion from this study is that the orthogonality of the FAIMS and 
MS separations can provide reductions in chemical noise that cannot be achieved by 
increased mass resolution. This suggests that low resolution LC-MS analysers would also 
benefit from the use of FAIMS. 
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Chapter 6 
Conclusions and Future Work 
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6.1 Thesis Overview 
The performance of a miniaturised field asymmetric waveform ion mobility spectrometry 
device combined with mass spectrometry (FAIMS-MS) has been studied and is reported in 
this thesis. In the following sections, each chapter is summarised and proposals for future 
research are discussed. 
6.2.1 Summary of Chapter One 
Chapter one discussed the principles of differential mobility spectrometry and mass 
spectrometry along with parameters that are important in determining FAIMS performance. 
The benefits of the addition of FAIMS to mass spectrometry systems for chemical analysis 
were reviewed with reference to the relevant literature, demonstrating the potential for the 
separation of isobaric ions that using FAIMS offers. FAIMS was also shown to offer 
improvements in detection limits, reduction in chemical noise, faster run times and 
simplification of complex data. 
6.2.2 Summary of Chapter Two 
The effect of changing experimental conditions in the ion source and FAIMS-MS interface 
on the performance of the prototype miniaturised FAIMS device was studied using a test 
mixture of small molecules and peptides in Chapter two. The CV was found to be stable over 
the full functioning range of the electrospray source, meaning that optimised FAIMS 
conditions did not change significantly when optimising source conditions, solvent 
composition or liquid flow rate (up to 1 ml/min). Transmission of ions with a lower m/z was 
found to be reduced at higher DFs whereas for ions with a higher m/z where there was little 
change in transmission with increasing DFs.  
An investigation of three different systems including pairs of isobaric, isomeric and near-
mass ions showed that miniaturised FAIMS has the ability to distinguish between analytes 
that are challenging to separate by mass spectrometry. The FAIMS separation of 
decarboxylated acids using deprotonated ions fragment ions and adducts formed with group I 
metal ions showed that the choice of ion is important in FAIMS separations, as are the effects 
of DF and temperature on the FAIMS spectra. The addition of a modifier to the carrier gas 
was also shown to improve separation, particularly where higher temperatures are required 
for desolvation. Signal loss of FAIMS-selected analytes is compensated for by reductions in 
chemical noise and the simplification of complex spectra. Combining FAIMS-selection of 
180 
 
analytes in tandem with fragmentation by in-source CID (FISCID-MS) enables the 
acquisition of FAIMS-selected fragment ions on a single mass analyser, where in-source CID 
alone produces complex spectra from multiple precursors. The FAIMS-MS analysis of the 
isomers 2β- and 6β-hydroxytestosterone showed relatively small structural changes may be 
sufficient to allow FAIMS separation. 
The results reported in this chapter provide insight into the capabilities and limitations of 
miniaturised FAIMS. Further studies using a larger database of analytes, including series of 
homologous compounds, would be useful for further understanding the capabilities of 
miniaturised FAIMS combined with mass spectrometry. This study would also need to be 
expanded to different temperatures and analytes formed as adducts with other metal ions, 
including metals from different groups and with different charge states. 
The separation of the hydroxytestosterone isomers demonstrates proof of principle, where the 
6β-hydroxytestosterone was transmitted using FAIMS without significant interference from 
2β-hydroxytestosterone. The next step is to combine FAIMS with a rapid method of sample 
clean up, such as off-line or on-line SPE, for the analysis of mixtures of the isomers spiked 
into human liver microsomes, in order to evaluate the sensitivity and selectivity of FAIMS-
MS when presented with a more challenging sample matrix. Success at this step could be 
followed by testing real samples used in drug screening assays as an alternative to current 
LC-MS methods in a high-throughput environment. 
6.2.3 Summary of Chapter Three 
The effects of adding solvent vapour gas modifiers to the carrier gas of the miniaturised 
FAIMS were explored in Chapter three. A heated nebuliser-based vapour generator was 
constructed to introduce solvent vapours into the carrier gas to investigate the effect of 
alcohol modifiers on the performance of FAIMS-MS using small molecules, peptides and 
proteins. The results show that for small molecules, large shifts in the CF spectra are 
observed in the presence of modifiers and that modifier type and concentration combined 
with DF influences the order of the ions appear in the CF spectrum. In this study, only 
methanol and 2-butanol were used as modifiers, but the effect of other aliphatic alcohol 
modifiers (including primary, secondary and tertiary alcohols) should be further investigated 
along with other solvents with different functionality. The aim of studying other modifiers 
with other analytes that also vary in functionality would be to better understand analyte and 
modifier molecule interactions by focussing on physical properties, including functionality, 
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polarity and solubility. A comprehensive study could allow an analyst to predict the most 
appropriate solvents for a FAIMS-MS analysis. 
Peptides exhibited a small shift in CF, but the smaller peak widths observed in the presence 
of modifiers improved the selectivity between sequence isomers and doubly protonated 
peptides. Proteins in the presence of modifiers showed a reduction in number of peaks, where 
multiple peaks are associated with different conformations or solvation states; a CF shift with 
alcohol modifiers was not observed for proteins. It would be interesting to explore if there is 
a size trend, where large molecules (like proteins) show little or no change in CF maxima 
position in the presence of modifiers, but smaller molecules show large CF shifts, and if this 
trend of size is related to type of modifier. Further investigation into the effect of modifiers 
on proteins is also important to better understand the selective reduction of other protein 
peaks while others remain. 
There may be potential to explore the kinetics of clustering and declustering of solvent 
molecules to analytes using FAIMS, where temperature and modifier concentration may give 
insight to the interaction of each solvent molecule with analyte ion. This may also help 
explain the phenomenon observed with peptides and proteins in the presence of modifiers. 
6.2.4 Summary of Chapter Four 
Chapter four reported an investigation of the advantages of combining a fast FAIMS 
separation with TOF MS to analyse two systems of nitrogen-containing pharmaceutical 
impurities. The direct FAIMS-MS analysis of a degradation product of an antibiotic drug and 
of potentially genotoxic impurities in a surrogate active pharmaceutical excipient were 
investigated. The former system presents an analytical challenge due to the antibiotic drug 
fragmenting readily by in-source CID to form the same ion as the degradation product. The 
unique positioning of the FAIMS device at the inlet of the mass spectrometer enabled 
FAIMS-selection of the in-source generated degradation product, preventing interference 
from in-source CID of the antibiotic drug. Further experiments should include full validation 
of the quantitative FAIMS-MS analysis of the degradation product. It would also be 
beneficial to automate the sample preparation to shorten the run time and reduce solution 
degradation. 
Thermal desorption was used to evaporate potentially genotoxic impurities from a surrogate 
active pharmaceutical ingredient into the electrospray source of the FAIMS-MS spectrometer 
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to allow the PGIs to be ionized by extractive electrospray (EESI). Sufficient selectivity and 
precision was observed for the direct analysis of the PGIs at the threshold of toxicological 
concern by TD-FAIMS-EESI-MS. At present, the method requires manual loading of 
samples to the thermal desorber and automation could significantly improve run time. There 
are commercially available thermal desorbers with integrated autosamplers, and it would be 
interesting to combine these techniques with FAIMS-MS to increase the sample throughput. 
 
6.2.5 Summary of Chapter Five 
Chapter five reports the development of a UHPLC-FAIMS-MS method for the quantitative 
determination of a drug metabolite in urine. Initially, infusion studies of the drug ibuprofen 
and its glucuronide metabolite explored DF and chip trench lengths for optimum selectivity 
and sensitivity. The UHPLC-FAIMS-MS analysis was carried out without sample clean-up 
and used a shorter chromatographic run time for rapid elution of the metabolite which 
without FAIMS co-eluted with chemical/matrix interference. The FAIMS conditions were 
transferred to the UHPLC-MS method and found to offer significant reduction in co-eluting 
chemical noise, whereas narrowing the mass windows without FAIMS offered no 
improvement in signal-to-noise. FAIMS pre-selection of the metabolite simplified the mass 
spectra and improved signal-to-noise by 2-fold. The improvement in signal-to-noise gives 
lower limits of quantitation, which combined with no loss in linearity at the top end resulted 
in an improvement in the linear dynamic range. UHPLC-FISCID-MS also showed an 
increase in signal-to-noise for fragments of the FAIMS-selected metabolite. 
The data in this chapter demonstrate that the quantitative and qualitative performance for 
determination of the drug metabolite in urine is enhanced by the addition of a FAIMS 
separation. The orthogonality of the FAIMS and MS separations provide reductions in 
chemical noise that cannot be achieved by increased mass resolution, this suggests that low 
resolution LC-MS analysers would also benefit from the addition of a FAIMS device. It 
would be interesting to transfer the FAIMS method to a lower resolution LC-MS and assess 
the improvement in both qualitative and quantitative aspects for determination of urinary 
drug metabolites. Future work should also include an evaluation of lifetime of the FAIMS 
chip when subjected to routine analysis of urine samples without sample clean up to 
determine how robust the FAIMS device is with challenging sample matrices. 
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6.3 Summary of Thesis 
This thesis investigates the potential of using miniaturised chip-based FAIMS in combination 
with mass spectrometry for the analysis of a variety of compounds in different sample 
matrices. Exploration of carrier gas properties and adduct formation showed that FAIMS is a 
selective spectrometer that is highly orthogonal to mass spectrometry and has been shown to 
enhance sensitivity and selectivity of rapid analyses. There is a paradigm shift towards high 
resolution mass spectrometry and high throughput mass spectrometry to answer the 
requirement for analyses to be faster
1
 and provide more information with good quantitation.
2
 
Miniaturised FAIMS is shown to be rapid, selective and sensitive for samples that are 
challenging to high resolution and high-throughput mass spectrometry, this complementary 
technology has the potential to have a key position alongside modern mass spectrometry. 
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Appendices 
Appendix 1: Conference presentations 
Posters: 
• BMSS 2011 32nd annual meeting ‘From Atoms to Biomolecules’, and winner of the 
Bordoli Poster Prize ‘Optimisation of ultra-FAIMS-MS Parameters using a Central 
Composite Design’ 
• Research Network Meeting 2012 at Loughborough University ‘Determination of a 
Urinary Drug metabolite using LC-FAIMS-MS and LC-FAIMS-In Source CID-MS’ 
• ASMS Annual Meeting 2012: ‘Determination of a urinary drug metabolite using 
liquid chromatography combined with FAIMS-MS and FAIMS-in source CID-MS’. 
Presented by Prof. C.S. Creaser. 
• ISIMS 2012: ‘Direct Analysis of Potentially Genotoxic Impurities in Active 
Pharmaceutical Ingredients using Miniaturized Field Asymmetric Waveform Ion Mobility 
Spectrometry’. Presented by Dr. J.C. Reynolds. 
• IMSC 2012: ‘Evaluation of the performance of microscale FAIMS for the 
enhancement of the quantitative analysis of metabolites and peptides’. Presented by Dr. D.E. 
Toutoungi. 
• ASMS Annual Meeting 2013: Exploring the effects of carrier gas modifiers using 
chip-based field asymmetric waveform ion mobility spectrometry combined with mass 
spectrometry’ 
• BMSS Annual Meeting 2013: ‘The Effect of Alcohol Carrier Gas Modifiers on Chip-
based FAIMS-Mass Spectrometry Analysis of Small Molecules, Peptides and Proteins’  
• BMSS Annual Meeting 2013: ‘Determination of N-methylpyrrolidine in cefepime 
hydrochloride using field asymmetric waveform ion mobility spectrometry combined with 
mass spectrometry’. Presented by Prof. C.S. Creaser 
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Oral Presentations: 
• BMSS 2012 April ‘Determination of a Urinary Drug Metabolite using LC-FAIMS-
MS and LC-FAIMS in-source CID-MS’ 
• IMS Special Interest Group BMSS 2013 June ‘Enhancing Structural Studied by 
Incorporating Chip-based Field Asymmetric Waveform Ion Mobility Spectrometry with 
Mass Spectrometry’ 
• ASMS 2014 Annual Meeting: ‘Fast separation of hydroxytestosterone isomers using 
chip-based FAIMS combined with mass spectrometry for high-throughput drug assays’ 
• IMS Special Interest Group BMSS 2014: ‘Use of chip-based FAIMS to remove 
isomeric interferences for high-throughput measurement of drug-drug interactions’ 
 
Article: 
• Article published in BMSS Mass Matters (67, April 2012): ‘Optimisation of a 
miniaturised FAIMS-MS System with a Central Composite Design’ 
• Article published in International Labmate/Labmate Asia (39, January/February 
2014): ‘Enhancing Mass Spectrometric Performance with Field Asymmetric Waveform Ion 
Mobility Spectrometry’ 
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• ‘Enhanced Analyte Detection Using In-Source Fragmentation of Field Asymmetric 
Waveform Ion Mobility Spectrometry-Selected Ions in Combination with Time-of-Flight 
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• ‘Enhanced performance in the determination of ibuprofen 1-β-O-acyl glucuronide in 
urine by combining high field asymmetric waveform ion mobility spectrometry with liquid 
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186 
 
J.C.; Bristow, A.W.; Ray, A.; Sage, A.; Wilson, I.D.; Weston, D.J.; Boyle, B.; Creaser, C.S.; 
Journal of Chromatography, 2013, 1278, 76-81 
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Enhanced Analyte Detection Using In-Source Fragmentation of Field
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ABSTRACT: Miniaturized ultra high field asymmetric wave-
form ion mobility spectrometry (FAIMS) is used for the
selective transmission of differential mobility-selected ions
prior to in-source collision-induced dissociation (CID) and
time-of-flight mass spectrometry (TOFMS) analysis. The
FAIMS-in-source collision induced dissociation-TOFMS
(FISCID-MS) method requires only minor modification of
the ion source region of the mass spectrometer and is shown
to significantly enhance analyte detection in complex mixtures.
Improved mass measurement accuracy and simplified product
ion mass spectra were observed following FAIMS preselection and subsequent in-source CID of ions derived from
pharmaceutical excipients, sufficiently close in m/z (17.7 ppm mass difference) that they could not be resolved by TOFMS alone.
The FISCID-MS approach is also demonstrated for the qualitative and quantitative analysis of mixtures of peptides with FAIMS
used to filter out unrelated precursor ions thereby simplifying the resulting product ion mass spectra. Liquid chromatography
combined with FISCID-MS was applied to the analysis of coeluting model peptides and tryptic peptides derived from human
plasma proteins, allowing precursor ion selection and CID to yield product ion data suitable for peptide identification via
database searching. The potential of FISCID-MS for the quantitative determination of a model peptide spiked into human
plasma in the range of 0.45−9.0 μg/mL is demonstrated, showing good reproducibility (%RSD < 14.6%) and linearity (R2 >
0.99).
Collision-induced dissociation in the intermediate pressureregion between an atmospheric pressure ion source and
the vacuum of a mass analyzer, commonly referred to as in-
source collision-induced dissociation (CID) or cone voltage
fragmentation, may be used to induce fragmentation of ions
passing through the interface.1 The use of elevated interface
voltages in the mass spectrometer interface allows product ion
spectra to be generated for structural analysis of intact
protonated molecules generated by electrospray ionization.2
However, in the absence of precursor ion preselection, this can
result in a complex mass spectrum containing overlapping
precursor and product ions, which presents a challenge for
spectral interpretation. Information regarding the relationship
between precursor and product ions may also be lost because
different precursor ions are fragmented simultaneously.
Tandem mass spectrometry (MS/MS), in which a precursor
ion is first selected on the basis of mass-to-charge (m/z) ratio
and then subjected to CID with the resulting fragment ions
identified by a second mass analyzer, is therefore the method of
choice for obtaining fragmentation data for elucidation of
structure and quantitative analysis. An alternative approach is to
combine mass spectrometry analysis with the separation of gas-
phase ions by ion mobility spectrometry or field asymmetric
waveform ion mobility spectrometry (FAIMS).3−7
Field asymmetric waveform ion mobility spectrometry
(FAIMS) is a gas-phase atmospheric pressure separation
technique that exploits the difference in the mobility of an
ion in alternating low and high electric fields.8,9 The alternating
electric fields are generated in the gap between two closely
spaced electrodes by the application of an asymmetric RF
waveform, causing ions to oscillate between the electrodes. Ions
with different mobilities under low and high field conditions
accumulate a net drift toward an electrode eventually resulting
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in collision and neutralization. A small DC voltage is applied to
one of the electrodes to reverse the drift of the ion so that
collision with the electrode is avoided.5 This is termed the
compensation voltage (CV)8 and allows ions to pass between
the electrodes and be detected. The CV for ion transmission is
compound specific, resulting from the difference in mobility in
high and low fields.
FAIMS has been employed as an ion filter to select precursor
ions prior to mass spectrometry analysis, because differential
mobility is largely independent of m/z allowing orthogonal
separations.9 The ability to preselect using FAIMS has been
shown to simplify mass spectra by reducing background and
isobaric ions.10−13 The combination of FAIMS with tandem
mass spectrometry (FAIMS-MS/MS) has also been reported
for the structural and quantitative analysis of small molecules
and peptides, with CID of mass-selected ions occurring in the
collision cell located between the mass analysers of a Q-time of
flight (Q-TOF) or triple quadrupole spectrometer or after mass
isolation in an ion trap.13−15
The in-source fragmentation of ions in FAIMS-MS was
reported by Guevremont et al.,16 who observed a change in
cluster distributions of leucine enkephalin ions under low and
high energy in an electrospray ionization (ESI) ion source. It
was concluded that fragmentation comparable to MS/MS
analysis was induced under high energy conditions. Subsequent
fragmentation studies were pursued using MS/MS of mass-
selected ions in a triple quadrupole spectrometer rather than
through in-source CID. Eiceman et al. also described
fragmentation of chlorocarbon ions in the interface of an
atmospheric pressure ionization mass spectrometer, which
complicated the identification of FAIMS-selected ions.17
Measurements were carried out under conditions designed to
minimize rather than enhance ion decomposition in the mass
spectrometer interface. The use of FAIMS with in-source CID
and selected reaction monitoring MS/MS was used by Xia and
Jemal to determine the location of source fragmentation in the
analysis of ifetroban and its acylglucuronide metabolite.18
FAIMS was used to transmit either the parent drug or its
acylglucuronide, from which it was concluded that fragmenta-
tion inducing the conversion of the acylglucuronide metabolite
to the parent drug form occurred almost entirely after the inlet
orifice of the mass spectrometer. The objective of this work was
to minimize the effect of in-source CID on the LC-MS/MS
with selected reaction monitoring (SRM) for the quantitative
analysis of prodrugs and metabolites. The targeted use of in-
source CID-MS using FAIMS to isolate ions from a mixture
prior to fragmentation was reported by Coy and co-workers.19
The separation of a simple mixture containing five isobaric
model compounds (m/z 316) was achieved by direct infusion
into the ESI source and differential mobility spectrometry. Ions
were transmitted at their optimum CV and fragmentation
induced by increasing the inlet cone voltage in the interface of a
quadrupole MS.
Here, we describe the development of generic FAIMS-in
source CID-MS procedures (which we term FISCID-MS) that
exploit the ability to control the fragmentation of FAIMS-
selected ions in the interface of the mass spectrometer, by
combining the orthogonal separation characteristics of a
miniaturized high field FAIMS device and in-source CID with
time-of-flight mass spectrometry. The technique requires only
minor modification of the ion source region of the mass
spectrometer to incorporate the FAIMS device but is shown to
provide major enhancements for the analysis of complex
mixtures. FISCID-MS is demonstrated for the separation of
pharmaceutical excipients20 and for the qualitative and
quantitative analysis of model and tryptic peptides derived
from human plasma.
■ EXPERIMENTAL SECTION
Chemicals and Reagents. HPLC grade methanol
(MeOH), acetonitrile (ACN), water, and formic acid (FA)
were purchased from Fisher Scientific (Loughborough, UK).
Leucine enkephalin (YGGFL), bradykinin (RPPGFSPFR),
bombesin (EQRLGNQWAVGHLM), lutenizing hormone
releasing hormone (EHWSYGLRPG), and the tetrapeptide
MRFA were obtained from Sigma Aldrich (Gillingham, UK).
All peptide standards were prepared at a concentration of 10
Figure 1. Schematic diagram of the FAIMS-MS interface.
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pmol/μL in 50/50 (v/v) methanol/water containing 0.1% FA.
2-Hydroxy-(4-octyloxy) benzophenone and polyethylene glycol
(PEG) 400, obtained from Sigma Aldrich (Gillingham, UK),
were prepared in 50/50 (v/v) methanol/water with 0.1% FA at
respective concentrations of 5.1 and 104 pmol/μL (1:20 molar
ratio).
Sample Preparation. Human blood samples were
collected from volunteers in lithium heparin tubes (BD,
Oxford, UK) and centrifuged at 1500g for 15 min at 4 °C.
ACN (400 μL) was added to an aliquot of the collected plasma
(200 μL) before being vortex-mixed for 30 s and sonicated for
10 min to precipitate the proteins. The supernatant was
removed, and proteins were reconstituted in 2 mL of water.
Trypsin Gold Mass Spectrometry grade (100 μg; Promega,
Southampton, UK) was dissolved in 100 mM ammonium
bicarbonate, and 6 μL was added to the plasma extract. The
sample was digested overnight at 37 °C. The reaction was
quenched with 200 μL of 1% trifluoroacetic acid (TFA)
solution (Sigma Aldrich, Gillingham, UK) in water, and the
digested plasma was prepared for LC analysis via solid phase
extraction (SPE) using 3 mL volume Oasis C18 solid phase
microextraction cartidges (Waters, Manchester, UK). The
cartridge was conditioned with 3 mL of 50% ACN in water
and equilibrated with 3 mL of 0.1% TFA in water. Peptides
generated by protein digestion and retained on the SPE
cartridge were washed with 2 mL of 0.1% TFA in water. The
retained peptides were then eluted in 200 μL of 20:80 water/
ACN (v/v) with 0.1% FA. The eluate was dried down under
argon and reconstituted in 90:10 water/ACN (v/v) with 0.1%
FA. Standard solutions of Gramicidin S (cyclo(VOLDFP)2)
were prepared for quantitative analysis in 10:90 water/ACN
(v/v) with 0.1% FA at concentrations in the range of 5−500
ng/μL. Aliquots (20 μL) of these standards were spiked into
200 μL of the plasma tryptic digest to give concentrations of
0.45−45 μg/mL.
Instrumentation. FISCID-MS analysis was carried out in
positive ion electrospray ionization mode using a prototype
miniaturized FAIMS device (Owlstone, Cambridge, UK),
interfaced to an Agilent 6230 orthogonal acceleration time-of-
flight mass spectrometer (Agilent Technologies, Santa Clara,
CA, USA). The electrospray source of the TOF mass
spectrometer was modified to accommodate the presence of
the FAIMS chip within the spray shield (Figure 1). The FAIMS
chip has been described in detail elsewhere21,22 and consists of
47 electrode pairs with a channel width of 35 μm and a channel
length of 300 μm. The FAIMS chip was connected to a field
generator module, containing the electrical circuitry required to
generate field asymmetric waveforms. The frequency of the
applied asymmetric waveform was 25 MHz in a roughly 2:1
ratio of low field to high field. Comparative non-FAIMS data
were acquired with analytes transmitted through the FAIMS
chip with the dispersion field (DF) and CV set to 0 kV/cm and
0 V, respectively. FAIMS separation was carried out at a 47 kV/
cm DF, over a CV range of −1 V to +4 at 0.5 V/s CV sweep
rate. For LC-FISCID-MS analysis, FAIMS-selected analytes
were transmitted into the mass spectrometer interface by
scanning a 0.1 V window around the optimum CV for
transmission. The exact CV values and scan windows were
experiment dependent and as such are indicated in the text
where appropriate. Data were processed using Mass Hunter
version B.01.03 (Agilent Technologies, Santa Clara, CA, USA)
and Excel 2007 (Microsoft, Seattle, USA).
TOF spectral acquisitions were performed at a rate of 10
spectra/s for the analysis of peptide standards and 2 spectra/s
for the analysis of plasma samples. Analytes were infused into
the JetStream-ESI ion source at 50 μL/min and ionized using a
voltage of 1.5 kV. Source conditions for all experiments were
nozzle voltage, spray shield, and counter electrode, 400 V;
skimmer voltage, 65 V; drying gas temperature, 150 °C; sheath
gas temperature, 250 °C; nebulizer gas pressure, 25 psig.
HOBP/PEG analysis was carried out with the inlet capillary
voltage set to −29 V, the drying gas flow set to 4.6 L/min, and
the sheath gas flow set to 7 L/min. Peptide analysis was carried
out with the inlet capillary voltage set to −15 V, the drying gas
flow set to 10 L/min, and the sheath gas flow set to 12 L/min.
The fragmentor voltage was set to 150 V for transmission of
intact analytes without fragmentation and increased to the
region of 350−400 V in order to induce in-source
fragmentation by CID. The fragmentor voltage was compound
dependent and is indicated in the text where appropriate.
LC separation of peptide standards was carried out using an
XBridge C18 5 μm column, with dimensions 2.1 × 50 mm, 5
μm (Waters, Manchester, UK), operated at a flow rate of 0.2
mL/min using an isocratic mobile phase of 30:70 water/ACN
(v/v) with 0.1% FA, with a run time of 3 min and a 2 μL
injection volume. Analysis of the spiked plasma tryptic digest
was carried out using a Poroshell 300SB-C18 column, with
dimensions 2.1 × 7.5 mm, 5 μm (Agilent, Santa Clara, CA,
USA), at a flow rate of 0.4 mL/min with a 20 μL injection
volume. The gradient elution program consisted of a linear
increase from 95:5 water/ACN (v/v) to 60:40 water/ACN (v/
v) in 10 min and then to 10:90 water/ACN (v/v) in 2 min. The
gradient was then returned to the initial conditions giving a
total run time of 15 min.
■ RESULTS AND DISCUSSION
The control of fragmentation of FAIMS-selected ions in the
interface of a TOF mass spectrometer yields product ion
information on the selected precursor ions. The potential of
this FAIMS-in-source CID-MS (FISCID-MS) approach to
enhance the analysis of complex mixtures using a single mass
analyzer has been evaluated for the separation of pharmaceut-
ical excipients and for peptide sequencing and quantification.
Separation of Pharmaceutical Excipients. Ions derived
from the pharmaceutical excipients 2-hydroxy-4-octyloxybenzo-
phenone (HOBP, m/z 327.1955) and PEG 400 were chosen as
test analytes because the protonated HOBP and PEG n = 7
oligomer (m/z 327.2013) are sufficiently close in mass (17.7
ppm mass difference) that these ions could not be resolved by
the reflectron TOF mass analyzer (resolving power required
∼130K). Robust accurate mass measurement of these ions is
therefore not possible without separation prior to mass analysis.
The two components were analyzed as a mixture containing a
20-fold molar excess of the PEG (Figure 2). CV sweeps (−1 to
+4 V) with the DF set to 48 kV/cm were used to determine the
optimum CV required for selected transmission and subsequent
in-source fragmentation. The selected ion response for m/z
327.2 (Figure 2) shows that the protonated PEG n = 7 and
HOBP ions are resolved by FAIMS.
The mass spectrum of the mixture without FAIMS
separation (Figure 3a) shows the typical polymer distribution
of PEG ions, with the HOPB unresolved from the protonated
PEG (n = 7) ion. The measured mass of the overlapping peaks
is m/z 327.1994, a mass difference of 11.9 and −5.8 ppm from
HOBP and PEG, respectively. In-source CID-MS of this
Analytical Chemistry Article
dx.doi.org/10.1021/ac300212r | Anal. Chem. 2012, 84, 4095−41034097
mixture gives a complex product ion spectrum dominated by
PEG fragment ions (Figure 3b). Quasi-static FAIMS filtering
(CV range 0.6−0.7 V) was used to transmit the HOPB ion
selectively, which appears as the base peak in the resulting mass
spectrum (Figure 3c), with an observed mass of 327.1966 (3.3
ppm). The FISCID-MS product ion spectrum of the FAIMS-
selected HOBP ion (Figure 3d) shows the HOBP fragment
ions free of interference from PEG fragment ion peaks,
reducing the complexity of the mass spectrum and allowing
unambiguous identification of the HOBP fragments. These
observations demonstrate the mass spectral enhancement
possible using FISCID-MS, through the FAIMS preselection
of a precursor ion in a complex mixture, on the basis of
differential mobility, prior to in-source CID. FISCID-MS allows
the unresolved ions to be separated and a clean product ion
spectrum to be obtained for HOBP using a single mass analyzer
with only minor modification of the ion source to incorporate
the miniaturized FAIMS device.
Isolation of Peptide Ions for Sequence Analysis. The
FISCID-MS method was applied to the analysis of a mixture of
peptide standards, MRFA, bradykinin, luteinizing hormone
releasing hormone peptide (LHRH), leucine enkephalin, and
bombesin (Figure 4a). The mixture was first infused directly
into the ESI source of the mass spectrometer without FAIMS
separation, producing a mass spectrum containing the [M +
H]+ ions of the four peptides, the [M + 2H]2+ ions of
bradykinin, LHRH, and bombesin, and the [M + 3H]3+ ion of
bradykinin, resulting in a complex mass spectrum (Figure 4a).
FISCID-MS of the peptide mixture using a fragmentor voltage
of 350 V without FAIMS preselection results in a complex
product ion spectrum (Figure 4b) with a predominance of
singly changed ions which do not readily fragment. FAIMS
selection of singly charged peptide ions to generate a pseudo-
peptide mass fingerprint for protein identification has been
Figure 2. FAIMS-MS CV spectrum (m/z 327.2) of HOBP and PEG
400.
Figure 3. MS, FAIMS-MS, and FISCID-MS mass spectra of a mixture of HOBP and PEG 400 (1:20 molar ratio): (a) without FAIMS separation or
in-source CID, (b) in-source CID-MS without FAIMS separation, and (c) FAIMS-selected HOBP ion (CV = 0.6−0.7 V) without in-source CID; (d)
FISCID-MS product ion spectrum of the FAIMS-selected HOBP ion with in-source CID.
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reported previously,13 but higher charge state ions are preferred
for sequence analysis by CID. A FAIMS CV spectrum was
obtained by scanning the CV voltage in the range of 0 to +4 V
with a DF of 48 kV/cm, and the selected ion responses for the
[M + 2H]2+ ions were extracted from the total ion response.
The FAIMS device was then programmed to the appropriate
CV for transmission of each of the [M + 2H] 2+ species. The
isolation of the [M + 2H]2+ bradykinin ion from the other
singly and multiple charged peptide ions by FAIMS at a CV of
+2.6−2.7 V is shown in Figure 4c. Using FAIMS to transmit the
Figure 4. MS, FAIMS-MS, and FISCID-MS analysis of a peptide mixture: mass spectrum (a) without FAIMS selection or in-source CID, (b) in-
source CID-MS (350 V) without FAIMS selection, and (c) FAIMS-selection of the [M + 2H]2+ bradykinin ion (CV = 2.6−2.7 V) with (inset) mass-
selected CV spectra; (d) FISCID-MS product ion spectrum of the [M + 2H]2+ bradykinin ion (CV = 2.6−2.7 V, fragmentor voltage 350 V).
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bradykinin [M + 2H]2+ ion selectively in a FISCID-MS analysis
filtered out unrelated precursor ions producing a product ion
mass spectrum containing the characteristic fragments of
bradykinin (Figure 4d). A comparison of peak lists generated
by the TOFMS software identified 21 characteristic bradykinin
fragment ions using the FISCID-MS method, compared to just
6 without FAIMS separation, enhancing confidence in the
identification of bradykinin, based on sequence coverage.
FISCID-MS was then combined with an LC preseparation to
evaluate the potential of FAIMS to aid the identification of
coeluting peptides. The coeluting bradykinin and LHRH
peptide (RT 0.88 min; Figure 5a) produced a mass spectrum
containing singly and multiply charged peptide ions from both
peptides (Figure 5b). The [M + 2H]2+ ion of LHRH was
isolated from the other peptide ions by applying a CV of 1.7−
1.8 V (Figure 5c). The complex, overlapping LC-in-source
CID-MS spectrum of the coeluting peptides without FAIMS
separation (Figure 5d) is simplified by FAIMS preselection of
the LHRH [M + 2H]2+ ion enhancing the detection of the
characteristic product ions of LHRH (Figure 5e).
The LC-FISCID-MS method was applied to the analysis of a
complex mixture of tryptic peptides derived from human
plasma proteins. The plasma tryptic digest was initially analyzed
by LC-MS without FAIMS separation or in-source fragmenta-
tion (Figure 6a). The complex nature of the sample resulted in
the coelution of several tryptic peptides, even after LC
separation. One such example was m/z 480.7889, observed at
a retention time of 3.5 min. The selected ion chromatograms
obtained in the retention time range of 3.4−3.6 min without
FAIMS-selection shows overlap with other coeluting peptide
ions (Figure 6b). This can be seen on the corresponding mass
spectrum (Figure 6c) averaged across the m/z 480 LC peak at
half height. The mass spectrum, acquired with the FAIMS
programmed to the optimum CV (2.5−2.6 V) for transmission
of the m/z 480 peptide ions, is shown in Figure 6d. By applying
a FAIMS preselection, the coeluting m/z 564, m/z 707, and
other ions are filtered out, with the m/z 480 ion preferentially
transmitted, resulting in a much simpler mass spectrum (Figure
6d). In order to evaluate whether spectral quality could be
enhanced by FAIMS-selected ion transmission prior to in-
source CID, the peptides were subjected to a fragmentor
voltage of 340 V to induce fragmentation of the coeluting
peptides from the LC-MS analysis with and without FAIMS
separation. A complex product ion spectrum is obtained
without FAIMS selection (Figure 6e), compared to the product
ion mass spectrum observed using LC-FISCID-MS with
FAIMS selection at a CV of 2.5−2.6 V (Figure 6f).
The prominent peaks in the LC-FISCID-MS product ion
spectrum (Figure 6f) suggested the data acquired would be
suitable for database searching to identify the unknown plasma
peptides from the observed b and y fragments. Peptide
identification was carried out via the MASCOT search engine,23
Figure 5. LC-MS and LC-FISCID-MS analysis of a peptide mixture: (a) TIC of peptide mixture; mass spectrum of (b) LC peak at ∼0.9 min without
FAIMS selection or in-source CID and (c) FAIMS preselection of LHRH [M + 2H]2+ ion from coeluting peptides (CV = 1.8−1.9 V); (d) in-source
CID-MS (fragmentor voltage 350 V) product ion spectrum without FAIMS preselection; (e) FISCID-MS product ion spectrum (CV = 1.8−1.9 V,
fragmentor voltage 350 V) of FAIMS-selected LHRH [M + 2H]2+ ion from coeluting peptides.
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and all ions with intensities greater than 10% of the base peak
were included in the peak list generated by the TOF-MS
software for the data obtained both with and without FAIMS
filtering. The peak list was searched against the SwissProt
protein database. With no FAIMS separation, the LC-CID-MS
method yielded no significant hits on the database, and
therefore, no protein was identified. However, with the CV set
to 2.5−2.6 V, human serum albumin (HSA) was identified as
the top hit, the only significant match, with a confidence score
of 34 (where 27 or above was deemed statistically significant at
Figure 6. LC-MS and LC-FISCID-MS analysis of human plasma tryptic digest: (a) TIC, (b) selected ion chromatograms at 3.4−3.6 min, (c) LC-MS
spectrum of peaks at 3.52 min without FAIMS separation, (d) LC-FAIMS-MS spectrum with FAIMS selection of the m/z 480 ion (CV of 2.5−2.6
V), (e) LC-in-source CID-MS spectrum without FAIMS selection, and (f) LC-FISCID-MS spectrum with FAIMS selection of the m/z 480 ion and
in-source CID (CV 2.5−2.6 V, fragmentor voltage 340 V).
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a 95% confidence interval), based on the fragmentation of the
doubly charged FQNALLVR tryptic fragment (m/z 480.7854).
Peptide Quantification. The quantitative characteristics of
LC-FISCID-MS were evaluated for the determination of a
peptide spiked into human plasma. The peptide gramicidin S
was chosen as a test compound, as it is not present in plasma
and is therefore unaffected by natural fluctuations in abundance
between plasma samples. A reproducibility study was
performed using aliquots of human plasma tryptic digest
spiked with 9 ng on column mass (0.45 μg/mL) of gramicidin
S to determine the stability of LC-FISCID-MS for replicate
injections of plasma. The % relative standard deviation (%RSD)
for the peak area of the FAIMS-selected (CV +1.75−1.85 V)
[M + 2H]2+ precursor ion (m/z 571) without in-source
fragmentation was 5.1% (n = 6). LC-FISCID-MS peak area
precision for the fragment ions at m/z 311, m/z 424, m/z 685,
and m/z 798, generated by in-source fragmentation of the
FAIMS-selected m/z 571 precursor ion gave %RSDs (n = 6) of
13.3%, 14.6%, 13.1%, and 8.2% respectively, demonstrating
good reproducibility of LC-FISCID-MS for quantitative
measurement at this concentration.
Calibration graphs for the LC-FAIMS-MS analysis of the
gramicidin precursor ion (m/z 571) and the LC-FISCID-MS
analysis of the four product ions (m/z 311, 424, 685, and 798)
were prepared by spiking the plasma tryptic digest with
different concentrations of gramicidin S. A linear response (R2
> 0.99) was observed in the range of 0.45−9.0 μg/mL for the
precursor ion and all four product ions (Figure 7). The
enhanced selectivity, reproducibility, and linear response to the
spiked peptide in the plasma extract suggest that LC-FISCID-
MS has the potential to offer significant benefits compared to
the use of a single mass analyzer. This approach may also be an
alternative to LC-MS/MS with SRM for quantitative analysis,
while still being able to perform qualitative structural
characterization and elemental formula analyses in the same
experiment. This potential paradigm shift mirrors current
trends within the pharmaceutical industry, where time-efficient
use of one high-resolution mass analyzer for quantitative
bioanalysis and qualitative metabolite characterization is
receiving much attention.24,25
■ CONCLUSIONS
FAIMS preselection of precursor ions using a miniaturized high
field FAIMS device followed by in-source CID-MS requires
only minor modification of the ion source region of the mass
spectrometer but provides enhanced selectivity for the
qualitative and quantitative analysis of analytes in complex
mixtures. Thus, FISCID-MS successfully separated pharma-
ceutical excipient ions that are too close in m/z value to be
resolved by TOF-MS alone, providing improved accurate mass
measurement and a product ion spectrum free from
interferences. Transmission of FAIMS-selected peptide ions
from a mixture on the basis of differential mobility facilitated
peptide identification by enhancing the characteristic fragment
ions of the selected precursor ion in the FAIMS-selected
product ion spectrum. The LC-FISCID-MS analysis of these
model peptides and a human plasma tryptic digest reduced the
mass spectral complexity of coeluting peptides. The product
ion spectra obtained via LC-FISCID-MS enabled the
identification of plasma proteins with high confidence that
could not otherwise be identified without FAIMS selection of
the precursor ion, because of the presence of unrelated
fragment ions in the mass spectrum. The quantitative potential
of LC-FISCID-MS has also been demonstrated for the
determination of a FAIMS-selected peptide in a spiked plasma
tryptic digest sample. FISCID-MS therefore offers significant
improvements in selectivity for analyses conducted using a mass
spectrometer with a single mass analyzer, such as a TOF or
quadrupole analyzer, and has potential as an alternative to LC-
MS/MS for qualitative and quantitative analysis or for further
enhancing selectivity using LC-FISCID-MS/MS routines.
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The  incorporation  of  a chip-based  high  field  asymmetric  waveform  ion  mobility  spectrometry  (FAIMS)
separation  in the  ultra  (high)-performance  liquid  chromatography–high  resolution  mass  spectrome-
try  (UHPLC–HRMS)  determination  of  the  (R/S)  ibuprofen  1--O-acyl  glucuronide  metabolite  in  urine
is  reported.  UHPLC–FAIMS–HRMS  reduced  matrix  chemical  noise,  improved  the  limit of  quantitation
approximately  two-fold  and  increased  the  linear  dynamic  range  compared  to the  determination  of theeywords:
HPLC
AIMS
ass spectrometry
etabolite
metabolite  without  FAIMS  separation.  A quantitative  evaluation  of  the  prototype  UHPLC–FAIMS–HRMS
system  showed  better  reproducibility  for the  drug  metabolite  (%RSD  2.7%)  at biologically  relevant  concen-
trations in  urine.  In-source  collision  induced  dissociation  of the FAIMS-selected  deprotonated  metabolite
was  used  to fragment  the  ion prior  to  mass  analysis,  enhancing  selectivity  by removing  co-eluting  species
and aiding  the  qualitative  identification  of the  metabolite  by increasing  the  signal-to-noise  ratio  of  the
fragment  ions.rine
. Introduction
The performance of a liquid chromatographic separation is
etermined both by the on-column separation and by the
electivity of the detector. UHPLC has significantly reduced chro-
atographic run times, but the use of selective detection, such as
ass spectrometry, is required if the highest throughput is to be
chieved. Tandem mass spectrometry using a triple quadrupole
ass spectrometer capable of mass-selecting precursor ions for
elected reaction monitoring is widely used in the quantitative
hromatographic determination of drugs and metabolites. How-
ver, recent years have seen the emergence of high resolution mass
pectrometry (HRMS), using TOF or Orbitrap mass analysers, as an
lternative to triple quadrupole instruments [1,2]. The advantage
f coupling UHPLC with HRMS is that HRMS provides both robust
uantification and qualitative analysis using a single mass spec-
rometer platform. However, HRMS may  lack the selectivity and
ensitivity of selected reaction monitoring.
∗ Corresponding author. Tel.: +44 01509 222552; fax: +44 01509223925.
E-mail address: C.S.Creaser@lboro.ac.uk (C.S. Creaser).
021-9673/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.chroma.2012.12.065© 2013 Elsevier B.V. All rights reserved.
One approach to enhancing the selectivity of LC–MS analyses
is the incorporation of a rapid gas-phase separation by ion mobil-
ity (IM) spectrometry between the LC and the mass spectrometer.
Two  ion mobility approaches are currently utilised: drift tube-
ion mobility spectrometry, which separates ions based on time
taken to traverse a drift tube [3],  and field asymmetric wave-
form ion mobility spectrometry (FAIMS), also known as differential
mobility spectrometry [4].  Drift-tube IM has been interfaced with
ultra (high)-performance liquid chromatography-mass spectrom-
etry (UHPLC–IM–MS) to enhance the quantitative determination
of drugs and metabolites in urine by removing co-eluting inter-
ferences [5,6]. However, incorporation of a drift-tube ion mobility
separation significantly reduces the linear dynamic range (LDR)
compared to LC–MS alone [7–10].
FAIMS separation is orthogonal to MS  and acts as an on-line filter
for ions entering the MS.  Ions are pre-selected by FAIMS based upon
their differential ion mobility – the difference in mobility under
low and high electric fields. In FAIMS, a dispersion field (DF) with
an asymmetric waveform alternating between low and high fields
is applied across the gap between two parallel electrodes, caus-
ing ions to oscillate between the electrodes. If high and low field
mobilities are different, ions drift towards one of the electrodes as
R.W. Smith et al. / J. Chromatog
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uronate (II); dehydrated glucuronate (III); glucuronate (IV); and aglycone (V).
hey are carried through the electrode gap by a flow of nitrogen
uffer gas at atmospheric pressure. The drift will result in a neu-
ralising collision with one of the electrodes unless compensated
or by a compensation field (CF). The CF for transmission of an ion
s a characteristic of ion structure and is scanned at a fixed DF to
etermine the optimum CF at which the ion is preferentially trans-
itted, whilst other interfering ions are neutralised and filtered
ut [4,11].  FAIMS devices have been interfaced with MS  to improve
nalytical selectivity by providing a differential mobility separation
rior to MS  detection of small molecules, metabolites and peptides
12–14].
Fragmentation of ions using a single mass analyser can be
chieved by increasing voltages in the interface region between
he ESI source and the vacuum of the mass spectrometer, called
n-source CID, which will fragment all co-eluting ions gener-
ted in the ESI source [15]. The production of fragments from
ultiple precursors, without ion pre-selection, complicates frag-
entation spectra making identification difficult. The effect of
n-source CID on the analysis of glucuronide metabolites in bio-
ogical matrices has been explored [16]. A comparison between
n-source CID and collision cell CID using a triple quadrupole
ass spectrometer for characterising microcystins in water sam-
les showed that even though in-source CID proved to be
ore sensitive, CID in a collision cell was found to be more
elective for identification. Fragmentation patterns were found
o be similar for the two techniques [17]. Combining FAIMS
ith in-source CID, referred to FISCID–MS, has been used for
he identification of an active pharmaceutical ingredient in
 common pharmaceutical excipient and the qualitative and
uantitative analysis of peptides in plasma by LC–FISCID–MS
12].
In this paper, we report enhanced chromatographic per-
ormance in the UHPLC–MS analysis of the drug metabolite
R/S) ibuprofen 1--O-acyl glucuronide, IAG (Fig. 1, I), in
rine, without sample clean-up, by the incorporation of
 FAIMS separation using a prototype chip-based FAIMS
evice. FAIMS pre-selection of the metabolite is shown to
mprove the limit of quantification, linear dynamic range
nd reproducibility, and allow a shorter chromatographic run
ime compared to UHPLC–MS by reducing chemical/matrixr. A 1278 (2013) 76– 81 77
interference. The FAIMS device was also used to pre-select IAG for
UHPLC–FISCID–MS, enhancing the qualitative identification of the
metabolite.
2. Experimental
2.1. Chemicals
HPLC grade methanol (MeOH), acetonitrile (ACN), water,
formic acid (FA) and ammonium acetate were purchased from
Fisher Scientific (Loughborough, UK). (R/S) Ibuprofen 1--O-acyl
glucuronide was supplied by AstraZeneca (Alderley Park, UK).
Ibuprofen was extracted into methanol from an ibuprofen tablet
(200 mg).
2.2. Sample preparation
Aliquots of urine (5 ml)  from healthy adult males
(2×) and females (2×)  (AstraZeneca, UK) was pooled
(20 ml)  and filtered (0.45 m),  diluted (2×)  with a solu-
tion of the IAG metabolite (0.055–44 g/ml in 50:50
acetonitrile:aqueous ammonium acetate (10 mM)  at pH
3), corresponding to urine concentrations in the range
0.028–22 g/ml.
2.3. Instrumentation
UHPLC–FAIMS–MS and UHPLC–FISCID–MS analyses of IAG were
carried out using an Agilent 1200 series HPLC interfaced with
an Agilent 6230 time-of-flight mass spectrometer fitted with a
JetStream ESI source operated in negative ion mode (Agilent Tech-
nologies, Santa Clara, CA, USA). The prototype chip-based FAIMS
device (Owlstone, Cambridge, UK) has been previously described
elsewhere [12] and was  located in front of the transfer inlet capil-
lary, behind a modified spray shield within a Jet Stream ESI source.
The dispersion field (DF) feeder supplied asymmetric waveforms
to the FAIMS device through a hole in the desolvation assem-
bly. The FAIMS device has a 100 m electrode gap and a depth
of 700 m with the FAIMS electrodes arranged as multiple par-
allel channels, linked by a serpentine channel – trench length
(50–100 mm).  Dispersion fields in the range 200–300 Td were
applied at a 27 MHz  frequency with an approximate low to high
field ratio of 2:1. Nitrogen (99.5% purity) was  used as the carrier gas
for the FAIMS system and for the ESI source and mass spectrometer
interface.
Samples were introduced into the ESI source either by
direct infusion or from the liquid chromatograph. UHPLC sep-
aration was  carried out, with a 5 l sample injection volume
on a Zorbax C18 column (2.1 mm × 50 mm,  1.8 m) with an
isocratic 0.2 ml/min flow of 50:50 acetonitrile:aqueous ammo-
nium acetate (10 mM)  at pH 3. The scan rate of the TOF
MS was  10 scans/s for scanning FAIMS–MS experiments and
1 scan/s for UHPLC–FAIMS–MS and UHPLC–FISCID–MS experi-
ments. Data were acquired with the instrument mode set to
extended dynamic range (2 GHz) at a resolution of 5700. Source
conditions for LC experiments were nozzle voltage, 2000 V;
sheath gas temperature and flow, 350 ◦C and 11 L/min; dry-
ing gas temperature and flow, 150 ◦C and 10 L/min; nebuliser
pressure, 25 psig; transfer capillary, 4000 V; skimmer voltage,
65 V; fragmentor voltage, −150 V and −250 V for transmission
and in-source CID respectively. Data were processed using Mass
Hunter Qualitative Software B.04.00 (Agilent Technologies, Santa
Clara, CA, USA) and Microsoft Excel 2010 (Microsoft, Seattle,
USA).
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. Results and discussion
.1. Direct infusion FAIMS analysis of IAG and ibuprofen
Direct infusion of ibuprofen and the IAG metabolite (0.65 g/ml)
as used to optimise the microscale FAIMS conditions for separa-ion and sensitivity. FAIMS compensation field (CF) spectra of the
M−H]− ions of the analytes obtained at a dispersion field (DF)
f 200, 230 and 260 Td are shown in Fig. 2. The IAG response is
ig. 3. Selected ion chromatograms (m/z 381) for IAG (highlighted) spiked into urine (
81  ± 0.02 and (b) m/z 381 ± 0.008; and by UHPLC–FAIMS–MS (FAIMS on) with selective tr
nd  (d) m/z 381 ± 0.008.r. A 1278 (2013) 76– 81
separated from that of the parent drug ibuprofen as a result of
structural differences between the two  ions. The separation of IAG
and the parent drug improves with increased DF. A decrease in the
absolute intensity of IAG was observed when the DF was increased
from 200 to 260 Td, but with a significant increase in the response
relative to ibuprofen, which falls sharply with increasing DF. The
optimum CF for transmission of IAG was at 2.2 Td with a DF of
260 Td, based on the best separation without significant loss of sig-
nal intensity for IAG, and these conditions were used in the high
resolution UHPLC–FAIMS–MS analyses.
3.2. Determination of IAG by UHPLC–FAIMS–TOF-MS
The UHPLC–MS (FAIMS off) and UHPLC–FAIMS–MS (FAIMS on)
selected ion chromatograms ([M−H]−; m/z 381) obtained for the
analysis of IAG spiked into urine with a high resolution mass win-
dow of m/z 381 ± 0.02 (±50 ppm) is shown in Fig. 3a. The UHPLC
gradient was adjusted to minimise the run time for the IAG, but this
resulted in a significant overlap between the IAG peak and urine
matrix components. The observed co-elution of IAG with matrixto separate the metabolite from the urine matrix, but at the cost of a
significantly increased chromatographic run time. A narrower mass
window, m/z 381 ± 0.008 (±20 ppm) was  therefore investigated to
0.55 g/ml) analysed by UHPLC–MS (FAIMS off) using a mass window of (a) m/z
ansmission of IAG (DF 260 Td, CF 2.2 Td) using a mass window of (c) m/z 381 ± 0.02
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etermine whether this would improve selectivity without extend-
ng the chromatographic run time. The absolute intensity of the IAG
eak, with the FAIMS switched off, is reduced by a factor of two  if
he mass window is narrowed from ±50 ppm to ±20 ppm (Fig. 3b),
ut there is no additional discrimination against the chemical noise
rom the urine matrix at the mass resolution used in the analysis
5700 FWHM).
The advantage of the incorporation of the FAIMS separation is
emonstrated by a significant reduction in the co-eluting chemi-
al noise from the urine matrix (Fig. 3c and d), whilst maintaining
 rapid elution time. Ionisation suppression in the ESI source was
ot determined, but was the same in both FAIMS on and FAIMS
ff modes, allowing an evaluation of the improvement in the
hromatographic performance offered by FAIMS. The removal of
hemical noise resulted in an improvement in signal-to-noise ratio
nd better peak integration with FAIMS on, even though the abso-
ute intensity of the IAG peak was reduced because of ion losses
n the device. FAIMS pre-selection of IAG removes matrix ions to
aseline for both the m/z  381 ±0.02 and ±0.008 mass windows,
ut at a cost of lower sensitivity and signal-to-noise ratio for the
arrower window. The ±0.02 mass window was  therefore used in
ubsequent studies.
The mass spectrum taken from the IAG UHPLC peak with FAIMS
ff (Fig. 4a) showed IAG (m/z 381.1570; −3.9 ppm) to be a minor
eak in a complex mass spectrum. The mass spectrum for IAG with
AIMS on (Fig. 4b) was simplified, with IAG as the base peak in the
ass spectrum (m/z 381.1553; 0.52 ppm), as a result of discrimina-
ion against interferences from urine matrix.
Table 1 compares the quantitative performance of the
HPLC–MS and UHPLC–FAIMS–MS methods for the determination
f IAG. The limit of quantitation (LOQ; signal-to-noise 10:1) for
AG was reduced from 18 ng/ml (FAIMS off) to 10 ng/ml (FAIMS
n), based on the selected ion peak areas of IAG (m/z 381 ± 0.02)
sing UHPLC–FAIMS–MS. The upper limit of the linear dynamic
able 1
 comparison of LOQ; LDR (R2) and intra-day reproducibility for the determination
f IAG spiked into urine (15.5 g/ml, n = 5).
UHPLC–MS UHPLC–FAMS–MS
LOQ(g/ml) 0.018 0.010
LDR(g/ml) 0.018–11 0.010–11
R2 0.9991 0.9987
Intra-day (%RSD) 5.0 2.702 min  with (a) FAIMS off, and (b) FAIMS on.
range (LDR) was  the same in both FAIMS off and on modes,
giving an increased LDR of >3 orders of magnitude for the minia-
turised FAIMS–MS, in contrast to ∼2 orders of magnitude with
cylindrical FAIMS–MS [18,19] and <2.5 orders of magnitude for
drift tube IM–MS  [5,6]. The intra-day reproducibility of the proto-
type UHPLC–FAIMS–MS system was compared with UHPLC–MS by
analysing IAG spiked into urine (15.5 g/ml) and running FAIMS
in on and off modes respectively (Table 1). %RSDs, sufficient for
good quantification, were obtained for both UHPLC–MS (5.0%)
and UHPLC–FAIMS–MS (2.7%), with the UHPLC–FAIMS–MS show-
ing better reproducibility. These data demonstrate that the FAIMS
device enhances quantitative performance compared to high reso-
lution UHPLC and MS  analysis.
3.3. Qualitative identification of IAG by UHPLC–FISCID–MS
The in-source CID fragmentation of IAG ion was used to assess
the improvement offered by the UHPLC–FISCID–MS technique for
the qualitative identification of IAG. The FAIMS-selected [M−H]−
ion of IAG was subjected to in-source CID to produce the charac-
teristic fragments of the ion (Fig. 1). A comparison of the selected
ion chromatograms of the aglycone fragment (m/z 205.1234) for a
urine sample spiked with IAG (3.9 g/ml), with and without FAIMS
pre-selection prior to in-source CID, was used to define the level of
isobaric chemical interference present in the sample spiked with
IAG (Fig. 5a and b). Peak integration of the UHPLC–FISCID–MS data
was  more reliable than UHPLC–MS data because chemical interfer-
ence was  reduced almost to baseline.
Mass spectra extracted from the aglycone peaks (Fig. 6) shows
the effect of applying the FAIMS separation to the UHPLC–CID–MS
analysis of IAG. Four diagnostic fragment ions for IAG are observed
in the production mass spectrum (Fig. 1) [20]: decarboxylated di-
dehydrated glucuronate (II, m/z 113); dehydrated glucuronate (III,
m/z 175); glucuronate (IV, m/z 193); and the aglycone (V, m/z 205).
In Fig. 6a, these fragments are difficult to locate due to the com-
plexity of the mass spectrum and poor signal to noise as a result of
other ions in the matrix. Pre-selecting IAG using FAIMS before in-
source CID reduced the intensity of interfering ions, increasing the
relative intensity of the IAG (Fig. 6b). The signal-to-noise ratios for
the fragment ions increased by approximately 2-fold with FAIMS
on (Table 2), enhancing the response of the IAG fragments relative
to other interfering peaks to aid identification.
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Fig. 5. Selected ion chromatograms (m/z 205 ± 0.02) of the [Aglycone−H]− for the urine blank (grey) and IAG (black) spiked into urine (3.9 g/ml) by (a) UHPLC–CID–MS and
(b)  UHPLC–FISCID–MS.
Fig. 6. Mass spectra at RT 0.97–1.02 min  with (a) U
Table 2
A comparison of signal-to-noise ratios for in-source CID generated IAG fragment
ions from the analysis of a spiked urine sample with FAIMS off and FAIMS on.
Fragments S:N ratio(FAIMS off) S:N ratio(FAIMS on)II 14.9 33.0
III 17.5 34.0
IV  13.9 31.6
V 8.6 16.4HPLC–CID–MS, and (b) UHPLC–FISCID–MS.
4. Conclusions
The incorporation of the chip-based FAIMS in the ESI source of
the UHPLC-TOF spectrometer is a novel approach for improving the
qualitative and quantitative performance of the chromatographic
analysis of IAG by reducing co-eluting chemical interference
from the urine matrix. UHPLC–FAIMS–HRMS showed a lower
LOQ, increased LDR and better reproducibility, compared to
UHPLC–HRMS without a FAIMS separation. The FAIMS device
was  able to distinguish IAG from ibuprofen, preventing interfer-
ence from the drug when observing the aglycone fragment. The
UHPLC–FISCID–MS technique removed interference from urine in
matog
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This journal is ª The Royal Society ofDirect analysis of potentially genotoxic impurities by
thermal desorption-field asymmetric waveform ion
mobility spectrometry-mass spectrometry
Robert W. Smith, James C. Reynolds, Sze-Ling Lee and Colin S. Creaser*Fig. 1 The structures of (a) 2,4,6-trimethylaniline, and (b) N,N-dimethyl-m-
toluidine.Thermal desorption has been combined with field asymmetric
waveform ion mobility spectrometry and mass spectrometry for the
rapid, direct analysis of isobaric potentially genotoxic impurities
(PGIs) in a surrogate active pharmaceutical ingredient. FAIMS-
selected PGIs were detected with limits of quantification <0.2 ppm,
below the threshold of toxicological concern, with %RSD <8.4%, at
the 1 ppm level.1 Introduction
Potentially genotoxic impurities (PGIs) have characteristic
structures that may exhibit carcinogenicity.1,2 PGIs need to be
monitored during the production of active pharmaceutical
ingredients (APIs) to ensure that their concentrations remain
below the threshold value of toxicological concern (TTC)
required by the European Medicines Agency;3,4 which is typi-
cally 1.5 mg per day, equivalent to 1.5 ppm assuming a 1 g
per day dose. Gas chromatography-mass spectrometry (GC-MS)
and high performance liquid chromatography-mass spec-
trometry (LC-MS) are widely used techniques for monitoring
the levels of PGI compounds in APIs. However, these
conventional pharmaceutical analysis methods require
lengthy sample preparation and chromatographic separation.
Consequently, there is a need for new analytical strategies to
meet the fast-paced pharmaceutical research and discovery
environment.5,6
Thermal desorption is an extraction technique, where an
analyte is transferred into the gas phase from a solid or liquid.
The technique requires minimal sample preparation and is
oen interfaced with gas chromatography-mass spectrometry.7
Desorbed PGIs have been ionised via extractive electrospray in
an electrospray ionisation source (ESI) and detected by mass
spectrometry.8,9 Thermal desorption has also been interfaced
with dri tube ion mobility-mass spectrometry (IM-MS) for theof Chemistry, Loughborough University,
.Creaser@lboro.ac.uk; Fax: +44 (0)1509
Chemistry 2013analysis of breath samples collected on solid adsorbents, with
the ion mobility separation adding selectivity to the analyses.10
Field asymmetric waveform ion mobility spectrometry
separates gas phase ions using a waveform with alternating low
and high electric elds known as the dispersion eld (DF). A
compensation eld (CF), is superimposed on the DF andmay be
scanned or xed to transmit selected analytes based on their
differential ion mobility under low and high electric elds
conditions. FAIMS separation using a miniaturised, chip-based
device is fast as a result of the short ion residence times (50–
250 ms) and has been shown to enhance the selectivity of mass
spectrometry analyses.11,12 FAIMS separation is orthogonal to
mass spectrometry and can distinguish between isobaric ions,
making hyphenation of these techniques highly desirable.11,13
We report a rapid method for the determination of the
isobaric PGIs, 2,4,6-trimethylaniline and N,N-dimethyl-m-tolui-
dine (Fig. 1) by thermal desorption from a surrogate API with a
FAIMS separation prior to detection using mass spectrometry.
Good precision was observed at the 1 ppm level for the FAIMS
pre-selected PGIs, with a limit of quantication established well
below the required TTC.2 Materials and methods
2.1 Chemicals
2,4,6-Trimethylaniline (2,4,6-TMA), N,N-dimethyl-m-toluidine
(N,N-DMT), starch, and HPLC grade acetonitrile, methanol,
water and formic acid were obtained from Sigma Aldrich (Gil-
lingham, UK).Anal. Methods, 2013, 5, 3799–3802 | 3799
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View Article Online2.2 Sample preparation
Standard solutions of 2,4,6-TMA (50 ng mL1) and N,N-DMT
(50 ng mL1) were prepared in methanol–water (50 : 50) with
0.1% formic acid for infusion studies and in acetonitrile for
thermal desorption studies. The PGI mixture (4 mL, 2.5 mg mL1)
was added to a surrogate API, starch (10 mg) which was
immediately inserted into a thermal desorption tube between
two pieces of Siltek Deactivated Wool (Borosilicate, Markes
Int.), as shown in Fig. 2. The concentration of each of the PGIs
in the starch was 1 ppm (w/w).Fig. 3 FAIMS CF scan of 2,4,6-TMA (dashed) and N,N-DMT (solid) with DF set to
230 Td.2.3 Instrumentation
TD-ESI-FAIMS-MS analyses were carried out using a Markes
UNITY1 thermal desorption unit (Markes International, Swan-
sea, UK) combined with an Agilent 6230 TOFMS (Agilent tech-
nologies, U.K.) tted with a prototype chip-based FAIMS device
(Fig. 2). 2,4,6-TMA and N,N-DMT were desorbed from the
surrogate API (starch) at 230 C for 2 min onto a cold trap
(Tenax, 10 C) and then rapidly desorbed from the trap
(250 C, >40 C s1, 2 min). The thermal desorption cycle time
was 10 minutes. The heated transfer line from the thermal
desorber, containing a fused silica capillary (0.25 mm i.d.) was
maintained at 200 C and introduced into the JetStream ESI
of the TOFMS by removing the glass from a viewing window in
the source housing. The tip of the fused silica capillary was
positioned in the source at an angle of approximately 55 to
the nebuliser, but set back 10 mm to give the maximum
response. Extractive electrospray and direct infusion electro-
spray were carried out in positive ion mode using a 10 mL min1
infusion of methanol–water (50 : 50) with 0.1% formic acid.
The ESI spray nebuliser pressure was set to 30 psig with an
8 L min1 sheath gas ow at 250 C. The nozzle voltage was set
to 2000 V; the transfer capillary, spray shield and counter
electrode were set to 3000 V and the drying gas ow to 6 Lmin1
at 150 C.Fig. 2 A schematic diagram of the thermal desorber interfaced to the ESI-FAIMS-M
3800 | Anal. Methods, 2013, 5, 3799–3802The miniaturised chip-based FAIMS (Owlstone Ltd., Cam-
bridge), consisting of multiple parallel electrode gaps (100 mm)
with a short path length (700 mm),13–15 was located behind the
spray shield of the TOFMS inlet. Scanning FAIMS-MS experi-
ments were carried out by direct infusion of 2,4,6-TMA and N,N-
DMT individually to evaluate the potential for separation of
these isobaric compounds. The DF was stepped (10 Td) from
200 to 300 Td and the CF was scanned from 2 to +5 Td to
determine optimum separation conditions. The mass spec-
trometer fragmentor voltage was set to 175 V for FAIMS-selected
transmission experiments. The MS scan rates were 10 scans per
s and 1 scan per s in the mass range m/z 70–1000 for direct
infusion and thermal desorption experiments respectively.3 Results and discussion
The thermal desorption of volatile compounds from a less
volatile solid sample, such as an API, has the potential to speedS ion source.
This journal is ª The Royal Society of Chemistry 2013
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View Article Onlineup analysis by removing time consuming sample preparation
and chromatographic separation steps. Furthermore, there is
an even greater potential advantage in that such approaches are
matrix independent and can be applied to the analysis of a wide
range of APIs without the need to develop individual specic
methods for each PGI/API combination. Increasing sample
throughput is important for efficient quality control, but
selectivity may be compromised to reduce analysis times,
particularly for isobaric analytes that cannot be distinguished
by mass spectrometry. Miniaturised, chip-based eld asym-
metric waveform ion mobility spectrometry incorporated into
the ion source of a time-of-ight mass spectrometer (FAIMS-
MS), was therefore investigated for the separation of the
isobaric PGIs 2,4,6-trimethylaniline (2,4,6-TMA) and N,N-
dimethyl-m-toluidine (N,N-DMT) (Fig. 1).16,173.1 Direct infusion FAIMS-MS studies
The two substituted anilines, 2,4,6-TMA and N,N-DMT, were
introduced by direct infusion into the ESI-FAIMS-MS to explore
the potential for a rapid separation step which would be
compatible with the thermal desorption of these analytes. A DF
stepping experiment, with the CF scanned at each DF, was used
to determine the optimum DF for maximum separation without
compromising sensitivity.12 The CF spectrum obtained at the
optimum DF, which was determined to be 230 Td, is shown in
Fig. 3. The spectrum contains two peaks corresponding to 2,4,6-
TMA and N,N-DMT centered at a CF at 1.0 and 1.5 TdFig. 4 TD-ESI-FAIMS-MS selected ion profiles (m/z 136.1) of (a) 2,4,6-trimethylanili
Td), desorbed directly from starch at 1 ppm (w/w). Inset are the corresponding ma
This journal is ª The Royal Society of Chemistry 2013respectively. There is also a small peak at CF 2 Td in Fig. 3,
which is assigned to the protonated dimer of 2,4,6-TMA. The
N,N-DMT peak lies between the 2,4,6-TMA monomer and dimer
peaks where there is no signicant interference from either.
2,4,6-TMA and N,N-DMT were sufficiently resolved at a DF of
230 Td to enable the selective transmission of each without
signicant interference from the other.3.2 TD-FAIMS-MS analysis of 2,4,6-TMA and N,N-DMT
2,4,6-TMA and N,N-DMT are sufficiently volatile to be thermally
desorbed from a surrogate API (starch) and transferred to the
ESI source via a heated transfer line. The desorbed molecules
were ionised using extractive electrospray (EESI) and detected
using FAIMS-time-of-ight mass spectrometry (TOF MS). The
FAIMS CF was set to transmit either 2,4,6-TMA (CF 1.0 Td) or
N,N-DMT (CF 1.5 Td) selectively at a DF of 230 Td following
ionization. Fig. 4 shows typical thermal desorption proles (m/z
136) for the FAIMS pre-selected 2,4,6-TMA and N,N-DMT, spiked
as a mixture into a surrogate API (starch) at 1 ppm (w/w). A good
peak shape for the thermal desorption prole of each PGI was
achieved by using a single sorbent (Tenax) in the desorber cold
trap. The time axis corresponds to the mass spectrometry
acquisition time, which was started 1 minute before the heating
of the cold trap. Fig. 4a and b inserts show mass spectra cor-
responding to the maximum point of the thermal desorption
proles of FAIMS-selected 2,4,6-TMA and N,N-DMT respectively,
showing the protonated ions at m/z 136. The use of a FAIMSne (CF ¼ 1 Td, DF 230 Td); and (b) N,N-dimethyl-m-toluidine (CF ¼ 1.5 Td, DF 230
ss spectra at the desorption peak maxima.
Anal. Methods, 2013, 5, 3799–3802 | 3801
Table 1 Quantitative determination of 2,4,6-TMA and N,N-DMT by TD-
FAIMS-MS
Compound LOQ/ppm RSD/%
2,4,6-Trimethylaniline 0.19 8.4
N,N-Dimethyl-m-toluidine 0.13 7.5
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View Article Onlineseparation at the appropriate DF and CF determined from the
direct infusion studies, adds selectivity to the analysis by
discriminating between N,N-DMT and 2,4,6-TMA.
The quantication limits and precision were evaluated to
test performance of the prototype TD-FAIMS-MS analysis
(Table 1). The limit of quantication (LOQ) was determined to
be 0.19 ppm and 0.13 ppm for the FAIMS pre-selected 2,4,6-TMA
and N,N-DMT respectively (10 : 1 signal : noise), spiked as a
mixture into 10 mg of the surrogate API. These LOQs are
approximately an order of magnitude below 1.5 ppm, the TTC
limit assuming a 1 g per day dose (EuropeanMedicines Agency).
However, detection of PGIs at ‘as low as reasonably possible’
(the so-called ALARP concept) levels1,2 is encouraged, but not
essential, for unusually toxic impurities where detection below
the TTC may be required. This requirement is easily met using
TD-FAIMS-MS, as well as reducing sample preparation and
analysis times.
4 Conclusion
Chip-based FAIMS combined with TOF MS has been used for
the rapid determination of the isobaric PGIs 2,4,6-TMA and
N,N-DMT, without the need for a chromatographic separation.
The ability to lter ions based on differential mobility, an
orthogonal technique to mass spectrometry, provides an added
dimension of separation to the TD-MS analysis. Direct thermal
desorption of 2,4,6-TMA and N,N-DMT from a solid matrix was
demonstrated at 1 ppm, below the TTC, with good precision
(<8.4%). The combination of good reproducibility and limits of
quantication almost an order of magnitude below the TTC,
shows that TD-FAIMS-MS has the potential as a rapid, quanti-
tative screening method for monitoring volatile PGIs in active
pharmaceutical ingredients. Other API matrices would need to
be investigated to demonstrate the ubiquity of this technique.
The approach may also be used for the analysis of volatile
organic compounds in other solid matrices.
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